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ABSTRACT 
 The gastrointestinal microbiota is intimately tied to a person’s health and well-being.  
This collection of bacteria, archaea, and fungi is assembled during a person’s infancy and 
achieves the stability of an “adult-like” microbiota in early childhood.  Research has begun to 
uncover several host and external factors that influence the rate and course of assemblage.  
Historically, the immune system was considered the primary driver of microbial balance in the 
gastrointestinal tract.  While the immune system is certainly a key component, research has now 
identified the importance of, among others, an infant’s route of delivery, gestational age, early-
life diet, and exposure to antibiotics.  This dissertation has evaluated the modulation of the gut 
microbiota following exposure to fermentable carbohydrates and explored the pathogenesis of 
two important infantile pathogens. 
 At birth, an infant’s gastrointestinal microbiota is largely devoid of bifidobacteria, and 
within the first week, this bacterial genus dominates the community.  It is well-known that 
breastmilk contains oligosaccharides that promote the growth of bifidobacteria.  However, 
formula-fed infants lack access to these carbohydrates and have a delayed establishment of 
bifidobacteria.  Therefore, infant formula companies began supplementing bovine and soy-based 
infant formulas with prebiotics.  Prebiotics, non-digestible carbohydrates that promote bacterial 
growth, stimulate the growth of bifidobacteria and lactobacilli in infants.  Microbial analysis of 
infants fed prebiotics is restricted to measuring alterations in the fecal microbiota.  Typically, 
prebiotics are fermented in the ascending colon, and the fecal microbiota may not be an 
appropriate representative of the colonic microbiota.  In Chapter 2, the impact of 
galactooligosaccharides and polydextrose on the ileal and ascending colon microbiota of 
neonatal piglets was evaluated.  More specifically, hundreds of lactobacilli were isolated and 
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sequenced to characterize the lactobacilli community composition.  Additionally, these 
lactobacilli isolates were evaluated for their ability to ferment galactooligosaccharides and 
polydextrose.  It was hypothesized that exposure to galactooligosaccharides and polydextrose 
would promote a lactobacilli community more capable of fermenting these prebiotics in vitro.  
While a significant increase of lactobacilli in the ascending colon of prebiotic-exposed piglets 
was observed, the lactobacilli community was not more capable of fermenting 
galactooligosaccharides and polydextrose than lactobacilli isolated from piglets never exposed to 
these prebiotics.  Therefore, it was concluded that the observed increase was not due to a direct 
ability to ferment the provided prebiotics, but rather due to factors not directly measured. 
 An additional concern with prebiotic supplementation in infant formula is the promotion 
of pathogenic microorganisms.  In preterm infants, the gastrointestinal tract lacks the maturity of 
term infants.  A severe consequence of an immature gastrointestinal tract is an increased risk of 
local and disseminated infections.  A common secondary complication is consumption of infant 
formula, lacking human milk oligosaccharides, rather than breastmilk.  As observed in Chapter 
2, the exposure to prebiotics did not directly stimulate lactobacilli in vivo.  A potential 
mechanism is a cooperative breakdown of prebiotics in the gastrointestinal tract by other 
microbes.  Several commensal microbes are strongly glycolytic and liberate mono- and 
disaccharides from fermentable fibers and the gastrointestinal mucin layer.  These liberated 
carbohydrates are available for any microorganisms capable of utilization.  Therefore, the 
presence of prebiotics in the gastrointestinal tract may lead to an increase in pathogenic 
microorganisms.  The study presented in Chapter 3 explored the ability of several 
Enterobacteriaceae, a bacterial family that includes common neonatal pathogens, to ferment a 
variety of prebiotics and human milk oligosaccharides.  The ability to utilize prebiotics for 
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growth was strain-dependent.  Galactooligosaccharides supported the growth of many 
Enterobacteriaceae, whereas fructooligosaccharides were less fermentable.  Fortunately, 
Enterobacteriaceae were incapable of fermenting the intact human milk oligosaccharides tested.  
Conversely, several Enterobacteriaceae were capable of fermenting the mono- and disaccharides 
that comprise the human milk oligosaccharides.  Taken together, the inclusion of prebiotics and 
human milk oligosaccharides in infant formula can increase health-promoting microorganisms 
while conversely, promoting pathogenic microorganisms. 
 While prebiotics and human milk oligosaccharides can support the growth of health-
promoting microbes, exposure to pathogenic microorganisms is inevitable.  Once in an infant’s 
gastrointestinal tract, pathogenic microbes upregulate virulence traits and begin an infection.  In 
Chapter 4, the mechanism of autoaggregation in the neonatal pathogen, Cronobacter sakazakii 
ATCC 29544 (wild-type) is described.  Upon isolation of two independent nonautoaggregating 
clonal variants, two unique single nucleotide polymorphisms in the flagella proteins, FlhA and 
FliG, were identified.  Furthermore, it was hypothesized that structurally intact and functional 
flagella were required for autoaggregation in C. sakazakii ATCC 29544.  Several gene knockouts 
were constructed to target the flagella structure (ΔflhA, ΔfliG, ΔfliC, ΔflaA, and ΔfliCΔflaA) and 
function (ΔmotAB).  A loss in autoaggregation in ΔflhA, ΔfliG, and ΔfliC gene knockouts was 
observed, whereas ΔflaA and ΔmotAB retained the ability to autoaggregate.  Complementation of 
FliC restored autoaggregation to the ΔfliC and ΔfliCΔflaA strains.  Therefore, it was 
hypothesized that a direct interaction between FliC filaments of neighboring cells allowed 
autoaggregation to proceed.  Autoaggregation was disrupted following the addition of detached 
wild-type flagella in a dose-dependent manner.  It was concluded that flagellation with FliC 
mediates direct interactions between neighboring C. sakazakii ATCC 29544 cells which promote 
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autoaggregation.  Further experiments utilizing animal models will need to be conducted to 
determine if autoaggregation in C. sakazakii ATCC 29544 is necessary for its pathogenesis in 
vivo. 
 In Chapter 5, a model for Candida albicans colonization in neonatal piglets was 
developed.  C. albicans is a commensal fungus for which colonization mechanisms are 
understudied.  A surveillance analysis identified a C. albicans–negative piglet population at the 
University of Illinois-Urbana Champaign, which provided the basis for the work.  Neonatal 
piglets were orally inoculated with either a laboratory strain, piglet, or human isolate of C. 
albicans.  C. albicans was present on swabs of the mouth, rectum, and environment for at least 
14 days post-inoculation demonstrating stable colonization of the animals.  Necropsy showed 
that C. albicans most readily colonized the piglet esophagus.  This model provides an 
opportunity for subsequent studies of C. albicans colonization mechanisms. 
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CHAPTER ONE 
LITERATURE REVIEW 
1.1 Overview 
 The human’s symbiotic microbial community has evolved over thousands of generations.  
Upon birth, infants enter the world teeming with microbial diversity.  The infant’s microbiota is 
assembled through a complex microbial succession that requires a homeostasis between helpful 
microbes, harmful microbes, and the host (1,2).  Several factors including diet, environment, and 
host genetics influence which microbes can colonize the host.  In some instances, early 
colonization by pathogenic (“harmful”) microbes may require antibiotic treatment which further 
shapes the microbiota.  Eventually, the infant’s microbiota will result in a stable “adult-like” 
community that will remain relatively consistent during one’s life.  In this review, the 
establishment and assembly of the infant microbiota will be discussed, along with interventions 
utilized to assist with the assembly process, particularly for at-risk infants.  Additionally, the 
impacts of pathogenic colonization during assembly will be explored. 
 
1.2 Establishment and assembly of the infant gut microbiota 
 A common misconception in the research literature is the claim that infants are devoid of 
microbial colonization until birth (1).  Recent literature suggests that fetal microbial colonization 
may begin in utero; specifically, colonization of the placenta (3–6), umbilical cord (7), and 
amniotic fluid (6,8–11).  Histopathological examination of vaginally and cesarean-delivered 
placentas (27%) had visible morphologically diverse Gram-positive and -negative bacteria (4).  
An in-depth microbiological analysis reported that the placenta microbiota was a diverse and 
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distinct community composed of common gut-associated phyla; Actinobacteria, Bacteroidetes, 
Firmicutes, and Proteobacteria, the dominant phyla (5,6).  Further classification revealed the 
placenta microbiota harbored a high relative abundance of Enterobacteriaceae, particularly 
Escherichia coli (5), and Enterobacter spp. (6).  Several studies reported culturing or detecting 
by PCR common skin and oral microbes in the placenta (3,5,6).  Specifically, Corynebacterium 
spp., Propionibacterium spp., Staphylococcus spp., and Lactobacillus spp. were cultured from 
cesarean-delivered placentas (3), low relative abundances of Propionibacterium acnes, 
Staphylococcus epidermidis, and Lactobacillus iners were reported (5), and very low relative 
abundances of Lactobacillus spp. (0.83%), Staphylococcus spp. (0.26%), and Propionibacterium 
spp. (1.8%) were detected in cesarean-delivered placentas (6).  Similarly, a single study cultured 
Gram-positive bacteria, Enterococcus faecium, P. acnes, S. epidermidis, and Streptococcus 
sanguinis, from the umbilical cord blood of cesarean-delivered healthy neonates (7).  These 
results are consistent with detection of skin and oral microbes in the placenta.  These findings 
suggest that the umbilical cord may transport commensal placenta microbes from the placenta to 
the fetus.  However, this study should be interpreted cautiously due to a very low sequencing 
depth (an average of 9.3 sequences (SD = 6.9) per neonate) and the lack of Gram-negative 
isolates (7).  Furthermore, a recent study defined amniotic cavity “colonization” by relating low 
levels of interleukin 6 (<2.6 ng/mL), a marker of inflammation, with the presence of Ureaplasma 
urealyticum, a common genital-tract bacterium (11).  Additional culture-based studies (8–10) 
and PCR-based studies (6,9) characterized the microbial population in amniotic fluid.  Similarly 
to the placenta and umbilical cord, skin and oral microbes were readily cultured and detected 
from amniotic fluid, including Streptococcus spp., Fusobacterium nucleatum, Staphylococcus 
spp., and Propionibacterium spp. (6,8–10).  Other microorganisms commonly reported in the 
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amniotic fluid were Lactobacillus spp. (6,8,10), Ureaplasma spp. (8,10,11), Candida spp. (8–
10).  Collado and colleagues (6), observed a high degree of microbial similarity between their 
amniotic fluid and placental samples specifically, the predominance of Enterobacter spp. (73% 
relative abundance).  Although all studies reviewed report detailed methods to reduce 
contamination, there is the possibility that skin microbes from the mother, healthcare 
professionals or research staff could be isolated/detected using the techniques described.  
Therefore, researchers should design studies to determine links between the colonization of the 
placenta, umbilical cord, amniotic fluid microbiota, and the infant after birth.  Specifically, the 
focus should be on which microbes passing from the mother to the fetus in utero are “colonizers” 
or “transients”.  Also, in this era of whole genome sequencing, it is possible to determine if any 
of the fetal isolates are identical to isolates from any of the potential contamination sources. 
 Additional evidence that colonization begins in utero is the presence of detectable 
microbes in an infant’s first passage of stool, the meconium.  Since the meconium is more 
readily available to researchers, several studies have analyzed its microbiota (2,6,12–18).  The 
absolute quantity of microbes in the meconium ranged from 10
4
 to 10
8
 rRNA gene copies per 
gram of meconium (2).  Additionally, a low microbial diversity has been reported for meconium 
samples (13,15,19).  The two dominant phyla detected in meconium samples were consistently 
the Proteobacteria and Firmicutes (2,13–16,19).  Uniquely, Collado and colleagues (6) detected 
very low abundances of Proteobacteria in their meconium samples and reported the Firmicutes as 
the primary phyla detected.  Additional phyla detected were Bacteroidetes, Actinobacteria, 
(2,6,13,16), Tenericutes (15), and Verrucomicrobia (13,16); however, in significantly lower 
abundances.  A consistent finding was a high abundance of Enterobacteriaceae in the meconium 
(2,12,16–18).  Oral and skin microbes were commonly detected in the meconium and the 
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placenta, umbilical cord, and amniotic fluid, including Streptococcaceae (2,12,14,16,17), 
Staphylococcaceae (2,6,14,16–18), and Propionibacteriaceae (16), along with Lactobacillaceae 
(6,14,17).  It is hypothesized that members of the Enterobacteriaceae, Staphylococcaceae, and 
Streptococcaceae families are early gut colonizers which reduce the gut environment allowing 
subsequent colonization by strict anaerobes (16).  Taken together, these results suggest that the 
placental microbiota may serve as the in utero inoculum to prime the infant’s immune system for 
life outside the mother. 
 An infant’s gut microbiota at birth, as detected in the meconium, is naïve and composed 
of only a few microbial taxa.  The microbiota is assembled and is influenced by several factors, 
such as length of gestation (20), route of delivery (21–23), infant feeding (20–25), weaning 
(22,23,25,26), and antibiotic use after birth (2,21,22,25).  The microbiota composition fluctuates 
as the infant ages until it resembles an adult’s microbiota.  Currently, the time to microbial 
maturity is unknown; however, several studies suggested that maturity occurs around 1 to 3 years 
(2,25,27,28) while, others observe significant alterations in the gut microbiota in young children 
(3 to 5 years) (26,29,30).  Bacterial diversity is commonly used as a metric to determine overall 
similarity in microbial communities between two distinct populations.  It is widely reported that 
the bacterial diversity in infant’s stool upon birth is low and that as an infant ages bacterial 
diversity increases (25,28,29,31,32).  However, this upward trend in diversity is not linear 
(25,31,32).  In general, the inclusion of solid foods and cessation of human milk corresponds 
with shifts in bacterial diversity (25,31,33).  Furthermore, as compared to adults, bacterial 
diversity in infants and young children remains low (28–31).  Therefore, the gut microbiota may 
not be fully assembled for several years. 
5 
 
 Assembly of the infant’s gastrointestinal microbiota proceeds via a specific succession of 
bacterial taxa.  As discussed above, the meconium is characterized by a predominance of 
Proteobacteria and Firmicutes (2,13–16).  During the first few days of life, there is a dramatic 
decrease in aerobic bacteria, including Bacilli and Gammaproteobacteria (2,34), and a 
concomitant increase in anaerobic bacteria (20,31,34).  In two cohorts studied, the relative 
abundance of Proteobacteria decreased rapidly and remained low during the observation period 
(25,30) while, in other studies Proteobacteria persisted at higher abundances (2,16,20,23,34,35).  
The appearance of Bifidobacteriaceae was observed during the first week after birth 
(16,20,25,33,36) and was slightly delayed in preterm (20) and cesarean-delivered infants 
(23,31,37).  Additionally, a higher relative abundance of Bifidobacteriaceae was reported in 
breastfed infants as compared to formula-fed infants (20,22,36).  Perhaps unsurprisingly, several 
studies reported a rapid decrease in Bifidobacteriaceae abundance at the cessation of 
breastfeeding (22,23,26,28,30,32,33).  The emergence of Bacteroidetes is typically associated 
with the transition to solid food (22,25,30); however, several groups have reported its presence at 
and shortly after birth (2,14,16,20,23,24,27,31,35,36).  Furthermore, breastfeeding (20) and 
vaginal delivery (22,23,32) have been associated with an early appearance of Bacteroidetes and 
higher abundance.  The post-weaned gut microbiota is characterized by an emergence of 
butyrate-producing Firmicutes, specifically members of the order Clostridiales (23,26,27,29–32).  
This final transition represents a major compositional change that is more readily described as 
“adult-like”; however, other minor compositional changes occur for several years.  Several 
studies reported instability in the gut microbiota of young children (3 to 5 years) and concluded 
that an adult gut microbiota composition occurs later in childhood (26,29,30).  Additional 
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research with either a longitudinal design or with large cohorts will be useful in determining the 
time at which the gut microbiota matures. 
 
1.3 Modulation of the gut microbiota with prebiotic supplementation 
 Human milk has evolved over a couple hundred million years and is considered the gold 
standard for infant nutrition (38).  The macronutrient composition of human milk is lactose (~70 
g/L), lipids (~40 g/L), human milk oligosaccharides (HMOs, 5-23 g/L), and proteins (~8 g/L) 
(39,40).  The HMO fraction is a pool of neutral or acidic lactose-containing oligosaccharides 
decorated with galactose, N-acetylglucosamine (GlcNAc), N-acetylneuraminic acid (also sialic 
acid), and fucose in an assortment of glycosidic linkages.  A variety of analytical methods have 
been used to annotate the milk glycome and have identified hundreds of structures (41,42).  
Fucosylated HMOs (i.e. 2'-fucosyllactose, 2'-FL) were the major fraction (~77%), followed by 
sialylated HMOs (i.e. 3'-sialylactose, 3'-SL) at 16% relative abundance and the remaining 7% 
constituted Type I (lacto-N-tetraose) and Type II (lacto-N-neotetraose) based HMOs (42).  The 
composition and abundance of the HMO fraction in human milk were decreased significantly 
during four months of lactation (43–45), but more recently, only minor changes have been 
reported during that same period of lactation (42).  Additionally, the HMO composition of 
mother’s milk was predictive of the dominant members of the infant’s GI microbiota (46) and 
HMOs resist digestion and are excreted in feces (47) and urine (39,48).  Therefore, alterations in 
HMO composition contribute to the assembly of the infant’s microbiota. 
 It is well-established that HMOs are readily fermented by members of the genera 
Bifidobacterium (49–55) and to a lesser extent Lactobacillus (53,55–57).  Several bifidobacteria 
have been isolated from the feces of breastfed infants, including B. longum subsp. infantis (B. 
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infantis), B. breve, and B. bifidum (52), suggesting that bifidobacteria are HMO consumers.  B. 
infantis, highly abundant in breastfed infant’s feces, is a prolific consumer of HMOs (49–51,53–
55).  B. breve and B. bifidum have been reported to utilize HMOs, but to a lesser extent than B. 
infantis, the most dynamic HMO utilizer (50–52,54,55).  More specifically, in vitro fermentation 
studies have reported that B. infantis strains are capable of consuming fucosylated, sialylated and 
Type I & II HMOs (51,53–55), albeit HMOs sized less than or equal to 8 degrees of 
polymerization (49,50).  In contrast, B. breve and B. bifidum preferentially consume Type I and 
Type II HMOs and their consumption of fucosylated and sialylated HMOs is strain-dependent 
(50–52,54).  Whole-genome sequencing of B. infantis ATCC 15697 (type strain) revealed a 43 
kbp gene cluster specifically for HMO utilization (58).  This HMO utilization gene cluster is 
highly conserved among B. infantis and is missing in closely related strains, B. longum subsp. 
longum and B. longum subsp. suis incapable of consuming HMOs (59).  Follow-up studies have 
begun to characterize specific loci functionally and have identified fucosidases (60), a sialidase 
(61), β-galactosidases (62), and β-hexosaminidases (63) in B. infantis.  Similarly, a lacto-N-
biosidase (64) and two α-fucosidases (65) have been described in B. bifidum.  Additionally, a 
few lactobacilli have been found to be HMO utilizers, including Lactobacillus acidophilus, L. 
casei, and L. plantarum (55–57).  L. acidophilus was found to cleave enzymatically fucosylated, 
sialylated and Type I HMOs (57); however, only Type II HMOs supported growth in vitro (55).  
L. plantarum had a similar capacity to cleave HMOs enzymatically (57); however, its ability to 
ferment HMOs for growth has not been tested.  Finally, a single L. casei strain possesses an α-
fucosidase capable of cleaving 2’-fucosyllactose (56) and recently, has been grown in the 
presence of Type I HMOs (66).  It is evident that HMOs, typically delivered to the infant via 
breastmilk, are strongly bifidogenic and moderately lactogenic.  Unfortunately, many infants are 
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formula-fed and therefore, lack access to these health-promoting HMOs.  While there are 
oligosaccharides in bovine milk, the concentration and composition are vastly different from 
HMOs (67).  Therefore, alternatives are needed to provide the benefits of HMOs to formula-fed 
infants. 
 Several researchers consider the oligosaccharides in breastmilk as prebiotics, primarily 
due to their bifidogenic effects (68–70).  Prebiotics are defined as non-digestible carbohydrates 
that stimulate the growth of beneficial bacteria, thereby providing a health benefit to the host 
(71).  Unfortunately, HMO supplementation in infant formula is extremely cost-prohibitive.  
Therefore, supplementation with alternative prebiotic-like carbohydrates is desired.  Several 
commercial long-chain carbohydrates, such as galactooligosaccharides (GOS), polydextrose 
(PDX), and inulin-derived fructooligosaccharides (FOS) have been evaluated for their prebiotic 
potential.  These food ingredients have GRAS (generally recognized as safe) status and have 
been extensively studied as functional ingredients in infant formulas (Table 1.1). 
 Overall prebiotic supplementation of infant formula is well-tolerated (72,73).  
Additionally, prebiotic supplementation did not negatively affect the weight gain of infants and 
was not associated with any reported adverse effects (Table 1.1).  Based on the studies reviewed, 
a specific beneficial prebiotic dosage has not been established and in many cases, the exact dose 
consumed is not specified (Table 1.1).  Furthermore, prebiotics are often supplemented in 
combination with varied ratios making comparisons difficult.  GOS/FOS supplementation, either 
1:1 or 9:1 ratios, significantly improved both the frequency of defecation and consistency (74–
77), while some studies only observed an improvement in stool consistency (72,78–80).  When 
GOS was in combination with PDX, stool frequency (80) and consistency (72,79,80) was 
improved.  GOS supplementation alone can significantly impact stool frequency (81,82) and 
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consistency (79,82,83).  Likewise, sole FOS supplementation can improve stool frequency 
(84,85) and consistency (85).  Several studies reported no impact on stool frequency or 
consistency following prebiotic supplementation (86–90). 
 Many studies reported a significant increase in the fecal bifidobacteria and lactobacilli 
populations (Table 1.1).  The combination of GOS and FOS, either 1:1 or 9:1 ratios, correlated 
with a significant increase in bifidobacteria (74–77,86,89,91–94) and lactobacilli 
(75,76,92,95,96).  A single study reported no change in fecal bifidobacteria following 
supplementation with GOS/FOS (97).  A formula containing GOS/PDX had no impact on fecal 
bifidobacteria and lactobacilli (88).  The fecal bifidobacteria and lactobacilli communities 
significantly increased in formula supplemented with GOS (81,83) alone.  Sole FOS 
supplementation only leads to an increase in fecal bifidobacteria (84,85,87,98) and lactobacilli 
(87).  An additional study did not detect an increase in fecal bifidobacteria or lactobacilli with 
sole FOS supplementation (90).  Recently, a study reported that increasing dosages of GOS (2.5 
– 20 g/L) or HMO (1.7 – 3.4 g/L) in infant formula over five weeks did not alter the 
bifidobacteria population, especially compared to their human milk reference group (99).  
Interestingly, several studies correlated prebiotic supplementation with a significant decrease in 
fecal pH (75,76,78,81–83,86,89,92,97).  A decrease in pH compared with the control formula 
suggests that the prebiotics are fermented in the colon; however, very few studies showed direct 
evidence of prebiotic fermentation by bifidobacteria and lactobacilli. 
 Characterization of the ex vivo fecal microbiota following the inclusion of prebiotics has 
been explored.  Overwhelmingly, fermentation of GOS and GOS-like prebiotics corresponds 
with an increase in the fecal bifidobacteria (100–106) and lactobacilli (101,103–106).  Similarly, 
the inclusion of FOS and inulin, of varied chain lengths, led to an increase in bifidobacteria 
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(100,101,103–105,107) and lactobacilli (100,103–105,107).  While the fecal bifidobacteria 
increased when PDX was added, the fecal lactobacilli remained unchanged (103,104,107), 
except for one study that measured an increase in lactobacilli (105).  Several studies correlated 
the increase in bifidobacteria and lactobacilli with an increase in either acetate (100,102–107) or 
lactate (100,106).  Therefore, it is tempting to conclude that the tested prebiotics are bifidogenic 
and lactogenic; however, these studies did not exclude the possibility of cross-feeding in the 
fecal community.  Several researchers have explored direct fermentation of prebiotics by pure 
cultures of bifidobacteria or lactobacilli.  In general, pure cultures of bifidobacteria were found to 
utilize GOS and FOS readily (55,108–113) and to a lesser extent, PDX and inulin (55,109,112).  
Prebiotic utilization was strain dependent with B. infantis strains found to be strong GOS 
fermenters, while B. bifidum strains were weak GOS utilizers (113,114).  Lactobacilli strains, 
typically commercial probiotics, were good utilizers of GOS and weak to moderate utilizers of 
FOS (55,108,111,112).  Consistently, pure lactobacilli cultures were unable to ferment PDX or 
inulin in vitro (55,112). 
 
1.4 Gastrointestinal microbiota and its role in pediatric necrotizing enterocolitis 
 As previously discussed, the establishment of an infant’s gastrointestinal microbiota is an 
elaborate process that is susceptible to perturbations.  Several factors, including gestational age 
(20), route of delivery (21–23), infant feeding (20–23,25), and exposure to antibiotics 
(2,21,22,25), influences the pace and direction of assembly.  An improper assembly of the 
neonatal gastrointestinal microbiota could have severe consequences for the neonate.  
Specifically, a dysbiotic gastrointestinal microbiota, along with prematurity (birth before 37 
weeks) and enteral feeding, puts an infant at risk of developing necrotizing enterocolitis (115–
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117).  Necrotizing enterocolitis (NEC) is a common cause of morbidity and mortality among 
neonates requiring extended hospitalizations.  The incidence of NEC is inversely correlated with 
an infant’s birth weight, a consequence of prematurity (118,119)  The overall incidence rate has 
been reported as 0.2 - 1 cases per 1,000 live births or 0.20 - 0.1% (120,121).  High birth weight 
(HBW, >2500 g) infants incidence rate ranged between 0.01 - 0.04% (121,122), while low birth 
weight (LBW, 1500-2500 g) infants had an incidence rate slightly higher (0.4 – 0.7 %) than the 
overall average (121–123).  More attention has been given to very low birth weight (VLBW, 
<1500 g) infants due to the significantly higher rate of incidence (4.3 - 11%) (118,119,121–126).  
Accordingly, mortality rates are highest among the VLBW infants (20 – 40%) (121,122,126,127) 
and are lowered to 5.8% in LBW infants (121).  While prematurity is a key risk factor for NEC, 
it occurs in term infants.  Interestingly, the time of onset for NEC is far quicker (7-14 days versus 
>18 days) for term infants than for premature infants; respectively (122,123,126).  Regardless of 
birth weight or prematurity, a NEC diagnosis is commonly associated with co-morbidities (118), 
including respiratory, cardiovascular, and gastrointestinal issues (120–123,126,127).  
Specifically, colonization of the respiratory tract by Ureaplasma spp. is associated with an 
increased risk of developing NEC in preterm infants (128).  An additional risk of mortality and 
morbidity occurs when infants undergo surgical procedures to treat suspected and confirmed 
cases of NEC (118,121,122,127). 
 NEC is a disease spectrum characterized by inflammatory necrosis of the gastrointestinal 
tissues (129).  Nanthakumar and colleagues (130) hypothesized that NEC progression in 
premature infants results from an improper immune response during the initial stages of 
microbial colonization.  Clinically, NEC pathology is classified by Bell’s staging criteria (three 
stages) based on the progression and severity of the illness (129).  However, a recent review has 
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disseminated NEC into five subsets focusing on risk factors and differing etiologies (131).  A 
focal point of the subsets is the role of an aberrant colonization of the gastrointestinal tract in the 
onset and progression of NEC (131).  In neonates that do and do not develop NEC, the early 
gastrointestinal microbiota is composed of Proteobacteria and Firmicutes (2,13–16,116,117,132–
135).  Based on infants sampled before and after a NEC diagnosis, a decrease in alpha diversity 
(132,134–136) is associated with a change in the Proteobacteria to Firmicutes ratio 
(116,117,133–135).  Two studies were observed cases of NEC that resulted from either an 
increased or decreased Proteobacteria to Firmicutes ratio, suggesting that NEC’s etiology may be 
a variety of causative microbial agents (134,135).  When NEC is linked to an increase in 
Proteobacteria, it is typically at the expense of Firmicutes (116,117,133–135) and due to an 
increased abundance of members of the Enterobacteriaceae family (18,117,133,134).  Specific 
Enterobacteriaceae reported in NEC infants are Citrobacter–like sequences (12), Enterobacter 
spp. (137), Escherichia spp. (136), and Klebsiella pneumoniae–like sequences (116,138).  On the 
other hand, an increase in Firmicutes occurs at the expense of Proteobacteria (134,135) and is 
associated with an increase in Clostridia and Bacilli classes, specifically Clostridium perfringens 
(18,138) and Enterococcus spp. (12,134).  The relative abundance of Staphylococcus spp. has 
been positively- (134,137) and negatively-associated (18) with NEC diagnosis.  Interestingly, the 
time of onset occurred earlier in Firmicutes-associated NEC (7-21 days) than Proteobacteria-
associated NEC (19-39 days) (134).  Also, infants who later developed NEC were found to lack 
colonization by Propionibacterium spp. (134), which has been reported to participate in the 
proper assembly of the neonatal gastrointestinal microbiota (3,6).  Several studies collected 
meconium and fecal samples before and after NEC diagnosis (18,116,133,134).  In case-control 
studies, the fecal microbiota of infants with NEC was characterized by a predominance of 
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Enterobacteriaceae (139,140) or Bacilliales (139).  A recent study reported the detection of 
Clostridium butyricum in feces significantly correlated with neonates with NEC as compared to 
case-matched control neonates (141).  Finally, neonatal intestinal candidiasis, by the yeast 
Candida albicans, has been reported as an atypical cause of NEC (142).  Routine monitoring of 
the infant fecal microbiota may assist in early detection of dramatic microbial shifts and blooms 
of suspected causative microbial agents; however, the fecal microbiota may not be indicative of 
the microbiota intimately-associated with the necrotic tissue.  The microbiota of resected tissues 
and mucosa from NEC infants were composed primarily of Firmicutes and Proteobacteria with a 
lesser abundance of Bacteroidetes (143,144).  Similar to fecal samples, Clostridium spp. and 
Enterobacteriaceae were found in higher abundances than control tissue (143) and mucosal 
samples (144).  Interestingly, two cases of NEC were characterized by an overabundance of 
Bacteroides spp. which has not been observed in fecal samples (144). 
 The association of Proteobacteria with NEC is particularly concerning because this 
phylum is composed of a plethora of pathogens responsible for gastrointestinal illnesses and 
diseases.  As discussed above, an increased abundance of members of the Enterobacteriaceae 
family has been linked to NEC in infants (18,117,133,134,139,140,144).  Clinical presentations 
of NEC have been associated with culturing Cronobacter (Enterobacter) sakazakii (145–147), 
Enterobacter cloacae (148), E. coli (149–151), and K. pneumoniae (149,150) from blood, feces, 
or gastric aspirate.  Furthermore, a high abundance of Enterobacteriaceae has been observed 
using 16S rDNA sequencing methods (117,132,138,143,144).  Specifically, Citrobacter spp. 
(143), Cronobacter spp. (117), Enterobacter spp., (117,132), Escherichia/Shigella spp. 
(117,132,143,144), Klebsiella spp. (117,132,138,144).  Additionally, animals with NEC had a 
significantly higher abundance of Citrobacter spp., Klebsiella spp., and Tatumella spp. as 
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compared to control animals (152).  Furthermore, NEC was induced in rat pups orally-fed 
Cronobacter muytjensii, reported as C. sakazakii (153).  Of the Enterobacteriaceae discussed, 
only C. sakazakii contamination in powdered infant formula has been epidemiologically linked 
to sepsis (154), meningitis (155), and NEC (146) in neonates.  Therefore, additional research was 
conducted to understand C. sakazakii’s persistence in dehydrated infant formula and it’s 
pathogenesis in humans. 
 
1.5 Cronobacter sakazakii physiology and pathogenesis 
 The family Enterobacteriaceae is taxonomically diverse and over the last few decades, 
several genera have undergone reclassification with continuing research.  Specifically, 
Enterobacter sakazakii, previously known as “yellow-pigmented” Enterobacter cloacae, was 
first proposed as a new species in 1980 (156).  Continued research revealed that E. sakazakii was 
phenotypically (157) and genomically (157,158) distinct from other Enterobacter spp.  At last, 
Cronobacter gen. nov., originally consisting of five species, was proposed to describe the diverse 
biotypes of Enterobacter sakazakii properly (159).  Researchers developed several biotyping 
(157), serotyping (160,161), and genotyping (157,162,163) methods to speciate former 
Enterobacter sakazakii isolates quickly.  Utilization of multilocus sequence typing (MLST) 
revealed two additional Cronobacter species (164) and was found to speciate all seven 
Cronobacter spp. accurately (162,165).  In total, 115 sequencing types (ST) represent the genetic 
diversity of the genus Cronobacter, with more than 53 sequencing types for C. sakazakii (162).  
Several studies have reported an association between C. sakazakii ST1 & 4 clinical isolates and 
severe neonatal cases (162,166–168).  The C. sakazakii type strain (ATCC 29544), which is 
studied in Chapter 4, belongs to ST8 (162,166). 
15 
 
 C. sakazakii, an opportunistic pathogen, is linked to fatal infections in neonates, the 
elderly and immunocompromised individuals (145).  The first infant deaths, described in 1961, 
involved two infants diagnosed with general infections caused by “yellow-pigmented” 
Enterobacter cloacae (169).  To date, several hundred cases of infantile C. sakazakii infections 
have been reviewed (145,147).  These studies report that the majority of C. sakazakii infections 
have occurred in neonates with clinical outcomes of necrotizing enterocolitis, meningitis, 
bacteremia, and septicemia.  Additionally, the overall fatality rate has been reported as 26.9% 
(147) and 50% (145) with life-long neurological and gastrointestinal complications in surviving 
neonates (145,147).  Initially, C. sakazakii was thought to originate from the birthing canal; 
however, infections were observed in cesarean-delivered infants (170,171) and samples obtained 
from the mother’s cervix, vagina, and feces were negative (171).  Furthermore, C. sakazakii has 
been found to persist within clinical settings for several years (172), which is the likely source 
for C. sakazakii recovered from breastfed neonates (173,174) and asymptomatic carriers 
(170,175).  Farmer and colleagues (156), were the first to report the isolation of C. sakazakii 
from an unopened canister of dried milk.  Unfortunately, it wasn’t until several years later that a 
global surveillance study confirmed extensive C. sakazakii contamination of milk powders (176).  
This survey (176), along with another (177), reported low levels of contamination (0.36 – 66 
CFU/100g); however, both groups cautioned that the observed level of contamination might be 
problematic if growth were to occur during preparation or storage.  Not long after, C. sakazakii 
infections in infants were epidemiologically linked to contaminated powdered infant formula 
(PIF) (146,154,155). 
 The natural reservoir for C. sakazakii does not appear to be a single source but rather C. 
sakazakii’s distribution in nature is ubiquitous (178–182), including raw milk (183,184).  While 
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C. sakazakii is widespread, its association with milk powders presents a unique challenge for the 
populations at-risk for infection.  C. sakazakii has been found to be extremely tolerant to heat, 
desiccation and osmotic stresses (185–191).  Several studies have determined C. sakazakii’s 
thermal inactivation parameters (D- and z-values) in reconstituted infant formula (185–
188,191,192).  The D-value at 58 °C ranged from 30.5 sec to 9.85 min and was highly strain- and 
substrate-specific (185–188,191,192).  In general, clinical isolates tended to be more heat-
resistant (185,187) as well as the C. sakazakii type strain (ATCC 29544) with its D-value at 58 
°C reported as 2.6 (188) and 6 min (187).  As expected, the nutritional components of 
reconstituted milk powders significantly impacted the D-value.  Osaili and colleagues (191) 
observed higher D-values corresponding to increasing fat contents (0, 1.29, 3.64% fat).  
Interestingly, three studies reported highly consistent z-values; 5.82 (185), 5.6 (187), and 5.7 °C 
(188).  Taken together, the D- and z-values suggest that C. sakazakii, while tolerant to high 
temperatures, should not survive typical commercial pasteurization.  Some researchers have 
hypothesized that contamination of milk powders with C. sakazakii occurs post-pasteurization 
via carriage on filth flies (193,194) or by dry mixing with heat-sensitive micronutrients (179).  
Therefore, understanding the desiccation and osmotic tolerance of C. sakazakii is important.  A 
short-term survival study reported a 1 – 1.5-log decrease in several C. sakazakii isolates after 
storage in dehydrated PIF for 46 days (186).  An additional two research studies examined the 
survival of C. sakazakii in mock inoculated dehydrated PIF over several years (189,190).  
Previously, C. sakazakii strain 607, a clinical isolate, was observed to be extremely tolerant to 
heat (187).  Also, C. sakazakii strain 607 was found to survive 687 days (1.8 years) in 
dehydrated PIF (189).  Following storage for five months, the C. sakazakii population decreased 
by 2.3-logs with an additional 1-log reduction occurred during the last 17 months (189).  An 
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additional study screened a variety of clinical and PIF C. sakazakii isolates for desiccation 
tolerance in dehydrated PIF for 2.5 years (190).  Typically, a 3-log reduction was observed 
within the first six months of storage, followed by a slow decline in recoverability (190).  A total 
of five C. sakazakii strains (clinical and PIF isolates) were recoverable at two years, with only 
two strains (a clinical and a PIF isolate) detectable at 2.5 years (190).  Interestingly, the C. 
sakazakii type strain (ATCC 29544) was found to be the most sensitive to storage and was 
undetectable after 12 months.  A single study has reported osmotic stress tolerance in C. 
sakazakii (186).  All C. sakazakii isolates tested were detectable following extended storage in 
sorbitol supplemented (40 and 75% w/v) BHI (186).  All told, these studies highlight the unique 
ability for C. sakazakii to resist heat, desiccation, and osmotic stresses which contribute C. 
sakazakii’s prevalence in milk powders.  Additional research has shown that C. sakazakii can be 
easily inactivated (~4-log reduction) if PIF is reconstituted with hot water (>70 °C) (189,191) 
and suggests that proper handling of PIF during and after reconstitution can reduce one’s risk of 
C. sakazakii infections. 
 Since C. sakazakii does not survive pasteurization, there is interest in determining 
contributing factors for post-pasteurization contamination in milk powders.  Commonly, biofilms 
formed on food contact surfaces can be a source of microbial inoculum post-pasteurization.  
Many foodborne pathogens are biofilm-formers, and C. sakazakii is not an exception.  C. 
sakazakii forms biofilms on stainless steel; however, the biofilm population size is strain-, 
temperature-, and growth-media-dependent (188,195,196).  Biofilm formation during 
submersion in nutrient-dense or nutrient-limiting bacterial growth media at 37 °C produced 
biofilms with a maximum viable cell count of 5.5 and 6.5-log CFU/cm
2
, respectively (196).  Two 
additional studies evaluated biofilm formation on stainless steel in the presence of infant formula 
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broth (188,195).  C. sakazakii clinical, food, and environmental isolates readily adhered to 
stainless steel at 12 and 25 °C with on average 3.63 and 4.30-log CFU/cm
2
 population densities, 
respectively (195).  The biofilm population quickly reached equilibrium with the surrounding 
planktonic cell culture and did not change for the duration of the experiment (195).  Furthermore, 
C. sakazakii strains ATCC 29544 and 823 formed sparse biofilms on stainless steel incubated in 
rehydrated infant formula at 37 °C (188).  The final population density of C. sakazakii strains 
ATCC 29544 and 823 at 24 hours was 1.2 and 1.7-log CFU/cm
2
; respectively (188).  While the 
experimental methods are slightly different between the final two studies, incubation in infant 
formula at 25 °C correlates with a higher population density of C. sakazakii in stainless steel 
biofilms.  In addition to stainless steel, C. sakazakii forms biofilms on several plastic materials, 
including silicon (188), latex (188), polycarbonate (188), polyvinyl chloride (PVC) 
(195,197,198), and polyurethane (198).  Importantly, these plastics are common materials in 
hospitals and baby products.  Of particular interest are the latter two plastics as they are used for 
enteral feeding tubes.  A surveillance study of 57 C. sakazakii clinical, food, and environmental 
isolates reported that 58.9% of the isolates adhered and formed biofilms on PVC microtiter 
plates (197).  Additionally, a higher proportion (65%) of the food and environmental C. 
sakazakii isolates were observed biofilm formers as compared to clinical isolates (29%) (197).  
C. sakazakii biofilms on infant-feeding bottles, including silicon, latex, and polycarbonate, were 
determined with C. sakazakii strains ATCC 29544 and 823 incubated in rehydrated infant 
formula (188).  While C. sakazakii ATCC 29544 formed biofilms on all plastics tested, the total 
viable population was significantly lower (1.2 – 2.5-log CFU/cm2) than C. sakazakii strain 823 
(3.6 – 3.8-log CFU/cm2) (188).  Both C. sakazakii strain ATCC 29544 and 823 adhered best to 
latex submerged in infant formula at 37 °C (188).  Two studies have evaluated the ability for C. 
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sakazakii to form biofilms on enteral feeding tubes in the presence of rehydrated infant formula 
(195,198).  C. sakazakii clinical, food, and environmental isolates readily adhered to PVC tubes 
at 12 and 25 °C with on average 4.98 and 5.4-log CFU/cm
2
 population densities; respectively 
(195).  Over a ten-day incubation in infant formula, the C. sakazakii biofilm population densities 
on PVC tubing increased by 1-log CFU/ cm
2
 at 25 °C (195).  Meanwhile, C. sakazakii biofilm 
population densities on PVC tubing decreased significantly to below 4-log CFU/ cm
2 
at 12 °C 
(195).  Furthermore, biofilms formed by several C. sakazakii isolates were observed on PVC and 
polyurethane tubing following incubation in rehydrated infant formula (198).  The average C. 
sakazakii population densities on PVC and polyurethane ranged from 4.6 – 6.3-log CFU/cm and 
5.3 – 6.9-log CFU/cm; respectively (198).  Interestingly, silver-impregnated flexilene plastic had 
the highest C. sakazakii biofilm population densities (5.3 – 7.4-log CFU/cm) (198).  While this 
tubing is not used as a feeding tube, it is advertised as having antimicrobial properties.  The 
silver-impregnated flexilene plastic did not prevent biofilm formation by C. sakazakii and 
unfortunately, enhanced C. sakazakii biofilm formation (198).  Furthermore, these results were 
supported when C. sakazakii was recovered from a discarded enteral feeding tube (199); 
however, the C. sakazakii isolate came from an infant who was enterally fed breastmilk (199).  
Taken together, these studies demonstrate the importance of proper sanitation and cleaning to 
prevent C. sakazakii biofilm formation following contact with rehydrated infant formula. 
 As previously discussed, biofilm formation and thermal, desiccation, and osmotic 
tolerance contribute to the virulence and persistence of C. sakazakii in the environment.  A 
limited amount of research groups has begun to explore other factors involved in the 
pathogenesis of C. sakazakii.  Related to biofilm formation is the production of capsule 
polysaccharides (CPS).  The production of CPS within the C. sakazakii species is strain-specific 
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(163,188,190,197,198).  While capsule production did not correlate to biofilm formation on 
enteral feeding tubes or PVC microtiter plates (197,198), capsule production did enhanced the 
attachment and biofilm formation on latex, silicon, and polycarbonate (188).  Additionally, 
capsule production was associated with thermal (188) and desiccation tolerance (190).  
Interestingly, the C. sakazakii type strain (ATCC 29544) is not capsulated (188,197).  Recently, 
a novel K-antigen region has been identified and reported to be ubiquitous among C. sakazakii 
strains (n = 75); notably, C. sakazakii type strain (ATCC 29544) was included in the analysis 
(200).  Additionally, this study correlated the presence of a K2 antigen with highly virulent C. 
sakazakii strains, those causing meningitis and NEC (200).  Like other Gram-negative 
microorganisms, C. sakazakii expresses and presents lipopolysaccharides on its extracellular 
surface (160,201).  Initially, two serotypes were identified based on sequence variation of the O-
antigen locus (201).  The C. sakazakii type strain (ATCC 29544) expresses O1 antigen 
(160,201).  Further research has revealed a total of seven serotypes in C. sakazakii with O1 & O2 
representing the majority of isolates (160).  An O-antigen deficient C. sakazakii strain (ATCC 
BAA-894) had increased biofilm formation compared to wild-type (202).  C. sakazakii strains 
have peritrichous flagella and are motile (159).  The C. sakazakii flagella are associated with 
biofilm formation, intestinal adhesion, and inducement of an immune response (203,204).  
Aflagellate gene knockouts of C. sakazakii strain ES5 were deficient in biofilm formation and 
adhesion to the human cell line Caco-2 (203).  Additionally, detached flagella from C. sakazakii 
strains (ATCC BAA-894 and ATCC 29004) induced a TLR5-dependent immune response in 
monocyte-derived macrophages (204).  Since, the primary route of entry into an infant is through 
the oro-gastrointestinal tract, C. sakazakii must utilize mechanisms to promote adhesion and 
invasion of the gastrointestinal tract.  A surveillance study analyzed the ability for 50 clinical, 
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food, and environmental to adhere to the human epithelial cell line, Caco-2 (205).  A total of 29 
C. sakazakii strains adhered to Caco-2 cells with no reported differences due to their source of 
isolation (205).  Furthermore, the maximum percent adhesion of C. sakazakii strains to Caco-2 
was 1.9% (206) and 2.6% (207) of the inoculum.  The later study demonstrated that C. sakazakii 
percent adhesion was similar to the positive controls, Salmonella enterica ser. Enteritidis (1.4%) 
and Enterobacter cloacae (3.7%) and much higher than the E. coli K12 negative control (0.04%) 
(207).  The maximum percent invasion of Caco-2 cells by C. sakazakii  was 0.23% (207) and 1% 
(208) of the inoculum.  Invasion of Caco-2 cells by C. sakazakii was significantly higher than 
noninvasive controls (207,208).  Several studies have demonstrated that invasion of Caco-2 cells 
is mediated by outer membrane proteins, including OmpA (209,210), OmpX (209), and Inv 
(210).  These in vitro studies provide insights into the mechanisms C. sakazakii utilizes during 
pathogenesis in humans. 
 
1.6 Candida albicans physiology and oro-gastrointestinal colonization 
 The Candida genus is a morphologically and genetically diverse group of fungal 
microorganisms.  Traditionally, the Candida genus served as a reservoir taxon for “imperfect 
fungi” without a defined sexual cycle (211).  Consequently, the phylogeny of Candida species 
and closely related fungi has been challenging to resolve.  Recently, DNA-based typing methods 
confirmed that Candida species are polyphyletic and distributed across the two main clades, 
CTG and Saccharomyces, of the Saccharomycotina subphylum (212).  Several common 
pathogenic Candida species, including C. albicans, C. parapsilosis, and C. tropicalis, anchor the 
CTG clade characterized by an alternative codon assignment (the CTG codon codes for serine, 
not leucine).  Other Candida species, such as C. glabrata and C. krusei, are genetically distinct 
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from the CTG clade Candida species and are more closely related to Saccharomyces cerevisiae.  
Clinically C. albicans is responsible for > 65% of candidiasis cases (213) and has garnered the 
most attention.  C. albicans is a diploid yeast with eight pairs of chromosomes (214) and 
predominately undergoes asexual clonal replication.  Although rare, a parasexual cycle is stress-
induced (215) and contributes to the genetic diversity of C. albicans.  Early work found 
significant karyotypic variation in clinical (214,216–218) and laboratory (214,216) C. albicans 
isolates; however, karyotyping can be affected by C. albicans’ penchant for phenotypic 
switching (219).  Subsequent fingerprinting methods were developed to resolve the phylogenetic 
diversity of C. albicans.  A comparison of methods, including randomly amplified polymorphic 
DNA (RAPD), multilocus enzyme electrophoresis (MLEE), Southern blot hybridization with the 
Ca3 DNA probe confirmed the clonal nature of C. albicans (220).  Additionally, this study 
demonstrated that the Ca3 probe was able to discriminate microevolutionary changes (220).  
These authors further identified five distinct geographical clusters of C. albicans using the Ca3 
probe, representing North America (groups 1, 2, and 3) (220), South Africa (221), and Europe 
(222).  The C. albicans lineage has been expanded to 17 different clades using an optimized set 
of MLST loci (223,224).  Recently, whole genome sequencing of C. albicans has allowed for 
more thorough analysis of its evolutionary past.  The diploid genome of C. albicans type strain 
SC5314, utilized in Chapter 5, is publically available (225).  C. albicans SC5314 belongs to 
clade 1 which represents ~40% of all C. albicans isolates analyzed (224,226).  Additionally, 
clade 1 C. albicans isolates are commonly disease-causing (227) and correlated with higher 
mortality in neonates under one year of age (228). 
 Candida spp. are commensal fungi that innocuously reside on and within the human body 
(229); however, under certain circumstances many Candida spp. can become pathogenic to their 
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hosts (230).  Candida spp., of which C. albicans is the most clinically relevant (213), cause self-
limiting fungal infections of the skin and mucous membranes or life-threatening disseminated 
and systemic infections (230).  Oro-gastrointestinal colonization by Candida spp. is common in 
neonates with a total incidence rate of 4.6% (231) to 62% (232).  Most studies observed 
incidence rates between 12.8% and 29% (233–238).  While Candida was readily isolated from 
neonates, the relative abundance of oro-gastrointestinal Candida is low (<10
6
 cells per gram) 
(229).  C. albicans was the most prevalent yeast isolated from the mouth/oropharynx 
(231,233,235–240) and rectum/stool (231,233–240) of neonates followed by C. parapsilosis 
(233,234,236–238).  In contrast, a single study reported slightly higher isolation of C. 
parapsilosis than C. candida, though both were isolated from 85% and 77% of neonates, 
respectively (232).  Several studies observed C. albicans colonization by two weeks of age (231–
237,239,240); however, detailed experiments regarding the timing of C. albicans colonization in 
neonates are limited.  Overall Candida spp. colonization was correlated with, birth weight 
(235,238), gestational age (235,238), and vaginal delivery (236,238).  A decreased birth weight 
and gestational age are significantly negatively correlated with Candida spp. colonization 
(235,238).  The correlations reported in these studies should be interpreted with caution due to 
their small samples sizes.  Additionally, birth weight and gestational age are inherently 
correlated and therefore, it is not surprising that both were found to be correlated with Candida 
spp. colonization.  Furthermore, vaginal delivery was significantly positively correlated with 
Candida spp. colonization (236,238), suggesting transmission of maternal vaginal Candida spp. 
to the neonate during birth.  In a cohort of 347 mother/neonate pairs, all 16 C. albicans–positive 
neonates were born to C. albicans–positive mothers with identical pulsotypes (231). Another 
study found 84.6% of their mother/neonate (11/13) pairs had identical CARE-2 DNA banding 
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patterns of C. albicans (240).  The authors concluded that vertical transmission occurred in these 
11 neonates within one week postnatal.  Neither study robustly demonstrated that direct vaginal 
transmission occurred.  Limited research suggests that vertical transmission may occur before 
birth.  Candida spp. (9), including C. albicans (8,10) have been cultured from amniotic fluid 
samples.  More compelling research suggests that horizontal transmission (nosocomial) of 
Candida spp. readily occurs among neonates admitted to a neonatal intensive care unit 
(233,234,241).  Specifically, the hands of healthcare professionals, 29% positive for Candida 
spp., were strongly implicated in the transmission of C. albicans and C. parapsilosis (234).  As 
scientists gain more knowledge on C. albicans, and other Candida spp., role as a commensal 
microbe and its colonization in humans, healthcare professionals will be better suited to handle 
C. albicans infections and outbreaks. 
 As an opportunistic pathogen and near ubiquitous association with the human oro-
gastrointestinal tract, studying C. albicans colonization in humans is limited to observational 
studies.  Therefore, researchers began investigating C. albicans colonization in rodents following 
oral administration of the fungus.  Unfortunately, C. albicans is not a member of the commensal 
murine mycobiota and is unable to displace the resident bacterial and fungal community.  
Several groups found that reducing the resident microbiota by pretreatment with antibiotics 
(242–247), steroids (242,244), X-ray irradiation (243,244) increased the susceptibility of the 
adult rodents to colonization by C. albicans.  In pretreated rodents, the gastrointestinal C. 
albicans density ranged from 10
6
 – 107 cells per gram feces/contents/tissue and remained stable 
for 3 (246), 12 (243) and 21 days (242,247).  In one study, C. albicans-positive mice were 
treated daily with antibiotics (243) which continually depressed the resident microbiota.  Other 
groups colonized neonatal rodents with C. albicans while the resident microbiota was naïve and 
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susceptible (248–251).  The gastrointestinal C. albicans density at 102 -105 cells per gram 
feces/contents/organ at 20 days (248), 2 (250), 4 (251), or 10 weeks (249) was significantly 
lower than the pretreated adult mice.  To better model human colonization with C. albicans, 
adult mice with resident microbiota were orally inoculated with C. albicans.  Without 
pretreatment, the gastrointestinal C. albicans density at 10
2 – 104 cells per gram 
feces/contents/tissue (252–255) was similar in C. albicans inoculated neonatal mice (248–251).  
While these studies demonstrate C. albicans colonization in adult mice without pretreatment, the 
C. albicans inoculum was administered for 3 days (252) to 2 weeks (253–255).  Additionally, 
these studies reported significant increases in gastrointestinal C. albicans density to 10
5
 – 108 
cells per gram feces/contents/tissue following treatment with antibiotics (245,252,254,255) and 
immunosuppressants (252).  While these rodent models were designed to study C. albicans 
colonization in humans, the artificiality of these models is problematic, particularly, due to the 
natural resistance of the rodent gastrointestinal tract to C. albicans colonization.  Neonatal 
piglets are often used as human biomedical models, including microbial colonization.  While 
dissemination of C. albicans was investigated in gnotobiotic neonatal piglets (256), no current 
piglet models have been developed to examine C. albicans colonization. 
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1.7 Table 
Table 1.1. Human clinical trials evaluating prebiotic supplementation in infant formula.  Studies were included if prebiotics were 
clearly identified, were the sole supplement, and were delivered to healthy infants.  More specifically, excluded studies supplemented 
prebiotics in combination with a probiotic or other micro- or macronutrients or included infants with medical conditions. 
  
Microbial Response
3
 Stool Properties
3
 Infant Response
3
 
 Prebiotics  
(ratio )
2
 
Dosage
2
 Bifidobacteria Lactobacilli Frequency Consistency pH Growth Intolerance References 
GOS/FOS  
(9/1) 
10 g/L Up* No dif Improved
4
 Improved 
 
No dif
5
 
 
(74) 
GOS/FOS 4 g/L Up* Up* No dif Improved Down* No dif No dif 
(75) 
GOS/FOS 8 g/L Up* Up* Improved Improved Down* No dif No dif 
GOS/FOS 4 g/L Up* Up* Improved Improved No dif No dif No dif 
(76) 
GOS/FOS 8 g/L Up* Up* Improved Improved Down* No dif No dif 
GOS 2.4 g/L Up* Up* Improved 
 
Down* No dif No dif (81) 
FOS 10 g/day Up* 
    
No dif No dif 
(98) GOS 10 g/day Up* 
    
No dif No dif 
Inulin 10 g/day No dif 
    
No dif No dif 
GOS/FOS  
(9/1) 
6 g/L No change
6
 / dif 
   
Down* 
  
(97) 
GOS/FOS  
(9/1) 
8 g/L Up* 
 
No dif No dif Down* 
 
No dif (86) 
GOS/FOS  
(9/1)  
Up* No dif 
     
(91) 
GOS/FOS  
(9/1) 
8 g/L 
 
Up* 
     
(95) 
GOS/FOS  
(9/1) 
1 g/L 
   
Improved Down* No dif No dif (78) 
FOS 4 g/L Up* 
 
Improved No dif No dif Improved No dif (84) 
Inulin 0.75 g/kg/day Up* Up* No dif No dif No dif No dif 
 
(87) 
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Table 1.1. (cont) 
 
  Microbial Response
3
 Stool Properties
3
 Infant Response
3
  
Prebiotics  
(ratio )
2
 
Dosage
2
 Bifidobacteria Lactobacilli Frequency Consistency pH Growth Intolerance References 
GOS/PDX  
(1/1) 
4 g/L 
   
Improved 
 
No dif Yes (72) 
GOS 2.4 g/L Up* Up* 
 
Improved Down* No dif No dif (83) 
GOS/FOS  
(9/1) 4 g/L 
Up* 
 
Improved Improved No dif No dif No dif (77) 
GOS/PDX  
(1/1) 4 g/L 
No dif No dif No dif No dif 
 
No dif 
 
(88) 
GOS/FOS  
(9/1) 8 g/L 
Up* Up* 
  
Down* No dif No dif (92) 
GOS/FOS  
(1/1) 4 g/L 
No dif 
 
No dif Improved 
 
No dif No dif 
(93) 
GOS/FOS  
(1/1) 8 g/L 
Up* 
 
No dif Improved 
 
No dif No dif 
GOS/FOS  
(9/1) 8 g/L 
Up* 
 
No dif Improved 
 
No dif No dif 
GOS/PDX  
(1/1) 4 g/L   
Improved† Improved 
 
No dif No dif 
(79) 
GOS 4 g/L   
Improved† Improved 
 
No dif No dif 
GOS/FOS  
(9/1) 4 g/L 
Up* 
 
No dif No dif Down* No dif No dif (89) 
GOS/PDX  
(1/1) 1 g/serving   
Improved Improved 
 
No dif No dif (80) 
GOS/FOS  
(1/1) 4 g/L 
Up* 
 
No dif Improved 
 
No dif No dif (94) 
FOS 2 gL No dif No dif No dif No dif   
No dif 
(90) 
FOS 3 g/L No dif No dif No dif No dif   
No dif 
FOS/Inulin  
(1/1) 8 g/L 
Up* 
 
Improved Improved 
 
No dif No dif (85) 
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Table 1.1. (cont) 
 
  Microbial Response
3
 Stool Properties
3
 Infant Response
3
  
Prebiotics  
(ratio )
2
 
Dosage
2
 Bifidobacteria Lactobacilli Frequency Consistency pH Growth Intolerance References 
GOS 4 g/L   
No dif Improved 
 
No dif No dif 
(73) 
GOS 8 g/L   
No dif Improved 
 
No dif Yes 
GOS 4.4 - 5 g/L Up*  
Improved Improved Down* 
  
(82) 
GOS/FOS  
(9/1) 
0.5 - 
1.5g/kg/day  
Up* 
     
(96) 
GOS
7
 2.5 - 20 g/L No dif 
     
Yes (99) 
HMO 1.7 - 3.4 g/L No dif 
       
1 All studies reported either no adverse effects with prebiotics or no differences between groups; 2 Prebiotics ratio and dosage is listed 
if reported by authors; 3 Outcomes were limited to the headings to ease comparisons; 4 Improvement in outcome as compared to 
control formula; 5 No dif = no statistical differences from control formula; 6 No change = no statistical differences from baseline 7 
GOS served as the formula control as there was no formula group without prebiotics; Abbreviations used: FOS = 
fructooligosaccharides, GOS = galactooligosaccharides, PDX = polydextrose; * P < 0.05; † P < 0.1; Blank space = outcome was not 
measured.
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CHAPTER TWO 
CHARACTERIZATION OF THE INTESTINAL LACTOBACILLI 
COMMUNITY FOLLOWING GALACTOOLIGOSACCHARIDES AND 
POLYDEXTROSE SUPPLEMENTATION IN THE NEONATAL PIGLET
1
 
2.1 Abstract 
 Recently, prebiotic supplementation of infant formula has become common practice; 
however, the impact on the intestinal microbiota has not been completely elucidated.  In this 
study, neonatal piglets were randomized to: formula (FORM, n=8), formula supplemented with 2 
g/L
 
each galactooligosaccharides (GOS) and polydextrose (PDX, F+GP, n=9) or a sow-reared 
(SOW, n=12) reference group for 19 days.  The ileal (IL) and ascending colon (AC) microbiota 
were characterized using culture-dependent and -independent methods.  16S amplicon 
sequencing identified no differences at the genera level in the IL.  Interestingly, six genera in the 
AC were significantly different between FORM and F+GP (P<0.05): Lactobacillus, 
Ruminococcus, Parabacteroides, Oscillospira, Hydrogenoanaerobacterium, and Catabacter.  In 
particular, the relative abundance of AC Lactobacillus was higher (P=0.04) in F+GP as 
compared to FORM.  Culture-dependent analysis of the IL and AC lactobacilli communities of 
FORM and F+GP revealed a Lactobacillus spp. composition similar to 16S amplicon 
sequencing.  Additional analysis demonstrated individual Lactobacillus isolates were unable to 
ferment PDX.  Conversely, a majority of lactobacilli isolates could ferment GOS, regardless of 
piglet diet.  In addition, the ability of lactobacilli isolates to ferment the longer chain GOS 
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fragments (DP 3 or greater), which are expected to be present in the distal intestine, was not 
different between FORM and F+GP.  In conclusion, prebiotic supplementation of formula 
impacted the AC microbiota; however, direct utilization of GOS or PDX does not lead to an 
increase in Lactobacillus spp.  
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2.2 Introduction 
 Infants are readily colonized following birth from exposure to the environment, most 
notably, microbiota from their mother’s vagina, skin, feces and potentially human milk[1-4].  
After initial colonization, the infant microbiota is assembled through a complex succession of 
microbiota that is rapidly changing [5,6].  Additionally, the intestinal microbiota is influenced by 
infant nutrition [7].  Human milk is the gold standard for infant nutrition; however, formula 
feeding early in life is common and often required.  Human milk oligosaccharides (HMOs) and 
their related glycoproteins and glycolipids are a significant component of human breast milk [8].  
HMOs are a complex mixture of structurally diverse oligosaccharides that influence the gut 
microbial community, reviewed by Coppa and colleagues [9].  Bovine milk-based infant 
formulas are nearly devoid of complex oligosaccharides [10,11], which may negatively influence 
microbial colonization.  Therefore, there has been interest to supplement infant formulas with 
alternative prebiotic oligosaccharides to provide similar functional benefits as HMOs [12-14]. 
 Prebiotics are non-digestible carbohydrates that stimulate the growth of beneficial 
bacteria, thereby providing a health benefit to the host [14-17].  Several prebiotics are generally 
recognized as safe (GRAS) and are used as food ingredients, such as galactooligosaccharides 
(GOS), polydextrose (PDX) and fructooligosaccharides (FOS) [17-19].  Prebiotic 
supplementation of infant formula is well tolerated and stool softness and frequency are similar 
to breast-fed reference groups [20-22].  Additionally, GOS, commonly supplemented with FOS, 
increases counts of bifidobacteria [14,20,22,23] and to a lesser extent lactobacilli [23] in infant 
feces.  A recent study reported a dose-dependent increase in lactobacilli in response to PDX 
supplementation in neonatal piglets [24].  Both bifidobacteria and lactobacilli have been used as 
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commercial probiotics [25] and it is hypothesized that their health promoting functions in the gut 
may be enhanced by prebiotic supplementation. 
 Prebiotic supplemented formula is best suited for testing in infants; however, microbial 
community analysis is limited to feces.  Therefore, a suitable analogue for infant studies is the 
neonatal piglet as it allows for more invasive sampling [26-28].  Findings in human infants show 
that bovine milk-based formula supplemented with prebiotics does not negatively affect piglet 
development [24,29-32].  While several studies have investigated the impact of prebiotics on the 
piglet gut microbiota by older traditional and molecular techniques [24,29,30,32,33], there 
remains a need for a more descriptive analysis. 
 In this study, vaginally-delivered neonatal piglets were used to model the development of 
the infant microbiota in response to GOS/PDX supplemented formula.  We utilized culture-
dependent and -independent methods to perform a broad analysis of the ileal and colonic 
microbiota.  Additionally, we report several species of lactobacilli that are responsive to GOS 
supplementation. 
 
2.3 Materials and Methods 
2.3.1 Ethics statement 
 The experimental procedure and the use of animals were approved by the University of 
Illinois Institutional Animal Care and Use Committee (IACUC) in accordance with all laws and 
regulations pertaining to research with animals.  The approved protocol was #09268.  
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2.3.2 Animals and diets 
 Neonatal piglets (n=29) were obtained from the University of Illinois Swine Research 
Center at 48 h-of-age to allow for ingestion of colostrum.  Piglets were transported to animal 
facilities on campus and were individually-housed in custom cages in rooms maintained at 25 °C 
with 12 h light-dark cycles.  Additional heat was provided to an ambient temperature of 30 °C 
within the piglet cages.  The study was conducted in one replicate and used 3 litters (littermates 
were randomized into each treatment group).  All piglets were randomized to receive a non-
medicated bovine milk-based formula (Advance Baby Pig Liqui-Wean, Milk Specialties 
Company, Dundee, IL) alone (FORM, n=8) or formula supplemented with 2 g/L each GOS 
(FrieslandCampina, Meppel, Netherlands) and PDX (Danisco, Tarrytown, NY, USA) (F+GP, 
n=9).  Sow-reared (SOW, n=12) piglets were included as a reference group.  Formula was 
offered immediately after transport to the animal facility and delivered twenty-times daily by 
pump for a total volume of 360 mL/kg/d for 19 d. 
 
2.3.3 Sample collection 
 On d 21, the piglets were lightly sedated with Telazol (7 mg/kg
 
bodyweight; Fort Dodge 
Animal Health, Fort Dodge, IA, USA) and were euthanized by an intracardiac injection of 
sodium pentobarbital (72 mg/kg
 
bodyweight; Fatal Plus, Vortech Pharmaceuticals, Ltd., 
Dearborn, MI, USA).  Blood and tissue samples were collected for analysis as previously 
described [32].  Briefly, the small intestine was quickly excised from the pyloric sphincter to the 
ileocecal valve and its total length was measured.  The intestine was cut into three segments at 
10% and 85% of the total small intestine length to separate duodenum, jejunum and ileum.  Ileal 
and AC contents were collected for bacterial enumeration, measurement of pH and percent dry 
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matter or were flash frozen and stored at -80 °C for 16S amplicon sequencing.  The pH was 
measured using meter (Mettler Toledo, Columbus, OH, USA) equipped with a combination pH 
electrode (Hanna Instruments, Woonsocket, RI, USA).  Percent dry matter of IL and AC contents 
was calculated following drying at 100 °C for 24 h.  Following the removal of contents, 
intestinal sections were flushed with ice‐cold phosphate buffered saline (PBS) and fixed in 10 % 
(v/v) formalin. 
 
2.3.4 Intestinal histomorphology 
 Formalin‐fixed IL and AC tissue samples were embedded in paraffin wax, sliced to 
approximately 5 μm with a Leica RM2255 microtome (Leica Geosystems, Norcross, GA, USA), 
mounted on glass microscope slides and stained with hematoxylin and eosin.  Images were 
captured using the Nanozoomer Digital Pathology suite (Hamamatsu, Bridgewater, NJ, USA) 
and measurements were determined with AxioVision (Carl Zeiss Microscopy, Thornwood, NY, 
USA).  Images were analyzed for 8-10 well formed villi or cuffs.  IL villus height and crypt 
depth; AC cuff width and depth were measured. 
 
2.3.5 Fermentation products 
 IL and AC contents were analyzed for volatile fatty acid (VFA) products by gas 
chromatography, as previously described [34].  VFAs measured were acetate, propionate and 
butyrate (short-chain fatty acids [SCFA]). Additionally, several branch-chain fatty acids (BCFA) 
isobutyrate, isovalerate and valerate were measured.  
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2.3.6 Culture-dependent characterization of the microbiome 
2.3.6.1 Bacterial enumeration 
 Ileal and AC contents were homogenized in PBS by vortex and aseptically plated in 
triplicate using an Eddy Jet spiral plater (Neu‐Tec, Farmingdale, NY, USA) on Lactobacillus 
selective (LBS) agar (BD, Franklin Lakes, NJ, USA). The agar plates were incubated for 48 h at 
37 °C anaerobically (5 % CO2, 5 % H2 and 90 % N2).  Bacteria were counted using the spiral 
plater manufacturer’s methods and expressed as colony forming units (CFU) per gram of 
homogenized sample.  Ten colonies per piglet per sample were randomly selected, cultivated in 
MRS, resuspended in 12.5 % glycerol and stored at -80 °C. 
 
2.3.6.2 DNA extraction 
 Putative lactobacilli isolates were then grown in 2 mL MRS to stationary phase.  
Following growth, bacterial genomic DNA was isolated using a modified bead-beating technique 
[35].  Briefly, 2 mL of cells were pelleted at 10,000 x g and washed twice with molecular 
biology grade water (Mo Bio Laboratories, Carlsbad, CA, USA).  The pellets were resuspended 
in 750 µL of 0.5 M EDTA buffer pH 8.  The resuspended cells were subjected to bead-beating in 
a FastPrep-24 Instrument (MP Biomedicals, Solon, OH, USA) at 6 m/s for 1 min.  The samples 
were then centrifuged at 10,000 x g at 4 °C for 3 min.  A 600 µL aliquot of the supernatant was 
removed and frozen at -20 °C for subsequent analysis. 
 
2.3.6.3 Identification 
 A partial HSP60 sequence was amplified using lactobacilli specific HSP60 primers, 
LB308F (5’-TGAAGAAYGTNRYNGCYGG-3’) and LB806RM (5’-
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AANGTNCCVCGVATCTTGTT-3’), previously described by Blaiotta and colleagues [36].  The 
PCR amplification of a 499 bp amplicon was performed with a 50 µL total volume.  The reaction 
system consisted of 3 µL of target DNA, 5 µL of each primer (10 mM), 25 µL of EconoTaq Plus 
Green 2X Master Mix (Lucigen Corporation, Middleton, WI, USA).  The PCR consisted of an 
initial step of 2 min at 95 °C, followed by 35 cycles (30 s at 95 °C, 30 s at 50 °C, and 1.5 min at 
72 °C) and completed with an extension step at 72 °C for 15 min.  PCR products were purified 
using the Zymoclean DNA Clean & Concentrator Kit (Zymo Research Corp., Irvine, CA, USA) 
according to the manufacturer's instructions.  PCR products were quantified using a NanoDrop 
ND-1000 Spectrophotometer (NanoDrop, Wilmington, DE, USA).  Sanger sequencing was done 
with either primer (LB308F or LB806RM) using an ABI 3730XL capillary sequencers (Life 
Technologies).  The sequences were trimmed for quality and uploaded to the BLAST database 
(NCBI) to determine identity.  Species identity was determined at 97 % sequence similarity. 
 To confirm identity, a few isolates from each identified species was further sequenced by 
amplification of a partial 16S rRNA sequence by using the 16S rRNA primers, 8F (5’-
AGAGTTTGATCCTGGCTCAG-3’) [37] and 1392R (5’-GACGGGCGGTGWGTRCA-3’) 
[38].  The same PCR conditions, sequencing and identification was performed as outlined above. 
 
2.3.6.4 In vitro carbohydrate utilization 
 Lactobacilli isolated from IL and AC were tested for the ability to utilize glucose (Fisher 
Scientific), Purimune galactooligosaccharides (GOSP, Ingredion, Westchester, IL, USA), and 
PDX as the sole carbohydrate source.  In preparation for the assay, isolates were revived from -
80 °C storage by culturing in 2 mL of MRS anaerobically for 24 or 48 h.  Isolates were passaged 
(1%, v/v) one time into 2 mL semi-synthetic MRS medium (sMRS) containing per liter: 20 g 
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peptone, 5 g yeast extract, 5 g sodium acetate, 2 g disodium phosphate, 2 g ammonium citrate, 1 
mL tween 80, 0.1 g magnesium sulfate, 0.05 g manganese sulfate.  Glucose (10 g/L) was added 
when necessary.  Isolates were further incubated overnight (16-24 h).  Following growth, a 1 mL 
aliquot of sMRS grown cells were washed twice using PBS, pH 7.0 by centrifugation at 13,000 x 
g for 5 min and resuspended in 1 mL sterile carbohydrate-free sMRS. 
 Stock sMRS solutions containing either a 2 % (w/v) of the carbohydrates tested or blank 
(no added carbohydrate) were prepared and 130 µL aliquots were dispensed into a 96-well plate.  
The washed isolates were diluted 10-fold in 1 mL of carbohydrate-free sMRS and 20 µL was 
used to inoculate each well.  Experimental plates were pre-incubated anaerobically for 30 min, 
followed by the addition 50 µL of mineral oil (bioMérieux, Craponne, France) to each well.  
Immediately, the initial optical density (OD) at 595 nm was measured using a Multiscan Ascent 
96-well plate reader (MTX Lab Systems, Vienna, VA, USA).  The plates were incubated 
anaerobically at 37 °C for 48 h.  After 24 and 48 h incubation, the plates were vortexed to 
resuspend the cells and OD was recorded.  Each well was blank-corrected at each time point (0, 
24 and 48 h) and the maximum OD (ODmax) was calculated at 24 and 48 h.  Utilization cutoffs 
were defined by the ODmax obtained and are as follows; low utilization: OD<0.4, moderate 
utilization: 0.4>OD<0.7 and high utilization: OD>0.7.  The relative utilization of GOS and PDX 
was calculated to adjust for isolates incapable of growing in vitro. 
 
2.3.6.5 Thin layer chromatography 
 Consumption of GOSP was determined by measuring the GOS fractions remaining in the 
post-fermentation supernatants of lactobacilli isolated from the IL and AC as previously 
described [39].  Briefly, 2 μL of a 1 % (v/v) carbohydrate standard or bacterial post-fermentation 
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supernatant was spotted onto TLC silica gel plates (Sigma-Aldrich, St. Louis, MO, USA).  
Glucose, galactose (Sigma-Aldrich), lactose (Fisher Scientific) and GOSP were included as 
carbohydrate standards.  The TLC developing solvent was composed of a 2:1:1 mixture of n-
propanol (Fisher Scientific), acetic acid (Fisher Scientific) and water.  TLC plates were further 
prepared by spraying an ethanol based solution containing 0.5% (w/v) α-naphthol (Alfa Aesar) 
and 5% (v/v) H2SO4 (Sigma-Aldrich).  TLC plates were visualized by heating at 100°C for 5 
min. 
 
2.3.7 Culture-independent characterization of the microbiome 
2.3.7.1 DNA extraction 
 Bacterial genomic DNA was isolated from 200-300 mg of IL and AC contents using a 
modified bead beating method [40,41].  The modifications included: (1) IL and AC content 
samples were lysed using a 3 min homogenization step with beads using a vortexer and (2) 
extracted DNA was resuspended in TE buffer overnight at 4 °C instead of mechanical pipetting.  
These modifications were used to minimize DNA shearing for downstream applications.  The 
DNA was purified using QIAmp DNA Stool Kits (Qiagen, Valencia, CA, USA).  Extracted 
DNA was quantified by NanoDrop. 
 
2.3.7.2 Quantitative PCR 
 Butyrate productivity was quantified from extracted bacterial genomic DNA from AC 
contents. Butyrate productivity was determined by amplification of the Butyryl-Coenzyme A 
transferase using previously published methods [42].  Standard curves of 10
2
 to 10
8
 CFU/mL 
were produced using a 573 bp gene product synthesized and ligated into a plasmid (GeneArt, 
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Carlsbad, CA, USA).  The minimum detectable CFU/mL was 10
3
.  The AC bacterial genomic 
DNA was diluted 10-fold prior to quantification.  Quantitative PCR was performed using the 
Applied Biosystems 7900HT Fast Real-Time PCR System (Applied Biosystems, Carlsbad, CA, 
USA).  Each 10 µL qPCR reaction included 5 µL of 2x Power SYBR Green PCR Master mix 
(Applied Biosystems), bovine serum albumin at a final concentration of 1 μg/uL (New England 
Bio Labs, Ipswich, MA, USA), 0.5 µM of each primer and 2 µL of the DNA sample.  The PCR 
conditions were 50 °C for 2 min, 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s, 53 
°C for 1 min and 72 °C for 30 s.  Following amplification, a dissociation step was included to 
analyze the melting profile of the amplified products and ensure that no extraneous products 
were generated. 
 
2.3.7.3 16S amplicon sequencing 
 Genomic DNA isolated from IL and AC contents were analyzed by 16S amplicon 
sequencing at the Research and Testing Laboratory (RTL, Lubbock, TX) based upon RTL 
protocols [43].  Briefly, the V1-V3 hypervariable region of the 16S rRNA gene was amplified 
using the Gray28F (5’-GAGTTTGATCNTGGCTCAG-3’) and Gray519R (5’-
GTNTTACNGCGGCKGCTG-3’) primer set.  Sequencing was performed using the Roche 454 
FLX instrument (Roche, Indianapolis, IN, USA).  For a detailed description of the sequencing 
and bioinformatic analyses, refer to Ishak and colleagues [44].  Raw read data was submitted to 
the Sequence Read Archive (NCBI) and can be accessed with the accession number SRP049961.  
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2.3.8 Statistical analyses and illustrations 
 Analysis of piglet weight, weight gain, intestinal lengths and weights, intestinal 
histomorphology, fermentation products and bacterial enumeration was performed using the 
general linear model (GLM) procedure within SAS (Version 9.2, SAS Institute, Cary, NC, 
USA).  When significant comparisons (P<0.05) were observed, post hoc analysis using the least 
significant difference (LSD) was used.  Lactobacilli communities are presented as stacked bar 
charts produced with R [45] using the gplots [46] package.  Dendrograms were constructed using 
the Bray-Curtis Dissimilarity index using the vegan [47] R package.  Prior to analysis of the 16S 
amplicon sequencing data, rarefaction was used to standardize richness to 3118 sequences per 
sample, thus facilitating comparisons among groups.  In addition, IL samples were analyzed 
separately from AC samples.  Microbial diversity and richness was quantified as the number of 
operational taxonomic units (OTUs) or with Chao1's richness estimator (each were defined based 
on 3% divergence).  The impact of diet on bacterial diversity and total estimated richness was 
evaluated using one-way ANOVA.  The overall variability within the microbiota was illustrated 
using Principle Coordinates Analysis (PCoA), and multivariate differences among diet groups 
were evaluated using distance-based redundancy analysis (dbRDA) [48].  For PCoA and 
dbRDA, phylogenetic distances among samples were first calculated using the UniFrac distance 
measure, unweighted UniFrac distance considers only changes in composition (i.e., identities) 
[49].  UniFrac was calculated using QIIME [50], and all other analyses were conducted in R 
[45], using the vegan [47] and labdsv [51] packages.  Individual bacterial taxa were screened for 
differences among diets using ANOVA.  Prior to analysis, relative abundances were transformed 
using an arcsin transform (p’ = arcsin (√p)).  To control for errors due to multiple testing and to 
limit the amount of false positives, ANOVA model p-values were adjusted to maintain a false 
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discovery rate (FDR) of 10%.  Indicator species analysis [52] was used to identify individual 
species within the genus Lactobacillus that were indicative of each of the diets.  Indicator species 
analysis synthesizes information about occurrence and abundance of individual taxa, and this 
information is summarized as an indicator score.  The analysis also provides a randomization test 
of the degree to which taxa are indicative of a particular state.  Here, all species are shown, 
regardless of the results of the randomization test. 
 
2.4 Results 
2.4.1 Animal observations 
 The final body weight and overall weight gain of the piglets were not different between 
the groups (P>0.05, data not shown).  Additionally, the total intestinal weight and length did not 
differ between groups and averaged 196 ± 41.3 g/kg and 148.8 ± 40.3 cm/kg; respectively.  
Intestinal histomorphology demonstrated that the ileal (IL) villus length, crypt depth and 
ascending colon (AC) cuff width were not significantly different among the groups (P>0.05; 
Table 2.1).  However, the SOW group had significantly deeper AC cuff depth as compared to 
FORM and F+GP groups (P<0.0001).  While there were no differences in the percentage of dry 
matter in the AC contents (P>0.05, Table 2.1), the percentage of dry matter in the IL was lower 
in the F+GP group than the SOW group (P=0.04), but not the FORM group. 
 
2.4.2 Isolation and characterization of intestinal lactobacilli 
 Based on published research, we hypothesized that supplementation of GOS/PDX should 
selectively stimulate the growth of lactobacilli.  Therefore immediately following euthanasia, IL 
and AC contents were plated on Lactobacillus selective (LBS) agar to obtain lactobacilli isolates.  
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Total presumptive Lactobacillus counts (CFU/g) were not significantly different between the 
groups or location (P>0.05, data not shown).  While the absolute abundance of lactobacilli was 
not different between groups, it may be the composition of the lactobacilli community that is 
important.  Therefore, approximately 10 isolates per piglet were cultivated and speciated using a 
combination of the HSP60 and 16S rDNA gene sequences.  All of the isolates identified were of 
the order Lactobacilliales and were represented by eight Lactobacillus species and two non-
Lactobacillus genera.  Unfortunately, the co-isolation of Pediococcus and Weisella with 
Lactobacillus in the formula-fed piglets was quite significant (range 10-37% of total isolates).  
The Pediococcus and Weisella isolates were removed from further analyses. 
 Culture-dependent analysis showed a variable lactobacilli community between groups 
(Figure 2.1).  The SOW group was dominated by two lactobacilli: L. johnsonii (IL: 64%, AC: 
50%) and L. reuteri (IL: 33%, AC: 44%).  While L. johnsonii was also highly abundant in the 
FORM and F+GP groups, these two groups had a more diverse lactobacilli community as 
compared to the SOW group.  L. vaginalis was solely detected in the FORM and F+GP groups, 
representing 7-13% (IL and AC) of the isolates. 
 To determine if the supplementation of GOS/PDX selectively enriches for a GOS/PDX 
fermenting community, carbohydrate utilization was conducted with the FORM and F+GP 
lactobacilli isolates (Figure 2.2 and Table A.1).  The majority of lactobacilli isolates from both 
the FORM and F+GP piglets were found to utilize GOS well (ΔOD>0.7); whereas, the utilization 
of PDX was minimal.  While a larger proportion of lactobacilli isolates were defined as high 
utilizers of GOS in the IL (FORM: 87.5% vs. F+GP: 97.3%), this was not the case in the 
ascending colon (FORM: 86% vs. F+GP: 70.7%).  Thin layer chromatography was conducted to 
determine if the ability to consume different GOS fractions was different due to GOS 
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supplementation (data not shown).  In general, the lactobacilli isolates with a low (ΔOD<0.4) or 
moderate (0.4>ΔOD<0.7) ability to utilize GOS corresponded with a reduction in the mono- and 
disaccharide fractions (DP1-2).  The lactobacilli isolates classified as high utilizers (ΔOD>0.7) 
demonstrated partial consumption of trisaccharide GOS (DP3) as well as complete consumption 
of the DP1-2 fractions.  We did not observe any reduction in the longer GOS chains (DP4-6) by 
any of the isolates. Interestingly, L. vaginalis was observed to differentially utilize GOS in vitro.  
The few L. vaginalis isolates that grew to an OD>0.4 showed at least partial consumption of 
GOS (DP1-3); whereas, the majority of isolates were not capable of fermenting GOS as a sole 
carbon source.  Overall, the consumption of GOS was not different between the FORM and 
F+GP piglets regardless of location. 
 
2.4.3 Characterization of intestinal bacterial community 
 The IL and AC microbiota was analyzed by 16S amplicon sequencing which generated a 
total of 292,547 sequences with an average of 5,519 sequences per sample.  Following sequence 
normalization, overall microbial diversity was determined by calculating the total number of 
operational taxonomic units (OTUs) detected and total richness was estimated by the Chao1 
index (Table 2.2).  The SOW group had higher IL microbial diversity and total richness as 
compared to the formula-fed piglets (OTUs: P=0.01, Chao1: P=0.025; respectively).  The 
microbial diversity and total richness were not significantly different in the AC. 
 The overall variation in the piglet microbiota among the three groups was evaluated using 
a distance-based redundancy analysis (dbRDA).  Distances were calculated using the unweighted 
Unifrac distance measure and were illustrated using Principle Coordinates Analysis (PCoA).  
The PCoA of the piglet microbiome shows a clear divergence in location of samples (IL vs. AC) 
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and between the SOW piglets and the formula-fed piglets (Figure 2.3a).  This divergence was 
evident following characterization at the taxonomic level.  A heat map was constructed with the 
relative abundances of the dominant taxa in both locations (Figure A.1).  Groups were clustered 
using the unweighted Unifrac distances.  In the IL, the SOW group was characterized by a high 
abundance of Clostridium spp. whereas the formula-fed piglets were defined more by the 
presence of Weissella spp.  In the AC, the differences in relative abundance of Faecalibacterium 
and Parabacteroides showed separation of the SOW group from the formula-fed groups (Figure 
A.2). 
 In general, our data (Figure 2.3 and A.1-A.2) demonstrates that sow-reared piglets may 
not be an appropriate reference group.  The primary focus of this study was to analyze the 
bacterial composition due to a prebiotic supplementation.  The differences between the formula-
fed piglets and the sow-reared piglets were not solely dietary; therefore, the 16S amplicon 
sequencing data was reanalyzed without the SOW group in order to observe differences due 
solely to the prebiotic supplementation. 
 Consistent with the previous 16S amplicon sequencing data, the microbial diversity and 
total richness of the FORM and F+GP groups were not significantly different in the IL or AC 
(P>0.05, data not shown).  Similar clustering between the FORM and F+GP groups by location 
was observed when determining the overall variation of the microbiome with a PCoA of the 
unweighted Unifrac distances (Figure 2.3b).  In the IL, no detected genera had a FDR less than 
10%; therefore further statistical analysis was not performed.  However, six genera were detected 
in the AC that had an FDR less than 10% and were determined to be significantly different 
(P<0.05) between the FORM and F+GP groups based on differences in relative abundance 
(Table A.2 and Figure A.2).  Ruminococcus, Oscillopira, Hydrogenoanaerbacterium and 
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Catabacter were significantly more abundant in the FORM group, while Parabacteroides and 
Lactobacillus were significantly more abundant in the F+GP group.  Interestingly, the relative 
abundance of Parabacteroides more than two times greater in the F+GP piglets (FORM: 8.67 ± 
2.22 vs. F+GP: 18.33 ± 3.98; Table A.2). 
 
2.4.4 Culture-independent examination of lactobacilli community 
 16S amplicon sequencing analysis identified that the Lactobacillus genus differed 
between the FORM and F+GP groups in the AC (SOW group is included for reference).  Eight 
major species of Lactobacillus, having a relative abundance above 1% of the total lactobacilli 
community, were detected in IL and AC (Figure 2.4).  Consistent with the culture-dependent 
results, L. johnosonii is a dominant member of the lactobacilli community in all piglets.  On the 
other hand, L. mucosae was detected in all piglets by 16S amplicon sequencing; however, was 
not among the lactobacilli isolated from either the IL or AC. 
 Further analysis was conducted to determine if any lactobacilli were predictive of a 
particular treatment (Figure 2.5a-b).  Indicator species analysis showed that L. plantarum, L. 
amylovorous and L. pentosus to be indicative of the group FORM but not the F+GP group in the 
IL (Figure 2.5a).  Conversely, L. vaginalis, L. johnsonii and L. reuteri were more indicative of 
the F+GP group in the IL.  In the AC, L. johnsonii, L. mucosae, L. agilis and L. reuteri were 
highly indicative of the F+GP group as compared to the FORM group; whereas, L. vaginalis and 
L. rogosae, were slightly indicative of the FORM group (Figure 2.5b).  
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2.4.5 Fermentation products 
 Volatile fatty acids (VFA) were determined from the IL and AC contents (Figure 2.6).  In 
the IL, propionate was higher (P=0.028) in the FORM group as compared to the F+GP and SOW 
groups; (Figure 2.6a) and isovalerate concentration was lower (P=0.004) in the F+GP group 
when compared to the SOW group, but not the FORM group (Figure 2.6b).  The IL pH ranged 
from 7.7-7.8 and was not different among the treatment groups (P=0.892).  In the AC, there were 
no significant differences in the measured SCFAs (P>0.05, Figure 2.6c).  Furthermore, the SOW 
group had higher observed levels of isobutyrate (P=0.004), isovalerate (P=0.001) and total 
BCFA (P=0.008) than the formula-fed groups (Figure 2.6d).  The AC pH tended (P=0.055) to be 
lower in both formula-fed groups (FORM: 6.8, F+GP: 6.6) than in the SOW group (7.3). 
 The total butyrate productivity was evaluated in the AC contents using quantitative PCR.  
The absolute abundance of the butyryl-Coenzyme A transferase gene was not significantly 
different between the three groups (P=0.4281, data not shown). 
 
2.5 Discussion 
 Prebiotic supplementation of infant formula is well tolerated, improves the consistency 
and frequency of stools and provides a bifidogenic effect [14,20-22,53-57].  Additionally, our 
group has shown that prebiotic supplementation does not increase bacterial translocation in 
neonatal piglets [32].  Taken together, these studies demonstrate the nutritional benefits and 
safety for prebiotic supplementation of infant formula.  However, a detailed examination of the 
impact of prebiotics on the composition of the gut microbiome and the products of microbial 
fermentation is lacking.  In addition, identification of prebiotic-responsive lactobacilli could 
assist in determining which organisms are enhanced by prebiotic supplementation.  In this study, 
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the impact of GOS and PDX (2 g/L each) provided in a bovine milk-based infant formula was 
examined in neonatal piglets, a relevant infant model [26-28].  Since prebiotic fermentation is 
restricted to the distal GI tract [58], the IL and AC were targeted for analysis. 
 Prebiotic supplementation did not significantly affect the body weight gain or intestinal 
weight or length compared to SOW or FORM.  Formula feeding minimally impacted the 
intestinal histomorphology, compared to SOW with no impact of prebiotic supplementation.  The 
AC crypt depth was significantly deeper in the SOW piglets as compared to the formula-fed 
piglets, which is consistent with our previous study that investigated bacterial translocation of 
GOS/PDX-supplemented formula-fed piglets [32].  Another study that supplemented formula 
with inulin and GOS did not detect differences in colonic histomorphology due to prebiotic 
supplementation; however a sow-reared group was not included [59].  Additional piglet studies 
that measured intestinal histomorphology following prebiotic supplementation only reported ileal 
measurements [24,31].  Therefore, we can conclude that the addition of GOS and PDX to 
formula is well tolerated and minimally impacts piglet intestinal development. 
 Changes in the IL and AC microbiota due to prebiotic supplementation were evaluated by 
high-throughput 16S amplicon sequencing.  Significant differences in the intestinal microbiota 
composition were observed between the SOW and formula-fed piglets.  In this study, there were 
differences in nutrition (sow’s milk versus bovine milk-based formula), housing (group housing 
with siblings and sow versus individual-housing of formula-fed piglets) and exposure to novel 
microbiota.  Previous work has shown that formula-fed and breast-fed infants have different 
microbial composition [7,60], that stress can affect the microbial composition [61] and that 
homogenization of the gut bacterial community may occur in co-housed animals [62].  
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Therefore, future microbial studies examining formula-fed versus mother-fed animals should 
take care to minimize the variation between groups. 
 Due to the distinct differences between SOW and the formula-fed piglets, the 16S 
amplicon sequencing data was reanalyzed without SOW in order to isolate differences solely due 
to prebiotic supplementation.  The bacterial diversity and richness did not differ between FORM 
and F+GP; however, the relative abundance of several bacterial genera were significantly 
different in the AC.  Interestingly, Parabacteroides and Lactobacillus were identified as being 
significantly more abundant in the AC of F+GP piglets.  Parabacteroides, closely related to 
Bacteroides [63], may possess enzymes capable of utilizing either GOS or PDX; however, there 
is currently no published data to confirm this hypothesis.  Martinez and colleagues [64] did 
report a significant increase of Parabacteroides distasonis in human feces following 
consumption of resistant starch type 4 but not resistant starch type 2.  Future studies should 
evaluate the Parabacteroides community in relation to GOS/PDX supplementation in greater 
detail. 
 Historically, lactobacilli are considered health promoting microorganisms and have 
recently gained notoriety as probiotics [65].  Additionally, Lactobacillus sp. have been shown to 
be stimulated by prebiotic inclusion in formula milk [23,24].  Therefore, we hypothesized that 
the supplementation of GOS/PDX may alter the in vivo lactobacilli community.  Following 
speciation of presumptive lactobacilli isolates, we observed that L. johnsonii was the 
predominant member in the IL and AC of all piglets.  While the formula-fed piglets had a more 
diverse lactobacilli community, it was not apparent if any Lactobacillus sp. isolated were 
prebiotic-responsive.  Therefore, the lactobacilli isolates were tested for their ability to utilize 
GOS and/or PDX as a sole carbon source (direct fermentation).  We observed extensive 
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utilization of GOS but minimal utilization of PDX by Lactobacillus sp. isolated from the IL and 
AC of all formula-fed piglets.  Therefore, we further hypothesized that GOS supplementation 
may select for lactobacilli isolates that are capable of consuming longer chain GOS (DP3-6) 
rather than the mono- and disaccharide fractions (DP1-2) that are mostly removed by digestion 
prior to the IL and AC.  To test this hypothesis, the post-fermentate was analyzed by TLC for 
consumption of GOS fractions (DP1-6).  In general, most lactobacilli isolates were capable of 
consuming the mono- and disaccharide fractions (DP1-2); however, a smaller fraction of 
lactobacilli were capable of consuming trisaccharide GOS (DP3).  Importantly, there was no 
difference regarding the number of FORM and F+GP lactobacilli isolates that could ferment the 
longer GOS fractions.  Direct fermentation of GOS or PDX doesn’t appear to be responsible for 
the increase in the lactobacilli population in the AC of the F+GP piglets. 
 Consistent with culture-dependent analysis, L. johnsonii was highly abundant in both 
FORM and F+GP piglets and was indicative of the F+GP treatment in the IL and AC.  Various 
strains of L. johnsonii have been investigated in depth for their health promoting properties.  In a 
rodent model for diabetes mellitus type 1 (T1DM), L. johnsonii was differentially abundant in 
the T1DM-resistant rats versus their T1DM-prone cohorts [66].  Furthermore, transmission of the 
strain L. johnsonii N6.2 can delay the onset of T1DM in prone rats [67].  The potential 
mechanisms of action of L. johnsonii N6.2 in this rodent model have been investigated and 
include enhancement of intestinal barrier function [67], reduction of intestinal oxidative stress 
[67] and modulation of the immune system [68-70].  Administration of L. johnsonii (La-1) to 
mice with branchial induced asthma dampened the autoimmune response by reducing the 
proportion of CD4
+
 T lymphocytes expressing IL-4 and increasing CD4
+
 T lymphocytes 
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expressing IFNγ [71]. Thus, promoting the growth of L. johnsonii by feeding PDX and GOS has 
the potential to modulate immune development; however, this remains to be directly tested. 
 Indicator species analysis of the 16S amplicon sequencing data identified two additional 
Lactobacillus species that were characteristic of the F+GP piglets.  L. vaginalis was strongly 
indicative of the F+GP piglets in the IL, whereas L. mucosae was strongly indicative of the 
F+GP piglets in the AC.  Surprisingly, the majority of L. vaginalis representative isolates (79 %) 
were not GOS utilizers in vitro suggesting that direct GOS utilization did not lead to an increase 
in L. vaginalis in vivo. 
 Commonly, changes in microbial communities are coupled with the measurement of 
select byproducts of fermentation.  Prebiotics, resistant to host digestion in the proximal GI of 
piglets and humans, are selectively fermented by the microbial community in the distal GI where 
the primary metabolites produced are SCFA from carbohydrate fermentation, [72] and BCFA 
from protein fermentation [73,74].  In the IL, no increase in total SCFA due to the prebiotics was 
detected; F+GP had the lowest SCFA concentration.  Mono- and disaccharides are the primary 
substrate responsible for SCFA production in the IL, whereas prebiotics are largely fermented in 
the large bowel [58]. Total SCFA concentrations were not significantly different among the three 
groups in the AC; however, it is estimated that >95 % of SCFA are rapidly absorbed by 
colonocytes [58].  Without the ability to measure the rate of host absorption of SCFA, and the 
total amount of SCFA in AC contents, we cannot determine the degree to which GOS and PDX 
were fermented in vivo.  In young pigs fed a transgalactooligosaccharide-supplemented casein-
cornstarch diet [75], ileal SCFA concentrations were similar to the amounts observed in the 
current study.  Additionally, Fava and colleagues [76] reported that PDX supplementation did 
not affect SCFA in the distal small intestine or proximal colon of piglets.   Thus, our results are 
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consistent with these studies.  The production of BCFA is primarily due to the fermentation of 
amino acids rather than prebiotics [73,74].  The SOW group had significantly higher 
concentrations of isobutyrate, isovalerate and total BCFA.  This is consistent with additional 
piglet studies performed in our group [77], and may be due to proteins in sow milk that are 
resistant to small intestinal digestion, such as immunoglobulins. 
 This study provided a descriptive analysis of changes in the intestinal communities of 
neonatal piglets fed formula milk supplemented with GOS and PDX.  Most interestingly were 
the significant increases in Parabacteroides and Lactobacillus sp. in the F+GP piglets.  We did 
not observe an increase in the amount of lactobacilli that can utilize GOS nor the DP of GOS that 
was consumed.  Therefore, we conclude that direct utilization of GOS was not responsible for 
the observed increase in Lactobacillus sp.  Additional studies should be conducted to determine 
if GOS/PDX utilization by Parabacteroides sp. in vitro and to identify if this genus has 
physiological benefits to a neonatal piglet. 
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2.7 Tables and Figures 
Table 2.1.  Histomorphology of ileum and ascending colon of 21-d-old piglets fed formula (FORM), formula supplemented with GOS 
and PDX (F+GP) or sow-reared (SOW). 
 Diets 
 
FORM  F+GP  SOW  GLM ANOVA 
 
Mean SD  Mean SD  Mean SD  p-value 
Ileum           
 Villus Length (µm) 495 156  401 61  387 70  > 0.05 
 
Crypt Depth (µm) 184 45  177 30  202 32  > 0.05 
 
Dry Matter (%) 12.6
ab
 3.6  9.9
a
 2.9  15.3
b
 5.7  0.04 
Ascending Colon           
 
Cuff Width (µm) 51
b
 5  58
a
 6  56
ab
 5  0.05 
 
Cuff Depth (µm) 275
a
 24  261
a
 24  357
b
 38  < 0.0001 
 Dry Matter (%) 21.3 3.9  21.0 3.0  20.5 5.2  > 0.05 
a b
  values with the same letters are not different at α=0.05 (Tukeys LSD).  
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Table 2.2.  Microbial analysis from ileal and ascending colon contents of 21d old piglets fed formula (FORM), formula supplemented  
with GOS and PDX (F+GP) or sow-reared (SOW) as determined by 16S amplicon sequencing. 
  Diets 
  
FORM 
 
F+GP 
 
SOW  GLM ANOVA 
  
Mean SD 
 
Mean SD 
 
Mean SD  p-value 
Ileum  
 
Total Sequences 9597 2331 
 
7973 1823 
 
5154 2029  ND
2
 
 
OTUs
1
 (97%) 667
a
 157 
 
660
a
 150 
 
851
b
 146  0.01 
 
Chao1 (97%) 1266
a
 265 
 
1322
a
 263 
 
1647
b
 300  0.025 
Ascending Colon  
 
Total Sequences 5067 1529 
 
4674 912 
 
3457 1293  ND
2
 
 
OTUs
1
 (97%) 892 80 
 
902 95 
 
868 153  > 0.05 
 
Chao1 (97%) 1680 190 
 
1686 176 
 
1757 240  > 0.05 
1
 OTU and Chao1 normalized to 3118 sequences per sample. 
2
 ND = not determined. 
a b
 values within the row with the same letters are not different.  
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Figure 2.1.  Lactobacilli population is dominated by few members.  Lactobacilli communities 
isolated from the ileum (IL) and ascending colon (AC) of 21 d old piglets fed either a bovine 
milk-based formula (FORM), formula supplemented with GOS and PDX (F+GP) or sow-reared 
(SOW).  Stacked bar chart represents the percent relative abundance of each lactobacilli detected 
in the community.  Beta diversity was calculated using the Bray-Curtis Dissimilarity Index and is 
visualized by a dendrogram. 
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Figure 2.2.  Several isolated lactobacilli identified as GOS utilizers.  Carbohydrate utilization of lactobacilli communities isolated 
from the ileum (IL) and ascending colon (AC) of 21 d old piglets fed either a bovine milk-based formula (FORM), formula 
supplemented with GOS and PDX (F+GP).  (A) Percent relative utilization (OD>0.7) of glucose, Purimune galactooligosaccharide 
(GOSP) or PDX.  To account for isolates not capable of in vitro fermentation, utilization was normalized to maximum number of 
isolates capable of utilizing glucose as a sole carbon source. (B) Maximum optical density (595 nm) of Lactobacilli sp. when GOSP is 
supplemented as a sole carbon source.  Colored bar indicates the mean maximum optical density.  Not all Lactobacillus sp. were 
detected in each treatment or location.  
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Figure 2.3.  Bacterial communities vary greatly by location, but less by diet.  Ileal (IL) and ascending colon (AC) microbiome of 21 d 
old piglets fed either a bovine milk-based formula (FORM), formula supplemented with GOS and PDX (F+GP) or sow-reared (SOW) 
illustrated by Principle Coordinate Analysis (PCoA).  PCoA was constructed from the unweighted Unifrac distance measure which 
only considers the change in composition not abundance.  PCoA of the 16S amplicon sequencing data set: (A) all three treatments; (B) 
formula-fed piglets only. 
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Figure 2.4.  Culture-independent analysis reveals a more diverse lactobacilli community.  
Lactobacilli communities from the ileum (IL) and ascending colon (AC) of 21 d old piglets fed 
either a bovine milk-based formula (FORM), formula supplemented with GOS and PDX (F+GP) 
or sow-reared (SOW) as determined by 16S amplicon sequencing.  Stacked bar chart represents the 
percent relative abundance of each lactobacilli detected in the community.  Beta diversity was 
calculated using the Bray-Curtis Dissimilarity Index and is visualized by a dendrogram.  
Lactobacilli represented by the label Lactobacillus sp. were unable to be assigned a species.  
Minor Lactobacillus sp. is an aggregate of lactobacilli present in > 1 % percent relative 
abundance (Table A.3).  
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Figure 2.5.  Identification of the predominant Lactobacillus spp. in each group.  Indicator 
species analysis (ISA) of the lactobacilli community of 21 d old piglets fed either a bovine milk-
based formula (FORM), formula supplemented with GOS and PDX (F+GP) or sow-reared 
(SOW, included for reference).  Color change demonstrates the more a species is indicative of a 
diet.  The higher the indicator score (i.e. darker color), the more that species is indicative of that 
group.  ISA scores for the genera Lactobacillus detected in the (A) IL; (B) AC.  
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Figure 2.6.  Prebiotic supplementation leads to minimal changes in static volatile fatty acid 
concentration.  Volatile fatty acids detected in ileal (IL) and ascending colon (AC) contents of 21 
d old piglets fed either a bovine milk-based formula (FORM), formula supplemented with GOS 
and PDX (F+GP) or sow-reared (SOW). VFAs detected in IL: (A) Short-chain fatty acids; (B) 
Branch-chain fatty acids.  VFAs detected in the AC: (C) Short-chain fatty acids; (D) Branch-
chain fatty acids.  Values with different superscripts are significantly different (p<0.05). 
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CHAPTER THREE 
IN VITRO IMPACT OF HUMAN MILK OLIGOSACCHARIDES ON 
ENTEROBACTERIACEAE GROWTH
1
 
3.1 Abstract 
 Human milk oligosaccharides (HMOs) function as prebiotics in the infant gut by 
selecting for specific species of bifidobacteria and bacteroides, but little is known about their 
potential utilization by Enterobacteriaceae, the relative numbers of which have been linked to the 
onset of necrotizing enterocolitis in preterm infants.  In this study, the in vitro growth of purified 
HMOs and other related carbohydrates was evaluated using individual strains of 
Enterobacteriaceae and an Enterobacteriaceae consortia enriched from piglet feces.  None of the 
Enterobacteriaceae strains grew on 2’-fucosyllactose, 6’-sialyllactose or lacto-N-neotetraose 
(LNnT); however, several strains were capable of utilizing galactooligosaccharides, 
maltodextrin, and the mono- and disaccharide components of HMOs for growth.  The enriched 
fecal consortia also did not grow on 2’-fucosyllactose or 6’-sialyllactose, but there was limited 
growth on LNnT.  It was concluded that 2’-fucosyllactose and 6’-sialyllactose supplementation 
of preterm infant formula should not lead to an increase in Enterobacteriaceae; however, 
supplementation with LNnT may require further study. 
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3.2 Introduction 
 Human milk is replete with biological compounds that not only provide neonates with an 
optimal nutrition source
1
 but are associated with proper intestinal, and immunological 
development.
2
  Of particular interest are the human milk oligosaccharides (HMOs), a group of 
complex carbohydrates produced by the mother and abundantly expressed in breast milk at levels 
ranging from 5 to 23 g/L.
3,4
  Significant work has led to the annotation of the structural diversity 
of HMOs with over 200 unique compounds identified.
5
  Regardless of their structural 
complexity, HMOs are not digestible by human neonates and have been detected in feces.
6
 
 Over the past two decades, an extraordinary amount of work has been done to elucidate 
the relationship between HMOs and infant health.  The research shows that HMOs function as 
part of a neonate’s innate immune system and protect the neonate while the adaptive immune 
system is being developed.
7,8
  Furthermore, HMOs act as soluble receptor analogues to prevent 
invasion by common pathogenic microorganisms.
4,9
  Specifically, neutral and acidic HMO 
fractions altered the adhesion of enteropathogenic Escherichia coli to Caco-2 cells,
10,11
 whereas 
fucosylated HMOs reduced colonization of Campylobacter jejuni in mice.
12
  Finally, HMOs 
have been shown to contribute to the establishment of a healthy gut microbiota, in particular, by 
selectively promoting the colonization of specific Bifidobacterium
13-15
 and Bacteroides species.
16
 
 Improper establishment of the neonatal gastrointestinal (GI) microbiota has been 
implicated as one of several contributing factors to necrotizing enterocolitis (NEC),
17
 a highly 
detrimental and often fatal necrosis of intestinal tissue that is primarily observed in preterm 
infants.  Fecal microbiome studies in preterm neonates have documented a bloom in relative 
abundance of Proteobacteria, specifically members of the class Gammaproteobacteria, at the 
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expense of Firmicutes.
18-21
  It is hypothesized that this microbial imbalance increases intestinal 
inflammation and promotes development of NEC.
22
 
 Although there is a growing amount of literature regarding the utilization of HMOs by 
bifidobacteria and Bacteroides,
15,23,23
 little is known about the ability of Enterobacteriaceae, 
members of the Gammaproteobacteria class of bacteria, to metabolize or grow on individual 
HMOs.  Marcobal and colleagues
16
 observed that two strains of E. coli (OP50 and EC100) 
showed limited growth when provided with a complex mixture of HMOs that was purified from 
pooled human milk samples.  Hence, more data are needed to verify that other members of this 
family are unable to use individual purified HMOs. 
 In this study, several Enterobacteriaceae strains were selected and evaluated for their 
ability to grow in the presence of purified HMOs, prebiotics, and other related carbohydrates.  In 
addition, carbohydrate utilization was assessed using an Enterobacteriaceae consortia enriched 
from piglet feces.  Finally, the impact of HMOs on the ability for Enterobacteriaceae strains to 
utilize glucose, lactose, and maltodextrin for growth was investigated. 
 
3.3 Materials and Methods 
3.3.1 Bacterial strains 
 Enterobacteriaceae strains (Table 3.1) were chosen on the basis of published data 
showing their relationship with the incidence of necrotizing enterocolitis in mice
24
 and infants.
18-
20
  Bacterial strains were purchased from the American Type Culture Collection (ATCC, 
Manassas, VA, USA).  Confirmation of bacterial identity was completed prior to the bacterial 
growth assays.  Briefly, bacterial cultures were inoculated from frozen stock (12.5% glycerol, 
v/v) into brain-heart infusion (BHI; Difco, Franklin Lakes, NJ, USA) broth and incubated 
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overnight aerobically with shaking at 200 rpm at 37 °C.  Genomic DNA was isolated from 
stationary bacterial cultures.  Briefly, a 1.8 mL aliquot was centrifuged at 10,000g in a 2 mL 
centrifuge tube containing approximately 100 μg of 0.25 μm silicon beads (RPI Corp., Mount 
Prospect, IL, USA) for 1 min and the bacterial pellet was resuspended in nanopure water.  The 
tubes were boiled for 5 min (additional kill step for pathogens) and were then centrifuged at 
7000g for 5 min.  The bacterial pellet was resuspended in nanopure water and vortexed at 
maximum speed for 10 min.  The lysed bacterial cells were centrifuged at 12,000g for 3 min, and 
the supernatant was frozen at -20 °C.  An approximately 1400 bp amplicon of DNA was 
amplified from the crude DNA extract by 16S rRNA specific primers, 8F (5’ – 
AGAGTTTGATCCTGGCTCAG – 3’) and 1391R (5’ – GACGGGCGGTGWGTRCA – 3’).25,26  
The PCR reaction mixture contained 3 μL of target DNA, 5 μL of each primer (10 mM), and 25 
μL of EconoTaq Plus 2X Master Mix (Lucigen Corp., Middleton, WI, USA).  The PCR cycling 
parameters consisted of an initial step of 5 min at 95 °C, followed by 35 cycles (30 s at 95 °C, 60 
s at 54 °C, and 2 min at 72 °C) and an extension step at 72 °C for 7 min.  PCR products were 
purified using the Zymoclean DNA Clean & Concentrator Kit (Zymo Research Corp., Irvine, 
CA, USA) according to the manufacturer's instructions.  Sanger sequencing was done with either 
primer (8F or 1391R) using an ABI 3730XL capillary sequencer (Life Technologies).  The 
sequences were trimmed for quality and uploaded to the BLAST database (NCBI) to determine 
identity (>97% similarity).  All strains were confirmed as the species indicated in Table 3.1. 
 
3.3.2 Bacterial growth assays 
 Bacterial growth due to the addition of a carbohydrate was determined using a Bioscreen 
C (Growth Curves USA, Piscataway, NJ, USA).  Bacterial cultures were inoculated from frozen 
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stock (12.5% glycerol, v/v) into BHI broth and grown overnight aerobically with shaking at 200 
rpm and 37 °C.  A 1% (v/v) inoculum was passed into 5 mL of ZMB-1 broth,
27
 a chemically 
defined medium allowing for carbohydrate utilization experiments, supplemented with 1% 
glucose and incubated overnight aerobically with shaking at 200 rpm at 37 °C.  To prepare the 
bacterial inoculum for the Bioscreen C growth assay, bacterial cultures were centrifuged at 
4000g for 10 min and washed twice with phosphate-buffered saline (PBS; MP Biomedicals, 
Santa Ana, CA, USA), pH 7.4.  The washed bacterial pellets were resuspended in 5 mL of 
carbohydrate free ZMB-1 broth.  The final bacterial inoculum was prepared by transferring a 1% 
(v/v) volume of ZMB-1 suspended cells into a fresh aliquot of ZMB-1 broth.  The honeycomb 
plate was prepared with each well containing a total of 300 μL: 225 μL of washed cells in ZMB-
1 broth and 25 μL of 10% (w/v) sugar solution (Table 3.2), and 50 µL of mineral oil (to prevent 
evaporation).  Plates were preincubated anaerobically (90% N2, 5% CO2, 5% H2; Coy Laboratory 
Products, Grass Lake, MI, USA) for 1 h prior to the addition of mineral oil.  Plates were 
incubated anaerobically for 24, 48, 72 or 96 h (varied by experiment).  Optical density at 600 nm 
was measured at 30 min intervals, which were preceded by 30 s of shaking at maximum speed.  
Each carbohydrate was tested with a minimum of three independent replications. 
 
3.3.3 Enrichment of Enterobacteriaceae consortia 
 The following protocol was utilized to enrich and isolate Enterobacteriaceae from feces 
of weaned piglets (n = 10) aged 42 days.  Fresh fecal samples (~1 g) were collected from piglets 
raised at the University of Illinois Swine Research Center.  Samples were collected from their 
source (piglets) and stored on ice until use. 
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 Enrichment of an Enterobacteriaceae consortium was performed as follows.  
Approximately 200 mg of feces was added to 2 mL (10-fold dilution) of prewarmed sterile 
buffered peptone water (BPW), pH 7.0.  The fecal slurry was vortexed vigorously for complete 
homogenization.  The BPW slurry was incubated overnight aerobically with shaking at 200 rpm 
and 37 °C.  Following incubation, the BPW fecal slurry was vortexed and set aside for 4 min to 
allow settling of the solid material.  A 1 mL aliquot was combined with 9 mL (10-fold dilution) 
of Enterobacteriaceae Enrichment (EE) Broth (Oxoid, Basingstoke, UK) and incubated for 24 h 
aerobically with shaking at 200 rpm and 37 °C.  A 5 mL aliquot of EE cultures was used for a 
Bioscreen C growth assay (procedure same as above).  Upon completion of the Bioscreen C 
growth assay, 150 μL of cell suspension was centrifuged at 12,000g for 3 min.  A 100 μL aliquot 
was collected for HPLC analysis and stored at -20 °C.  The remaining fermentate was pipetted 
off, and the cell pellets were frozen at -20 °C for archiving. 
 
3.3.4 High-performance liquid chromatography (HPLC) 
 Selected fermentates from the in vitro growth assays were analyzed by HPLC using an 
Agilent Technologies 1260 Infinity HPLC (Agilent, Santa Clara, CA, USA) equipped with a 
refractive index detector using a Rezex ROA-Organic Acid H+ (8%) column (Phenomenex Inc., 
Torrance, CA, USA).  The column was eluted with 0.005 N H2SO4 at a flow rate of 0.6 mL/min 
at 50 °C.  Baseline samples were diluted 10-fold (20 μL of 10% sugar stock solution with 180 μL 
of ZMB-1), whereas fermentate samples were diluted 4-fold (50 μL of fermentate with 150 μL of 
water) prior to analysis.  
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3.3.5 Co-substrate growth assay 
 Bacterial growth resulting from the combination of a fermentable carbohydrate and an 
HMO was determined using a Bioscreen C as previously described.  Washed cells were grown in 
ZMB-1 media supplemented with 1% (w/v) fermentable carbohydrate (Glu, Lac, or Mal) and 1% 
HMO (2’-FL, 6’-SL, or LNnT).  Plates were incubated anaerobically for 48 or 72 h (varied by 
experiment).  Each combination of carbohydrates was tested with three independent replications.  
 The impact on bacterial growth due to the presence or absence of HMOs was evaluated 
using a growth curve regression script written in MATLAB (version R2013a, The MathWorks, 
Natick, MA, USA) with the curve fitting toolbox.  This script implements the modified logistic 
regression model which provides a quantitative assessment of bacterial growth.
28
  Additional 
heuristics were included in the modified logistic regression model to more accurately 
approximate the bacterial growth curves: (a) the death phase of the bacterial growth curve was 
not included in the regression, and (b) a threshold to detect cases where no growth occurred was 
set to an OD = 0.4 (600nm).  All regressions were judged by “goodness of fit” metrics, which 
were provided by the MATLAB curve fitting toolbox.  Acceptable regression curves were 
selected on the basis of an R
2
 > 0.98. 
 The growth curve was distilled into four calculable parameters: lag time (amount of time 
for bacteria to enter exponential growth phase), maximum specific growth rate (μmax), doubling 
time (db time, also known as generation time), and delta OD (ΔOD, 600 nm).  The lag time is 
defined as the x-intercept of the tangent line at the inflection point of the logistic regression 
curve (LRC) and is reported in hours.  The maximum specific growth rate is defined as the slope 
of the tangent line at the inflection point of the LRC and is reported in hours
-1
.  The doubling 
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time is mathematically related to the maximum specific growth rate and can be calculated using 
eq 1 (reported in hours):  
 𝑑𝑏𝑡𝑖𝑚𝑒 =  
ln (2)
𝜇𝑚𝑎𝑥
                                                                                                                (1) 
The ΔOD is calculated as the difference between the asymptote of the logistic curve (maximum 
OD) and the minimum OD, and is reported as unit OD 600 nm.   
 
3.3.6 Statistical analysis 
 Statistical differences in bacterial growth parameters due to the presence/absence of 
HMO were determined using SAS (version 9.2, SAS Institute, Cary, NC, USA).  Following 
satisfaction of the requirements of normality and homogeneity of variance, the bacterial 
parameters were evaluated using the generalized linear model (GLM).  In cases when statistical 
significance was seen (p < 0.05), a post hoc mean separation was done using Dunnett’s test.  This 
test determines the statistical significance of the difference of each treatment (addition of HMO) 
to the control (fermentable sugar).  Data visualized by heat map and dendrogram were conducted 
in R
29
 using the gplots package.
30
  The presented dendrogram (Figure 3.1) shows the relatedness 
of organisms by their pattern of growth. 
 
3.4 Results 
3.4.1 In vitro growth of selected carbohydrates 
 Nine pathogenic and two nonpathogenic Enterobacteriaceae strains (Table 3.1) were 
evaluated for their ability to grow in vitro using a selection of carbohydrates (Table 3.2).  
Preliminary experiments revealed that all tested Enterobacteriaceae were able to grow 
anaerobically in ZMB-1 supplemented with 1% glucose, whereas no growth was observed in the 
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absence of a carbohydrate (data not shown).  The resulting carbohydrate utilization data are 
displayed as a heat map (Figure 3.1).  Interestingly, three distinct groups were identified on the 
basis of the observed patterns of growth and demonstrated significant overlap with phylogeny.
31
  
Group 1 is represented by the closely related E. coli strains and Shigella dysenteriae.  Group 2 is 
represented by the two Klebsiella strains.  Whereas the two Cronobacter sakazakii strains are 
grouped together, the other three strains, Citrobacter freundii, Cronobacter muytjensii and 
Enterobacter cloacae, in group 3 are not grouped according to phylogeny. 
 Bacterial strains that are represented by group 1 are EC1000, EC11775, EC29425, and 
SD13313.  Their inability to utilize Suc and Lac (except EC11775) and weakened ability to grow 
in the presence of almost all carbohydrates tested are likely driving their clustering.  Within the 
in vitro testing environment, these organisms were observed to grow on Glu, Fru, and GlcNAc; 
however, they did not grow in the presence of the tested prebiotics or HMOs. 
 The bacterial strains included in group 2 are KP13883 and KO13182.  These two 
Klebsiella strains were strong utilizers of all carbohydrates tested except the HMOs.  The unique 
ability for KP13883 and KO13182 to utilize FOS and Inu for growth likely contributed to their 
clustering.  Interestingly, only SA and PDX were differentially fermented between KP13883 and 
KO13182.  Because KO13182 was observed to have a minimal increase in optical density in 
ZMB-1 supplemented with 1% LNnT (ODav = 0.386), the bacterial growth curve was 
scrutinized.  It was determined that an OD = 0.4 was an appropriate threshold because curves 
below this OD did not have a “characteristic” logistic curve with a distinct lag, exponential, or 
stationary phase.  Additionally, the increase in OD occurred incrementally throughout the 
duration of the experiment (up to 96 h) until the maximum OD reading observed.  We 
hypothesize that this small increase in growth was due to the presence of a small fraction of 
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mono- or disaccharides in the LNnT we used.  To test this hypothesis, the fermentate samples (n 
= 3) from KO13182 grown in ZMB-1 supplemented with 1% LNnT were analyzed by HPLC.  
The average percent decrease of LNnT detected in the fermentate as compared to the baseline 
(1% LNnT in ZMB-1) was 11.22 ± 0.29% (SEM) and was not considered significant.  
 Bacterial strains that are represented by group 3 are CSBAA894, CF8090, CS29544, 
CM51329 and EC13047.  Interestingly, all five bacterial strains were unable to grow on L-fuc, 
fructooligosaccharides, and HMOs.  Additionally, CF8090, CSBAA894, and CS29544 were 
observed to grow weakly on SA, whereas EC13047 and CM51329 were unable to utilize SA for 
growth.  Conversely, these strains readily utilized Lac and Gal.  Both CSBAA894 and CS29544 
were observed to be GOS utilizers due to their ability to ferment the UGOS-P. 
 
3.4.2 Enterobacteriaceae consortia growth 
 Enterobacteriaceae consortia were enriched from the feces of 42 day-old piglets (n = 10) 
who were weaned prior to fecal collection.  These fecal consortia (PFEC) readily utilized Glu, 
Gal, Lac, GlcNAc, SA, and Mal for growth (data not shown).  Interestingly, seven PFEC were 
capable of growing on UGOS-P with an extended lag time (Figure 3.2A), with three of the seven 
PFEC (4, 8 and 10) demonstrating multiphasic growth on UGOS-P.  None of the PFEC grew 
when 2’-FL or 6’-SL (OD < 0.3) was supplemented as a sole carbon source.  Conversely, three 
PFEC (1, 3, and 9) grew using 1% LNnT as a sole carbon source, albeit with a significant lag 
time (> 60 h, Figure 3.2B).  Subsequent HPLC analysis of the fermentate of all PFEC and two 
controls (EC29425 or no bacteria added) indicated that all of the PFEC, including the seven 
(piglets 2, 4, 5, 6, 7, 8, and 10) that did not show detectable growth (all OD < 0.25, Figure 3.2B), 
utilized at least some LNnT.  More specifically, approximately 39 ± 8.8% of the LNnT 
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disappeared from the fermentate of the seven PFEC that did not grow (OD < 0.25) on LNnT, and 
62.8-97.7% of LNnT disappeared from the three PFEC that grew on LNnT (OD > 0.4).  By 
contrast, the bacteria-free control (10.05 g/L) and EC29425 (9.4 g/L) showed no change in 
LNnT. 
 
3.4.3 In vitro co-substrate growth 
 Because HMOs are not the sole carbohydrates present in the diet of infants, we 
investigated the impact of providing various fermentable carbohydrates in combination with the 
HMOs on the growth of selected Enterobacteriaceae strains.  Bacterial strains were grown in 
ZMB-1 supplemented with 1% of a fermentable carbohydrate (Glu, Lac, or Mal) and compared 
to 1% fermentable carbohydrate + 1% HMO (2’-FL, 6’-SL, or LNnT).  The impact on bacterial 
growth was evaluated by determination of the bacterial lag time, doubling time, and ΔOD and is 
presented in Figure B.1-B.3, respectively.  To ease comparisons, the statistically significant 
percent of change between the experimental condition (addition of HMO) and control condition 
(fermentable carbohydrate) was illustrated using a heat map (Figure 3.3). 
 Combining individual HMOs with another fermentable carbohydrate affected lag time in 
only a few instances.  The lag time for EC1000 was significantly decreased in the presence of 
Mal supplemented with 6’-SL and LNnT but not 2’-FL.  Conversely, only Lac supplemented 
with 2’-FL caused a significant decrease in CSBAA894’s lag time.  Interestingly, both KP13883 
and KO13182 had shorter (p < 0.05) lag times with all three HMOs in the presence of Lac, 
although it was more pronounced with 6’-SL (p < 0.005).  Uniquely, EC11775 had a 
significantly increased lag time (6 h) when grown in the presence of Mal and 6’-SL. 
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 The bacterial db time was differentially affected depending on the strain/carbohydrate 
combination.  Several strains exhibited an increase in db time in the presence of an HMO.  
Specifically, the db time was significantly longer when an HMO was combined with Mal 
(EC13047: 2’-FL and LNnT, EC11775 and KP13883: 6’-SL and LNnT).  Additionally, several 
strains (CS29544, EC13047, and EC11775) were significantly affected by the presence of LNnT 
in combination with Lac but to a lesser degree.  Interestingly, only two strains (EC11775 and 
EC29425) had a significant decrease in db time.  A significant decrease in db time for EC11775 
was observed only when Glu was in combination with all three HMOs, whereas EC29425’s db 
time decreased 69.7% when Mal was combined with 6’-SL.  The largest percent change in db 
time was observed for EC11775 when Mal was combined with 6’-SL and LNnT (increases of 
284% and 186%, respectively). 
 High-throughput experiments use the ΔOD to describe the magnitude of bacterial growth 
achieved over the course of a carbohydrate utilization experiment.  It was observed that the ΔOD 
was differentially affected on the basis of the strain/carbohydrate combinations; however, the 
percent change was minimal (range -25 to 10%).  In general, the ΔOD was decreased in the 
presence of an HMO; however, no clear pattern was found.  Interestingly, the ΔOD of CM51329 
was significantly increased when Lac was in combination with 2’-FL.  Conversely, when Glu 
and Lac were in combination with LNnT the ΔOD of CM51329 was significantly decreased. 
 
3.5 Discussion 
 Human milk oligosaccharides are believed to contribute to the health and development of 
the infant GI tract by multiple mechanisms.  During the establishment of the intestinal 
microbiota,
2,11
 HMOs function as prebiotics by selecting for certain Bifidobacterium and 
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Bacteroides species.  Although it has been assumed that HMOs do not support the growth of 
Enterobacteriaceae, which are thought to promote the inflammatory response that occurs during 
NEC, the ability of various members of this family to utilize individual HMOs has not been 
thoroughly examined.  In this study, we assessed the ability of several Enterobacteriaceae strains 
and enriched piglet fecal Enterobacteriaceae consortia to utilize 2’-FL, 6’-SL, and LNnT as a 
sole carbohydrate for growth.  Additionally, we examined the impact of adding glucose, lactose, 
and maltodextrin on HMO utilization by the various Enterobacteriaceae strains. 
 Several Enterobacteriaceae tested were able to readily utilize mono- or disaccharides 
(Glu, Gal, Lac, Fru, and Suc) for growth; however, growth on prebiotic carbohydrates (FOS, Inu, 
UGOS-P, Mal, and PDX) was lessened or absent (Figure 3.1).  Utilization of prebiotics for 
growth may be limited due to an organisms’ inability to transport larger carbohydrates (> 3 
monomers) intracellularly.  Therefore, the presence of extracellular glycosidases may assist 
transportation by cleaving the prebiotics into mono- or disaccharides.  The extracellular 
glycosidases from Bifidobacterium bifidum have been studied extensively.  The extracellular 
lacto-N-biosidase allows for the intracellular transport of lacto-N-biose by removing the terminal 
galactose from type 1 HMOs.
13
  We hypothesized that KP13883 and KO13182 likely possess 
several extracellular glycosidases due to their ability to use a wide range of prebiotics (FOS, Inu, 
UGOS-P, Mal, and PDX) tested regardless of chain length.  On the basis of the inability of any 
of the selected Enterobacteriaceae to detectably grow when 2’-FL, 6’-SL, or LNnT was the sole 
carbon source, we also hypothesized that these organisms do not possess the appropriate HMO-
specific transporter or extracellular enzymes necessary for catabolism.  Our data do demonstrate 
the potential of cross-feeding, whereby commensal GI organisms could liberate monosaccharides 
from HMOs, thereby providing a substrate for pathogenic Enterobacteriaceae.  Ng and 
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colleagues 
32
 demonstrated that Salmonella enterica subsp. enterica serovar Typhimurium and 
Clostridium difficile advantageously catabolize liberated muco-glycans in a Bacteroides 
thetaiotaomicron monoassociated mouse model.  Salmonella Typhimurium and C. difficile were 
observed to have a growth advantage and induction of genes associated with the sialic acid (nan) 
operon when B. thetaiotaomicron was present.
32
 
 Analysis of the infant fecal microbiome in infants diagnosed with NEC detected a bloom 
in proteobacteria (>50% relative abundance) in the GI of infants diagnosed with NEC.
17-21
  
Interestingly, an analysis of an infants’ GI metabolome pre-NEC and following diagnosis 
revealed a significant increase in carbohydrate utilization genes mapped to members of the 
Enterobacteriaceae family.
21
  Although none of the selected Enterobacteriaceae were able to 
grow on the HMOs tested, it would be premature to assume that no Enterobacteriaceae strains 
are capable of utilizing HMOs for growth.  Therefore, Enterobacteriaceae consortia were 
enriched with piglet feces, a rich source of Enterobacteriaceae, and evaluated for their ability to 
ferment selected carbohydrates including 2’-FL, 6’-SL, and LNnT.  All PFEC tested were able to 
ferment HMO-associated mono- and disaccharides, whereas there was no detectable growth 
when 2’-FL or 6’-SL was supplied as a sole carbon source (data not shown).  Conversely, all 
PFEC were observed to reduce LNnT detectably; however, not all PFEC had detectable growth 
(Figure 3.2B).  Those PFEC that had detectable growth showed the largest reduction in LNnT 
(>63%); meanwhile, the other seven PFEC with no detectable growth converted only <40% of 
LNnT.  Therefore, supplementation of preterm infant formula with LNnT may require further 
study.  Additionally, seven PFEC were observed to utilize UGOS-P for growth (Figure 3.2B).  
Because galactooligosaccharides supplementation of infant formula did not cause a reduction in 
the incidence of NEC,
33
 we conclude that supplementation poses no additional risk. 
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 Considering that supplementation of HMOs in infant formula would likely be done in the 
presence of additional carbohydrates, we evaluated the impact of Enterobacteriaceae growth on 
Glu, Lac, and Mal in combination with HMOs.  Although the inclusion of HMOs would likely 
not affect Glu utilization in vivo, Glu was included as a control.  On the other hand, colonic 
lactose fermentation has been observed in premature infants.
34,35
  Maltodextrin was also included 
because it is often added to infant formula.  Because all included Enterobacteriaceae showed no 
detectable growth when 2’-FL, 6’-SL, or LNnT was provided as the sole carbon source, any 
change in growth was not attributed to direct fermentation of the tested HMOs.  The resulting 
bacterial growth was analyzed using a logistic regression analysis to obtain the lag time, db time 
and ΔOD.  On the basis of these three parameters, two patterns can be used to determine the 
impact of growth in the presence of HMOs.  A decrease in lag time and db time and a decrease in 
ΔOD would indicate an environment that favors bacterial growth, whereas an increase in lag 
time and db time and a decrease in ΔOD would indicate an environment that disfavors growth.  
Interestingly, no strain/carbohydrate combination tested had a significant fold change in all three 
parameters that favored growth.  Conversely, EC11775 was the only organism to have a 
significant fold change in all three parameters that did not favor growth.  The combination of 
Mal and 6’-SL led to a significant increase in lag time (44%) and db time (284%) and a 
significant decrease in ΔOD (-23%).  Hunt and colleagues36 reported that pooled HMOs in 
combination with glucose and lactose resulted in an enhanced growth of Staphylococcus 
epidermidis and Staphylococcus aureus breastmilk isolates.  The two Staphylococcus species did 
not directly catabolize the pooled HMO fraction, but rather metabolized amino acids.
36
  It 
appears that 6’-SL, an acidic HMO, may disturb EC11775’s ability to grow on complex 
carbohydrates; however, the impact of 6’-SL on gene expression was not tested. 
 104 
 
 In conclusion, this study demonstrates that individual Enterobacteriaceae strains do not 
detectably grow in the presence of 2’-FL, 6’-SL, and LNnT, whereas three PFEC did have 
detectable growth when LNnT was added as a sole carbon source.  Conversely, no PFEC had 
detectable growth on 2’-FL and 6’-SL.  In addition, no Enterobacteriaceae strain had 
significantly enhanced growth in all three calculated bacterial growth parameters (lag time, db 
time and ΔOD) when HMOs were combined with a fermentable carbohydrate.  On the other 
hand, Mal in the presence of 6’-SL did not favor the growth of EC11775.  Therefore, we 
conclude that supplementation of preterm infant formula with 2’-FL and 6’-SL should not lead to 
an increase in Enterobacteriaceae; however, supplementation with LNnT may require further 
exploration. 
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3.8 Tables and Figures 
 
Table 3.1. Selected Enterobacteriaceae strains associated with necrotizing enterocolitis 
bacterial strain ATCC no.  abbreviation origin
1
 
Escherichia coli EC1000
2
 NA EC1000 NA 
Citrobacter freundii 8090
T4
 CF8090 NA 
Cronobacter sakazakii 
BAA-894 CSBAA894 human 
29544
T
 CS29544 human throat 
Cronobacter muytjensii 51329
T
 CM51329 NA 
Enterobacter cloacae subsp. 
cloacae  
13047
T
 EC13047 human spinal fluid 
Escherichia coli  O1:K1:H7 11775
T
 EC11775 human urine 
Escherichia coli K12
2
 29425 EC29425 NA 
Klebsiella pneumoniae subsp. 
pneumoniae 
13883
T
 KP13883 NA 
Klebsiella oxytoca 13182
T
 KO13182 
human pharyngeal 
tonsil 
Shigella dysenteriae 13313
T
 SD13313 human 
1
 Origin as listed on ATCC Web site (http://www.atcc.org/). 
2
 Control strains classified as non-pathogenic Biosafety Level 1. 
3 
NA, information is not available 
4
 Organism designated as the species ATCC type strain.  
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Table 3.2. Carbohydrate substrates supplemented as a sole carbon source for bacterial growth assays. 
 carbohydrate source abbreviation purpose supplier 
monosaccharide glucose Glu control Fisher 
 fructose Fru nonrepressor Sigma Aldrich 
 galactose Gal component
1
 Acros Organics 
 N-acetylneuramic acid (sialic acid) SA component Carbosynth 
 N-acetylglucosamine GlcNAc component Sigma Aldrich 
 L-fucose L-fuc component Sigma Aldrich 
disaccharide lactose Lac component Fisher 
 sucrose Suc control Fisher 
trisaccharide 2’-fucosyllactose 2’-FL HMO2 Inalco 
 6’-sialyllactose 6’-SL HMO Inalco 
tetrasaccharide lacto-N-neotetraose LNnT HMO Abbott Nutrition 
polysaccharide short-chain fructooligosaccharides FOS prebiotic GTC Nutrition 
 inulin Inu prebiotic Sensus 
 
galactooligosaccharides-vivinal GOS-V prebiotic 
Friesland Foods 
Domo 
 galactooligosaccharides-purimune GOS-P prebiotic GTC Nutrition 
 ultrapurified galactooligosaccharides -purimune UGOS-P prebiotic 
37
 
 maltodextrin Mal prebiotic Ross Products 
 polydextrose PDX prebiotic Danisco 
1
 Component sugars are mono- or disaccharides present in HMO sugars 
2 
HMO, human milk oligosaccharides 
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Figure 3.1.  Maximal growth, OD 600 nm, achieved on 1% carbohydrate (glucose, galactose, 
lactose, N-acetylglucosamine (GlcNAc), N-acetylneuraminic acid (sialic acid), L-fucose, 
fructose, sucrose, short-chain fructooligosacharides (FOS), inulin, galactooligosaccharides-
vivinal (GOS-V), galactooligosaccharides-purimune (GOS-P), ultrapurified 
galactooligosaccharides-purimune (UGOS-P), maltodextrin, polydextrose (PDX), 2’-
fucosyllactose (2’-FL), 6’-sialyllactose (6’-SL) and lacto-N-neotetraose (LNnT)) in ZMB-1 
media.  No growth was observed in the absence of carbohydrates.  Blank is corrected by 
subtraction of wells containing no cells and no carbohydrate.  Dendrogram shows relatedness by 
pattern of growth.  Average of three or more independent experiments.  
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Figure 3.2.  Growth curves of enriched piglet fecal Enterobacteriaceae consortia (n = 10), OD 
600 nm, achieved at 96 h on 1% carbohydrate in ZMB-1 media.  (A) ultrapurified 
galactooligosaccharides-purimune (UGOS-P); (B) lacto-N-neotetraose (LNnT). Blank is 
corrected by subtraction of wells containing no cells and no carbohydrate.  One independent 
Enterobacteriaceae consortia enriched per piglet. 
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Figure 3.3.  Statistically significant percent change in growth parameters determined from co-substrate bacterial growth.  Bacterial 
cultures were grown in ZMB-1 with 1% fermentable carbohydrate (glucose, lactose and maltodextrin) and 1% HMO (2’-
fucosyllactose (2’-FL), 6’-sialyllactose (6’-SL), lacto-N-neotetraose (LNnT)).  Heat map was generated on the basis of the percent 
change of either an increase or a decrease in the growth parameters of co-substrate wells compared to wells containing only the 
fermentable carbohydrate (ANOVA with Dunnett’s mean separation).  No growth was observed in the absence of carbohydrates.  
Blank is corrected by subtraction of wells containing no cells and no carbohydrate. Average of three independent experiments.  Only 
organisms that were found to have a statistically significant percent change are shown.  An organism’s inability to grow in either 
lactose or maltodextrin is represented by gray boxes. 
 110 
 
3.9 References 
1. Coppa, G.V.; Zampini, L.; Galeazzi, T.; Gabrielli, O. Prebiotics in human milk: a review. Dig. 
Liver Dis. 2006, 38 Suppl 2, S291-4.  
2. Walker, A. Breast milk as the gold standard for protective nutrients. J. Pediatr. 2010, 156, S3-
7.  
3. Coppa, G.V.; Gabrielli, O.; Pierani, P.; Catassi, C.; Carlucci, A.; Giorgi, P.L. Changes in 
carbohydrate composition in human milk over 4 months of lactation. Pediatrics 1993, 91, 637-
641.  
4. Kunz, C.; Rudloff, S.; Baier, W.; Klein, N.; Strobel, S. Oligosaccharides in human milk: 
structural, functional, and metabolic aspects. Annu. Rev. Nutr. 2000, 20, 699-722.  
5. Ninonuevo, M.R.; Park, Y.; Yin, H.; Zhang, J.; Ward, R.E.; Clowers, B.H.; German, J.B.; 
Freeman, S.L.; Killeen, K.; Grimm, R.; Lebrilla, C.B. A strategy for annotating the human milk 
glycome. J. Agric. Food Chem. 2006, 54, 7471-7480.  
6. Albrecht, S.; Schols, H.A.; van Zoeren, D.; van Lingen, R.A.; Groot Jebbink, L.J.; van den 
Heuvel, E.G.; Voragen, A.G.; Gruppen, H. Oligosaccharides in feces of breast- and formula-fed 
babies. Carbohydr. Res. 2011, 346, 2173-2181.  
7. Eiwegger, T.; Stahl, B.; Schmitt, J.; Boehm, G.; Gerstmayr, M.; Pichler, J.; Dehlink, E.; 
Loibichler, C.; Urbanek, R.; Szepfalusi, Z. Human milk--derived oligosaccharides and plant-
derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr. 
Res. 2004, 56, 536-540.  
8. He, Y.; Liu, S.; Leone, S.; Newburg, D.S. Human colostrum oligosaccharides modulate major 
immunologic pathways of immature human intestine. Mucosal Immunol. 2014, 7, 1326-1339.  
9. Newburg, D.S.; Ruiz-Palacios, G.M.; Morrow, A.L. Human milk glycans protect infants 
against enteric pathogens. Annu. Rev. Nutr. 2005, 25, 37-58.  
10. Angeloni, S.; Ridet, J.L.; Kusy, N.; Gao, H.; Crevoisier, F.; Guinchard, S.; Kochhar, S.; 
Sigrist, H.; Sprenger, N. Glycoprofiling with micro-arrays of glycoconjugates and lectins. 
Glycobiology 2005, 15, 31-41.  
11. Coppa, G.V.; Zampini, L.; Galeazzi, T.; Facinelli, B.; Ferrante, L.; Capretti, R.; Orazio, G. 
Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: 
Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr. Res. 2006, 59, 377-382.  
12. Ruiz-Palacios, G.M.; Cervantes, L.E.; Ramos, P.; Chavez-Munguia, B.; Newburg, D.S. 
Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and 
fucosyloligosaccharides of human milk inhibit its binding and infection. J. Biol. Chem. 2003, 
278, 14112-14120.  
 111 
 
13. Wada, J.; Ando, T.; Kiyohara, M.; Ashida, H.; Kitaoka, M.; Yamaguchi, M.; Kumagai, H.; 
Katayama, T.; Yamamoto, K. Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for 
the degradation of human milk oligosaccharides with a type 1 structure. Appl. Environ. 
Microbiol. 2008, 74, 3996-4004.  
14. Asakuma, S.; Hatakeyama, E.; Urashima, T.; Yoshida, E.; Katayama, T.; Yamamoto, K.; 
Kumagai, H.; Ashida, H.; Hirose, J.; Kitaoka, M. Physiology of consumption of human milk 
oligosaccharides by infant gut-associated bifidobacteria. J. Biol. Chem. 2011, 286, 34583-34592.  
15. Sela, D.A.; Garrido, D.; Lerno, L.; Wu, S.; Tan, K.; Eom, H.J.; Joachimiak, A.; Lebrilla, 
C.B.; Mills, D.A. Bifidobacterium longum subsp. infantis ATCC 15697 alpha-fucosidases are 
active on fucosylated human milk oligosaccharides. Appl. Environ. Microbiol. 2012, 78, 795-
803.  
16. Marcobal, A.; Barboza, M.; Froehlich, J.W.; Block, D.E.; German, J.B.; Lebrilla, C.B.; Mills, 
D.A. Consumption of human milk oligosaccharides by gut-related microbes. J. Agric. Food 
Chem. 2010, 58, 5334-5340.  
17. Claud, E.C.; Walker, W.A. Hypothesis: inappropriate colonization of the premature intestine 
can cause neonatal necrotizing enterocolitis. FASEB J. 2001, 15, 1398-1403.  
18. Wang, Y.; Hoenig, J.D.; Malin, K.J.; Qamar, S.; Petrof, E.O.; Sun, J.; Antonopoulos, D.A.; 
Chang, E.B.; Claud, E.C. 16S rRNA gene-based analysis of fecal microbiota from preterm 
infants with and without necrotizing enterocolitis. ISME J. 2009, 3, 944-954.  
19. Mai, V.; Young, C.M.; Ukhanova, M.; Wang, X.; Sun, Y.; Casella, G.; Theriaque, D.; Li, N.; 
Sharma, R.; Hudak, M.; Neu, J. Fecal microbiota in premature infants prior to necrotizing 
enterocolitis. PLoS One 2011, 6, e20647.  
20. Smith, B.; Bode, S.; Petersen, B.L.; Jensen, T.K.; Pipper, C.; Kloppenborg, J.; Boye, M.; 
Krogfelt, K.A.; Molbak, L. Community analysis of bacteria colonizing intestinal tissue of 
neonates with necrotizing enterocolitis. BMC Microbiol. 2011, 11, 73.  
21. Claud, E.C.; Keegan, K.P.; Brulc, J.M.; Lu, L.; Bartels, D.; Glass, E.; Chang, E.B.; Meyer, 
F.; Antonopoulos, D.A. Bacterial community structure and functional contributions to emergence 
of health or necrotizing enterocolitis in preterm infants. Microbiome 2013, 1, 20-2618-1-20.  
22. Nanthakumar, N.N.; Fusunyan, R.D.; Sanderson, I.; Walker, W.A. Inflammation in the 
developing human intestine: A possible pathophysiologic contribution to necrotizing 
enterocolitis. Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 6043-6048.  
23. Marcobal, A.; Sonnenburg, J.L. Human milk oligosaccharide consumption by intestinal 
microbiota. Clin. Microbiol. Infect. 2012, 18 Suppl 4, 12-15.  
24. Carlisle, E.M.; Poroyko, V.; Caplan, M.S.; Alverdy, J.A.; Liu, D. Gram negative bacteria are 
associated with the early stages of necrotizing enterocolitis. PLoS One 2011, 6, e18084.  
 112 
 
25. Lane, D.J.; Pace, B.; Olsen, G.J.; Stahl, D.A.; Sogin, M.L.; Pace, N.R. Rapid determination 
of 16S ribosomal RNA sequences for phylogenetic analyses. Proc. Natl. Acad. Sci. U. S. A. 
1985, 82, 6955-6959.  
26. Lane, D.J. 16S/23S rRNA Sequencing, In Nucleic Acid Techniques in Bacterial Systematics, 
Anonymous ; John Wiley and Sons: New York, NY, 1991; pp. 115-175.  
27. Zhang, G.; Mills, D.A.; Block, D.E. Development of chemically defined media supporting 
high-cell-density growth of lactococci, enterococci, and streptococci. Appl. Environ. Microbiol. 
2009, 75, 1080-1087.  
28. Zwietering, M.H.; Jongenburger, I.; Rombouts, F.M.; van 't Riet, K. Modeling of the 
bacterial growth curve. Appl. Environ. Microbiol. 1990, 56, 1875-1881.  
29. R Development Core Team R: A language and environment for statistical computing. 2011, 
ISBN 3-900051-07-0,  
30. Warnes, G.R.; Bolker, B.; Bonebakker, L.; Gentleman, R.; Liaw, W.H.A.; Lumley, T.; 
Maechler, M.; Magnusson, A.; Moeller, S.; Schwartz, M.; Venables, B. gplots: Various R 
Programming Tools for Plotting Data. 2015, 2.16.0,  
31. Paradis, S.; Boissinot, M.; Paquette, N.; Belanger, S.D.; Martel, E.A.; Boudreau, D.K.; 
Picard, F.J.; Ouellette, M.; Roy, P.H.; Bergeron, M.G. Phylogeny of the Enterobacteriaceae 
based on genes encoding elongation factor Tu and F-ATPase beta-subunit. Int. J. Syst. Evol. 
Microbiol. 2005, 55, 2013-2025.  
32. Ng, K.M.; Ferreyra, J.A.; Higginbottom, S.K.; Lynch, J.B.; Kashyap, P.C.; Gopinath, S.; 
Naidu, N.; Choudhury, B.; Weimer, B.C.; Monack, D.M.; Sonnenburg, J.L. Microbiota-liberated 
host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502, 96-99.  
33. Srinivasjois, R.; Rao, S.; Patole, S. Prebiotic supplementation in preterm neonates: updated 
systematic review and meta-analysis of randomised controlled trials. Clin. Nutr. 2013, 32, 958-
965.  
34. Kien, C.L.; Liechty, E.A.; Myerberg, D.Z.; Mullett, M.D. Dietary carbohydrate assimilation 
in the premature infant: evidence for a nutritionally significant bacterial ecosystem in the colon. 
Am. J. Clin. Nutr. 1987, 46, 456-460.  
35. Kien, C.L.; McClead, R.E.; Cordero, L.,Jr In vivo lactose digestion in preterm infants. Am. J. 
Clin. Nutr. 1996, 64, 700-705.  
36. Hunt, K.M.; Preuss, J.; Nissan, C.; Davlin, C.A.; Williams, J.E.; Shafii, B.; Richardson, 
A.D.; McGuire, M.K.; Bode, L.; McGuire, M.A. Human milk oligosaccharides promote the 
growth of staphylococci. Appl. Environ. Microbiol. 2012, 78, 4763-4770.  
 113 
 
37. Thongaram, T. Probiotic Metabolism of Human Milk Oligosaccharides (HMOs) and 
Prebiotics. Doctoral Dissertation, University of Illinois at Urbana-Champaign, 2014. 
  
  
1This chapter has been prepared for publication under the title “Cronobacter sakazakii ATCC 29544 
autoaggregation requires FliC flagellation, not motility” with co-authors Hoeflinger JL and Miller MJ. 
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CHAPTER FOUR 
CRONOBACTER SAKAZAKII ATCC 29544 AUTOAGGREGATION REQUIRES 
FLIC FLAGELLATION, NOT MOTILITY
1 
4.1 Abstract 
 Cronobacter sakazakii is an opportunistic nosocomial and foodborne pathogen that 
causes severe infections with high morbidity and mortality rates in neonates, the elderly and 
immunocompromised individuals.  Little is known about the pathogenesis mechanism of this 
significant pathogen and if there are any consequences of C. sakazakii colonization in healthy 
individuals.  In this study, we characterized the mechanisms of autoaggregation in C. sakazakii 
ATCC 29544 (CS29544).  Autoaggregation in CS29544 occurred rapidly, within 30 mins, and 
proceeded to a maximum of 70%.  Frameshift mutations in two flagella proteins (FlhA and FliG) 
were identified in two nonautoaggregating CS29544 clonal variant isolates.  Strategic gene 
knockouts were generated to determine if structurally intact and functional flagella were required 
for autoaggregation in CS29544.  All structural knockouts (ΔflhA, ΔfliG, and ΔfliC) abolished 
autoaggregation, while the functional knockout (ΔmotAB) did not prevent autoaggregation.  
Complementation with FliC (ΔfliC/cfliC) restored autoaggregation.  Autoaggregation was also 
disrupted by the addition of exogenous wild-type CS29544 filaments in a dose-dependent 
manner.  Finally, filament supercoils tethering neighboring wild-type CS29544 cells together 
were observed by transmission electron microscopy.  In silico analyses suggests that direct  
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interactions of neighboring CS29544 FliC filaments proceed by hydrophobic bonding between 
the externally exposed hypervariable regions of the CS29544 FliC flagellin protein.  Further 
research is needed to confirm if flagella-mediated autoaggregation plays a prominent role in C. 
sakazakii pathogenesis. 
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4.2 Introduction 
 Cronobacter spp., reclassified from Enterobacter (1), are motile, biofilm-forming, 
facultative anaerobic Gram-negative bacilli.  Cronobacter sakazakii, the most prominent species, 
is an opportunistic pathogen associated with fatal infections in neonates and 
immunocompromised children and adults (2).  Most notably, C. sakazakii infections in neonates 
have been linked epidemiologically to the consumption of powdered infant formula (PIF) (3–5).  
Furthermore, C. sakazakii withstands desiccation in PIF and thrives in reconstituted PIF, 
especially when PIF is temperature-abused (6–8).  In response, medical and health professionals 
were cautioned regarding the use of PIF; however, C. sakazakii infections in neonatal units are 
not solely due to consumption of contaminated PIF (9).  C. sakazakii was reported in infants 
exclusively breastfed (10–12).  Another concern is the frequency with which nasogastric tubes 
are used to deliver enteral nutrition in premature neonates (13).  A surveillance study reported 
that several species of Enterobacteriaceae, including a single C. sakazakii isolate, were recovered 
from used nasogastric enteral feeding tubes (10).  These researchers cautioned that microbial 
biofilms on nasogastric enteral feeding tubes might serve as a continuous inoculum during bolus 
feedings while the tube is in place.  A simple solution may be to switch from indwelling 
nasogastric tubes to insertion of a nasogastric tube at each feeding; however, the comfort of the 
neonate and associated economic costs must be considered (14).  A multifactorial approach to 
protecting neonates from microbial infections associated with feedings is needed, including 
identification of the mechanisms C. sakazakii utilizes during biofilm formation and 
gastrointestinal colonization. 
 Many bacteria, especially pathogens, have developed elaborate mechanisms to permit 
attachment to and formation of dense sessile mono- or polymicrobial aggregates on biotic and 
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abiotic surfaces (15–17).  Following this initial attachment, bacterial aggregates may 
cooperatively form biofilms, whereby increasing their chance of survival.  Herein, the formation 
of monospecies aggregates is referred to as autoaggregation.  Autoaggregation is common in the 
Enterobacteriaceae family, including Escherichia coli (18–24), Salmonella spp. (25), Klebsiella 
pneumoniae (26), Edwardsiella tarda (27), Citrobacter freundii (28), Yersina pestis (29), and 
Proteus mirabilis (30,31) and often occurs via self-recognizing cell-surface appendages.  
Autoaggregation is mediated by adhesins (22,23,31–34) and other cell-surface molecules, such 
as surface-associated proteins (19,27), pili (18), fimbriae (20,21,25,35), flagella (36,37) and 
lipopolysaccharides (24,38).  Several studies observed by microscopy supercoiling between 
neighboring microorganisms promoted by pili in Escherichia coli (18) and flagella in 
Pseudomonas marina (36) and Pyrococcus furiosus (37).  The gastrointestinal colonization of 
two Escherichia coli pathotypes occurs via different fully characterized mechanisms of 
autoaggregation.  Bundle-forming fimbriae (AAF/I and AAF/II) in enteroaggregative E. coli 
promote autoaggregation and biofilm formation along the intestinal surface (20,35), while 
enteropathogenic E. coli adheres to the intestinal surface via interactions between Intimin and Tir 
(39) and establishes three-dimensional microcolonies using bundle-forming pilus (18).  While 
autoaggregation was observed in some C. sakazakii strains (38,40,41); the extracellular factor 
mediating autoaggregation in C. sakazakii and its biological function remains unknown. 
 The bacterial flagellum’s role in motility and bacterial chemotaxis is well characterized 
(42), but motility is not its sole biological function.  Bacterial flagella contribute to the virulence 
of bacterial pathogens, including adhesion, microcolony formation, invasion, and biofilm 
formation, reviewed by Haiko and Westerlund-Wikström (43).  Unlike other Enterobacteriaceae, 
the contribution of C. sakazakii’s flagellum to its virulence has received little attention.  The 
 118 
 
flagella of C. sakazakii ES5 are required for adhesion to Caco-2 monolayers and biofilm 
formation to microtiter plates (44).  This study describes the role the bacterial flagella plays in 
the autoaggregation of C. sakazakii ATCC 29544 (CS29544).  A collection of gene knockout and 
complementation strains revealed that structurally intact FliC containing filaments were required 
for autoaggregation.  Additionally, we provide evidence to suggest that direct interactions 
between neighboring filaments promote autoaggregation of liquid CS29544 cultures. 
 
4.3 Materials and Methods 
4.3.1 Bacterial strains and growth conditions 
 CS29544 was cultured in brain heart infusion (BHI) broth (BD, Franklin Lakes, NJ, 
USA), pH 7.38 at 37°C overnight aerobically with agitation (250 rpm) unless specified.  
CS29544 was enumerated and spread plated on BHI agar plates following serial dilution in 1X 
phosphate buffered saline (PBS, Dulbecco’s Formula), pH 7.4.  Escherichia coli was cultured in 
lysogeny broth (LB, Miller’s formula, Thermo Fisher Scientific, Waltham, MA, USA) at 37°C 
overnight aerobically with agitation (250 rpm) unless specified.  When necessary, ampicillin 
(Thermo Fisher Scientific) or chloramphenicol (Thermo Fisher Scientific) were added to BHI or 
LB at a final concentration of 100 μg/mL and 35 μg/mL, respectively.  To test for motility, 
CS29544 were grown on 0.4% agar composed of 3 g/L beef extract, 10 g/L Bacto peptone, and 5 
g/L sodium chloride (BPN) supplemented with 1% of 2,3,5-triphenyltetrazolium chloride (redox 
indicator) or observed microscopically by wet mount.  
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4.3.2 Autoaggregation assays 
 Stationary phase CS29544 cultures, grown in 10 mL BHI at 37°C, were held stagnantly 
at room temperature for 6 h to allow for autoaggregation.  The change in optical density (OD) at 
600 nm was gently measured at 30 min intervals for 2 h followed by 1 h intervals.  
Autoaggregation was reported as the maximum percent autoaggregation; typically the endpoint 
was used, and calculated by equation 1. 
 𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑜𝑓 𝑎𝑢𝑡𝑜𝑎𝑔𝑔𝑟𝑒𝑔𝑎𝑡𝑖𝑜𝑛 =
1−𝑂𝐷𝑡𝑖𝑚𝑒 𝑝𝑜𝑖𝑛𝑡
𝑂𝐷𝑖𝑛𝑖𝑡𝑖𝑎𝑙
∗ 100                                                   (1) 
 Several additional autoaggregation assays were conducted with modifications after 
growth of CS29544 in 10 mL BHI, including stagnant incubation at different temperatures (4°C 
and 37°C), the addition of 50 mM EDTA or PBS, and before and after blending on “whip” speed 
for 30 s (BL113SG, Black and Decker, Towson, MD, USA).  Furthermore, autoaggregation 
assays were completed with CS29544 following growth in 10 mL BHI at different pH values 
(pH = 4, 5, 6, 7.38, and 8) or incubated anaerobically (90% N2, 5% CO2, 5% H2; Coy 
Laboratory Products, Grass Lake, MI, USA).  Finally, autoaggregation assays were run with 
CS29544 following growth (10 mL) in different media, including Miller and Lennox LB 
formulations (LB10 and LB5, respectively), tryptic soy broth (TSB), and BPN broth. 
 Stationary phase CS29544 and nonautoaggregating clonal variant cultures (described 
below) grown in BHI were mounted and held stagnantly at room temperature for 1 h to allow for 
autoaggregation.  Still images were taken every 10 s for a total of 1 h by a stationary DSLR 
camera (Rebel T2i, Canon, Melville, NY, USA) with an intervalometer.  Images (360 frames) 
were stitched together to create a video file with 24 frames/s.  An additional time lapse video was 
constructed as previously described with the CS29544 and flagella competition assays (described 
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below) with still images were taken every 20 s for a total of 6 h.  Images (1080 frames) were 
stitched together to create a video file with 72 frames/s. 
 
4.3.3 Isolation of nonautoaggregating CS29544 variants 
 Stationary phase CS29544 cultures were allowed to autoaggregate for 2 h.  Then, two 
separate 100 μL (1%, v/v) aliquots, one from the top fraction of the CS29544 culture and one 
from the bottom fraction (autoaggregating control), were passed into two fresh tubes of 10 mL 
BHI broth and incubated as described above.  Successive passage following autoaggregation 
continued until autoaggregation was arrested.  Two independent nonautoaggregating variants 
were isolated and characterized. 
 
4.3.4 DNA extraction and whole-genome sequencing 
 Genomic DNA was isolated from CS29544 and clonal variants using the UltraClean® 
Microbial DNA Isolation Kit (MoBio Laboratories, Carlsbad, CA, USA) according to 
manufacturer’s instructions.  High-quality genomic DNA libraries were prepared and sequenced 
using the Illumina platform (Illumina, San Diego, CA, USA) by the DNA Services group 
affiliated with the Roy J. Carver Biotechnology Center at the University of Illinois-Urbana 
Champaign.  Paired-end libraries of CS29544 and clonal variants were prepared with the TruSeq 
Genomic DNA Sample Prep Kit (length: 200 - 600 bp) and sequenced on a HiSeq2500 with the 
TruSeq SBS Sequencing Kit v1 producing an average read length of 160 nt.  An additional mate-
pair library of CS29544 was prepared with the Nextera Mate Pair Library Sample Prep Kit 
(length: 3 – 8 kbp) and sequenced on a MiSeq V3 with the MiSeq 600-cycle Sequencing Kit v3 
producing an average read length of 300 nt.  Paired-end reads were imported into CLC Genomics 
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Workbench v7.5, quality and adapter trimmed using default settings.  Mate-pair reads were 
quality and adaptor trimmed using Cutadapt (45) and an in-house Perl script provided by the Roy 
J. Carver Biotechnology Center.  Processed mate-pair reads were imported into CLC Genomics 
Workbench, and de novo assembled using default parameters, only contigs larger than 1000 bp 
were kept.  The paired-end reads were mapped to the CS29544 de novo assembly and single 
nucleotide polymorphisms (SNPs) were identified (> 90% frequency) using the Basic Variant 
Detection tool with default parameters.  Putative SNPs were identified and confirmed by targeted 
Sanger sequencing using an ABI 3730XL capillary sequencer (Life Technologies, Carlsbad, CA, 
USA). 
 
4.3.5 Construction of CS29544 gene knockout strains and complementation vector 
 Targeted gene disruptions (flhA, fliG, motAB, fliC, and flaA) were constructed in the 
wild-type CS29544 using the lambda Red recombinase system (46,47).  All bacterial strains, 
plasmids, and primers used in this study are listed in Tables 4.1 & 4.2.  The FRT-Cm
r
-FRT 
cassette in the recombinant mutants was cured by transformation and subsequent removal of the 
temperature-sensitive flippase (FLP) recombinase helper plasmid.  The double gene knockout 
(fliC and flaA) was constructed as described above in the CS29544 ΔflaA strain.  Gene 
disruptions were confirmed by junction fragment PCR using the appropriate primer sets. 
 A fliC complementation vector was constructed by GenScript (Piscataway Township, NJ, 
USA).  Briefly, a 1011 bp sequence, containing the fliC coding sequence and native promoter, 
was obtained from the publically available CS29544 genome (NCBI Reference Sequence: 
NZ_CP011047.1).  The entire DNA fragment was synthesized and cloned into the pET-11a 
vector with the restriction enzymes, BglII and BamHI.  Upon receipt, the cfliC vector was 
 122 
 
electroporated into E. coli Top10 and subsequently electroporated into the CS29544 ΔfliC and 
ΔflaAΔfliC strains using LB broth.  Putative compliments were grown in BHI or on motility agar 
plates supplemented with 50 μg/mL ampicillin.  Restoration of wild-type function was assessed 
by autoaggregation assays, motility assays, microscopy and flagella harvest as detailed above 
and below. 
 
4.3.6 Flagella staining and microscopy 
 The presence of extracellular flagella of CS29544, gene knockout, and complementation 
strains were determined by a combination of imaging techniques.  Log or stationary phase 
CS29544, gene knockout, and complementation cultures were stained using a crystal violet-
based flagella stain (Hardy Diagnostics, Santa Maria, CA, USA) according to manufacturer’s 
instructions.  Stains were visualized using a light microscope at 1000x total magnification 
(BA210, Motic, Richmond, British Columbia, CA).  Images were captured with a 2-megapixel 
camera (Motic).   
 Several overnight colonies of CS29544, gene knockout, and complementation strains 
were gently lifted from BHI agar plates and suspended in phosphate buffered Karnovsky’s 
fixative containing 2% glutaraldehyde and 2.5% paraformaldehyde.  Transmission electron 
microscopy (TEM) was completed by the Beckman Institute’s Microscopy Suite at the 
University of Illinois-Urbana Champaign.  Briefly, the samples were stained with 2% uranyl 
acetate for 1 min and visualized using a CM200 LaB6 transmission electron microscope (FEI 
Co., Hillsboro, OR, USA).  TEM was conducted at 120 kV and images were captured with a 2 k 
x 2 k digital camera (Tietz, Gauting, Germany).  Several locations on the grids were examined, 
and the pictures are representative of the whole sample.  
 123 
 
4.3.7 Flagella harvest and filament protein identification, sequencing, and in silico 
analysis 
 The extracellular protein fraction of CS29544, gene knockout, and complementation 
strains was harvested by differential centrifugation (48).  Bacteria were cultured in two baffled 
flasks containing 500 mL of BHI each and incubated overnight at 37°C with agitation (250 rpm).  
Stationary phase cultures (1 L total) were centrifuged at 3220 xg for 10 min at 4°C.  Bacterial 
pellets were resuspended in 250 mL total of 0.1 M Tris-HCl, pH 7.8 and blended at room 
temperature for 30 s on “whip” speed.  Blended suspensions were centrifuged at 12000 xg for 10 
min at 4°C.  The supernatant was further ultracentrifuged at 55000 xg for 1 h at 4°C.  Protein 
pellets were resuspended in a total of 1 mL 0.1 M Tris-HCl, pH 7.8 containing 50% glycerol 
(v/v) and stored at -20°C.  Total protein was quantified with the Bradford Assay (BioRad 
Laboratories, Hercules, CA, USA) and visualized with SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE).  Typical flagella protein recovery was 0.5 - 0.7 mg/mL from 1 L of cell mass 
(~10
12 
cells). 
 The putative FliC (28.9 kDa) band from CS29544 flagella preparation was excised from 
an SDS-PAGE gel and treated in-gel with trypsin (G-Bioscience, St. Louis, MO, USA) by the 
DNA Services group affiliated with the Roy J. Carver Biotechnology Center at the University of 
Illinois-Urbana Champaign.  Protein was digested at a ratio of 1:20 (trypsin:protein) in 25 mM 
ammonium bicarbonate at 55°C for 30 min.  Following lyophilization, peptides were analyzed by 
liquid chromatography-mass spectrometry (LC-MS).  A total of 1 – 2 μg of digested peptides 
were loaded into a Dionex Ultimate 3000 RSLCnano connected directly to a Thermo LTQ-
Velos-ETD Pro Mass Spectrometer (Thermo Fisher Scientific).  Peptide were run on an Acclaim 
300 C18 nano-column (Thermo Fisher Scientific) using a gradient of 100% A (water + 0.1% 
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formic acid) to 60% B (acetonitrile + 0.1% formic acid) at a flow rate of 300 nL/min.  Raw data 
were collected by Xcalibur (Thermo Fisher Scientific) and processed with an in-house Mascot 
Distiller and Mascot Server (Matrix Science, Boston, MA, USA) and identified with the NCBInr 
database. 
 The secondary structure of the CS29544 FliC protein was predicted from the amino acid 
coding sequence (NCBI Reference Sequence: NZ_CP011047.1) using the Iterative Threading 
Assembly Refinement (I-TASSER) method (49) with default parameters.  The I-TASSER 
method is publically available at http://zhanglab.ccmb.med.umich.edu/I-TASSER/, accessed 
10/15/2015.  The theoretical secondary structures of FliC were visualized and modified using 
UCSF Chimera v.1.10.2 (50), publically available at https://www.cgl.ucsf.edu/chimera/.  The 
hydrophobicity index of the primary FliC amino acid sequence was determined using the 
ProtScale tool from the ExPASy Bioinformatics Resource Portal (51), publically available at 
http://www.expasy.org/, accessed 06/01/2016.  The hydrophobicity index was calculated using 
the Kyte & Doolittle amino acid scale (52) with a window size of 15 amino acids. 
 
4.3.8 CS29544 and flagella competition assays 
 A 3 mL aliquot of stationary phase CS29544 culture was mixed with detached flagella 
pieces at a concentration of 0.1, 1, 5, 10, or 20 μg/mL of total flagella protein and allowed to 
autoaggregate for 6 h.  Controls included, addition of 20 μg/mL of bovine serum albumin (BSA, 
New England BioLabs, Ipswich, MA, USA) or equal volume of protein storage buffer (no 
protein).  
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4.3.9 CS29544 biofilm formation to polyvinyl chloride tubing 
 Polyvinyl chloride tubing (PCV, 0.318 cm outer diameter, 0.159 cm inner diameter, U.S. 
Plastic Corporation, Lima, OH, USA) was cut with a sterile blade into 5 cm long pieces (external 
surface area ~5.15 cm
2
.  The PVC tube pieces were disinfected with submersion in 70% ethanol 
for 10 min and aseptically dried.  Two PVC tube pieces were aseptically transferred to a 15 mL 
centrifuge tube containing 10 mL of BHI, supplemented with 50 μg/mL ampicillin for 
ΔfliC/cfliC.  Each experimental vessel was inoculated with 1% (v/v) stationary phase CS29544, 
ΔmotAB, ΔfliC, and ΔfliC/cfliC cells and incubated vertically at 37°C aerobically with agitation 
(250 rpm) for 24 h.  After incubation, each PVC tube piece was transferred with sterile forceps 
and washed three times in 5 mL PBS, pH 7.4.  After washing, each PVC tube piece was placed 
into 30 mL PBS, pH 7.4 containing 3 g of autoclaved 0.1 mm diameter glass beads (Research 
Products International, Mount Prospect, IL, USA).  Biofilms were subsequently disrupted by 
vortex at maximum speed for 1 min.  Bacterial biofilm populations were enumerated by serial 
dilution (10
-1
 – 10-3) in 0.1 % peptone water, spread plated (0.1 mL in triplicate) on BHI agar 
plates, and incubated at 37°C overnight aerobically. 
 
4.3.10 Statistical Analysis 
 Autoaggregation assays and biofilm formation assay result from of three independent 
replicates.  The differences between the average maximum percent autoaggregation due to 
temperature, redox balance, pH, blending, and various media and the differences between 
biofilm formation due to the presence of FliC were determined with SAS® (Version 9.4, SAS 
Institute, Cary, NC) using the generalized linear model (GLM).  When statistical significance 
was observed (p < 0.05), a post hoc mean separation was run using the Tukey’s Honest 
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Significance Difference test.  All data satisfied the assumptions of normality and homogeneity of 
variance. 
 
4.4 Results 
4.4.1 Characterization of autoaggregation in CS29544 
 Stationary phase BHI cultures of CS29544 autoaggregated at 25°C within 30 – 60 min 
(Figure 4.1A).  Following 6 h stagnant incubation, the average maximum percent 
autoaggregation was 70.3 ± 2.2%.  Various growth media and physiological conditions were 
tested to better understand CS29544 autoaggregation (Figure 4.1B-F).  Autoaggregation of BHI 
grown cells at 37°C was significantly higher when stagnantly incubated at 37°C than 4 or 25°C 
(p = 0.0022, Figure 4.1B) or in the presence of EDTA (p = 0.0092; Figure 4.1C) compared to the 
PBS-added control.  Although the maximum percent autoaggregation was lower for cells grown 
in a reduced environment, the difference was not significant (p = 0.3003, Figure 4.1D).  
Autoaggregation following overnight growth in BHI was significantly higher than overnight 
growth in LB10, LB5, TSB and BPN (p = 0.0203, Figure 4.1E).  The difference in 
autoaggregation was not readily explained by the presence of salt, extracts, protein sources, or 
inclusion of phosphates but rather the initial pH of the media.  Therefore, CS29544 was grown in 
BHI with varying initial pH values (range pH 4 – 8).  CS29544 did not grow at pH 4, but its 
growth was not affected by BHI at pH 5 – 8 (Figure 4.1F).  As predicted, the average maximum 
percent autoaggregation decreased with decreasing pH (p < 0.0001, Figure 4.1F).  The average 
maximum percent autoaggregation in BHI at an initial pH 6 was 51.9 ± 1.6% which was slightly 
lower than the average maximum percent autoaggregation observed in the various media tested.  
During this initial characterization, an abolishment of autoaggregation was only achieved when 
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grown in BHI at pH 5; however, this observation did not clearly point to a specific mechanism.  
Since the average maximum percent autoaggregation never reached 100%, we hypothesized that 
there might be a nonautoaggregating subpopulation of CS29544 mediated by an identifiable 
genetic variation. 
 
4.4.2 Nonautoaggregating CS29544 are a stable genetically-distinct subpopulation 
 Following five successive passages selecting against autoaggregating CS29544, we were 
able to isolate two independent nonautoaggregating clonal variants (CV) of CS29544 (Figure 
4.2A & B, Video C.1).  De novo assembly of the mate-pair library preparation from wild-type 
CS29544 was used as the reference genome for comparative genomic analysis with the 
nonautoaggregating CV’s (2.10 & 3.6) assemblies.  A single unique SNP was detected in each of 
the nonautoaggregating CV.  Strain 2.10 contained a putative deletion of two consecutive base 
pairs (GC), while strain 3.6 contained a putative deletion of a single base pair (C).  Further 
corroboration by Sanger sequencing revealed the two nonautoaggregating CV contained 
frameshift mutations and NCBI BLAST analysis revealed these mutations were located in the 
open reading frames of two flagella proteins, FlhA (2.10) and FliG (3.6), referred to as flhA_CV 
and fliG_CV.  Accordingly, we assessed the flagellation of the wild-type CS29544 and the CV 
with motility assays and microscopy (Figure 4.2C).  Both the flhA_CV and fliG_CV were 
nonmotile and aflagellate by staining and TEM (Figure 4.2C).  As a result, we constructed a 
variety of gene knockouts to determine if structurally intact and functional flagella were required 
for autoaggregation in CS29544.  
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4.4.3 Flagella structure, not function, is required for autoaggregation in CS29544 
 Published C. sakazakii genomes, available from NCBI, have annotated some 40 genes 
related to their flagella’s structure, function, and regulation.  Therefore, gene knockout strains 
(Table 4.1) were constructed to disrupt the structure and function of the CS29544 flagella, refer 
to Figure 4.3A-C for a simplified diagram of the bacterial flagella outlining our knockout 
strategy.  Two basal body proteins, FlhA and FliG (same genes as the nonautoaggregating clonal 
variants) were targeted.  Previously, FlhA truncation mutants in Campylobacter jejuni resulted in 
aflagellate cells lacking flagellar components past the inner membrane (53).  FliG, along with 
FliN and FliM, forms the C ring of the basal body (54).  Proton-driven conformational changes 
in the MotA and MotB stator (motor) proteins (55) directly interacts with the C-terminus of the 
FliG protein of the C ring to provide rotation to the flagella (56,57).  While FliG is integral for 
the function of the flagella, its necessity for assembly is disputed (56,57).  It was hypothesized 
that disruption of motAB would render the cells nonmotile while retaining the structural 
components (Figure 4.4B).  Additionally, disruption of flhA and fliG would block the early 
assembly of the flagella and the cells would be aflagellate (Figure 4.4C).  Based on the published 
CS29544 genome, CS29544 has redundant filament proteins; therefore, both FliC and FlaA 
single and double gene knockouts were constructed.  Finally, the function of the flagella was 
disrupted by targeting the two motor proteins, MotA and MotB. 
 The ΔflhA, ΔfliG, ΔfliC, and ΔflaAΔfliC strains did not autoaggregate and were aflagellate 
by staining and TEM and nonmotile (Figure 4.4A-C).  Conversely, the ΔmotAB and ΔflaA strains 
remained autoaggregative and had visible flagella by staining and TEM (Figure 4.4A-C).  These 
two strains differed in their motility: ΔflaA was motile while ΔmotAB was not motile.  Therefore, 
we concluded that motility was not required for autoaggregation in CS29544.  Based on the 
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phenotypes of the structural gene knockouts, we hypothesized that filaments composed of FliC, 
not FlaA, were required for autoaggregation.  Upon mechanical removal of the filaments, only 
the autoaggregating CS29544, ΔmotAB, and ΔflaA strains possessed a heavily dense 28.9 kDa 
protein band (Figure 4.5).  The band was confirmed as FliC by a total of five peptides having 
individual ion scores of 44 and a Mascot ion score of 1191.  Furthermore, the ΔfliC strain did not 
contain a 50.1 kDa band, the predicted size for FlaA.  The autoaggregation phenotype, motility, 
and flagellation were restored in the ΔfliC/cfliC and ΔflaAΔfliC/cfliC complementation strains 
(Figure 4.6A-C).  Finally, we confirmed a loss of autoaggregation in CS29544 after mechanical 
removal of flagella from 79.4 ± 4.4% to 2.2 ± 2.2% with no reduction in cellular viability (data 
not shown). 
 
4.4.4 Flagella-mediated autoaggregation occurs by flagella-flagella interactions 
 Visual analysis of the CS29544 TEM image revealed supercoiled flagella linking several 
bacteria together in a cluster (Figure 4.7A).  Therefore, it was hypothesized that autoaggregation 
in CS29544 proceeds as flagella from one cell becomes entangled with the flagella from 
neighboring cells.  To test this hypothesis, mechanically detached flagella pieces were added to 
stationary phase CS29544 cultures.  Autoaggregation of CS29544 was not affected by the 
addition of 0.1 or 1.0 μg/mL of detached flagella, 20 μg/mL BSA, or the no-protein control 
(PSB, Figure 4.7B).  Autoaggregation was prevented when 20 μg/mL of detached flagella was 
added.  The addition of detached flagella altered the manner by which the CS29544 
autoaggregated.  The controls autoaggregated as before by forming small flocs of cells that 
settled to the bottom of the tube.  In the presence of 5 and 10 μg/mL of detached flagella flocs 
did not form, rather a large mass of cells settled gradually to the bottom of the tube (Video C.2). 
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 The predicted secondary structure of the CS29544 FliC protein was analogous to 
homologous flagellins with a highly conserved flagellin N- and C-termini linked by a 
hypervariable region (Figure 4.8A).  Analysis of the hydrophobicity scores of the linear amino 
acid sequence revealed a peak in hydrophobicity followed by a valley in hydrophobicity (Figure 
4.8B) located in the hypervariable region of the CS29544 FliC.  The bacterial filament is 
composed of several thousand flagellin proteins with the conserved regions stacked laterally.  
The hypervariable region is externally exposed and able to interact with its environment.  We 
hypothesize that the hypervariable hydrophobic peaks and valleys of neighboring cells interact 
laterally to promote autoaggregation in CS29544.  Further work will be required to test this 
hypothesis. 
 
4.4.5 Biofilm formation to polyvinyl chloride is not mediated by flagella 
 The total cellular population of wild-type CS29544 biofilms on PVC was 1.5x104 ± 
3.0x10
3
 CFU/cm
2
.  The total cellular populations of ΔmotAB, ΔfliC, and ΔfliC/cfliC on PVC 
biofilms were 4.8x10
3
 ± 2.2x10
3
, 2.4x10
4
 ± 7.0x10
3
, and 1.0x10
4
 ± 6.5x10
2
 CFU/cm
2
, 
respectively.  CS29544 biofilm formation on PVC was not mediated by FliC under the 
conditions tested (p = 0.0928, Figure 4.9). 
 
4.5 Discussion 
 While autoaggregation was demonstrated in C. sakazakii ATCCBAA-894 (38,41), the 
molecular basis for autoaggregation was not described.  To understand the genetic determinants 
of autoaggregation in CS29544, a set of structural and functional flagellar mutants were 
constructed.  These flagellar mutants revealed the requirement of FliC containing filaments in the 
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autoaggregation of CS29544.  Additionally, these results suggest an additional biological 
function for the CS29544 flagellum rather than its contributions to motility. 
 Protein-protein interactions, such as flagella-mediated autoaggregation, may require 
specific environmental conditions.  Previously, protein-protein aggregation in bacteria was 
influenced by altering the growth media (18), sodium chloride concentrations (23), pH (22,31), 
or the presence of divalent cations (32,36).  In this study, autoaggregation assays were conducted 
to identify nutritional dependencies and provide insights into potential mechanisms.  Different 
growth media containing various nutrient extracts, proteins sources, salts (NaCl and phosphates), 
and carbohydrates (dextrose) were tested.  Additionally, autoaggregation was observed under a 
variety of temperatures, redox potentials, and pH values.  Wild-type CS29544 was flagellated 
and highly motile under all growth conditions tested, except growth in BHI at pH 5.  In 
hindsight, it is not surprising that autoaggregation in CS29544 had only minimal nutritional or 
conditional dependencies, even though flagellar expression is a tightly regulated system that 
quickly responds to changes in the bacterium’s surrounding environment (58).  In favorable 
environmental conditions, such as nutrient-dense media, motility may be arrested following the 
downregulation of flagellar genes.  However, nonmotile bacteria do not immediately shed their 
structurally intact flagella and these flagella may participate in other biological functions.  While 
abolishment of autoaggregation in CS29544 was observed in structural mutants (ΔflhA, ΔfliG, 
ΔfliC, and ΔflaAΔfliC), autoaggregation was not affected in the functional mutant (ΔmotAB) 
which retained the structural components.  These results suggest that autoaggregation in 
CS29544 may serve as an additional biological function for the CS29544 flagellum in 
environmental conditions that favor the downregulation of motility but not the loss of structure. 
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 The CS29544 genome encodes < 40 genes that are required for the assembly, function 
and regulation of its flagellum.  In this study, autoaggregation was only mediated by the loss of 
structural proteins, specifically, the lack of the FliC containing filament.  Four structural mutants, 
two direct (ΔfliC and ΔflaAΔfliC) and two indirect (ΔflhA and ΔfliG), resulted in aflagellate 
nonautoaggregating CS29544 cells.  Since the extracellular filament, comprised of several 
thousand FliC monomers, extends several microns from the cell, it is physically able to promote 
cell-cell interactions.  Upon close examination of wild-type CS29544 cells by TEM, neighboring 
cells appeared tethered by their filaments.  Similar bundles were observed in Escherichia coli 
(18), Pseudomonas marina (36) and Pyrococcus furiosus (37).  Furthermore, flagella-mediated 
autoaggregation was disrupted in a dose-dependent manner by the addition of exogenous wild-
type FliC filaments.  Protein-protein interactions may be mediated by several factors, including 
ionic and hydrophobic bonds.  As discussed above, only growth in BHI at pH 5 abolished 
flagella-mediated autoaggregation in CS29544 and no other nutritional or conditional 
dependencies were observed.  Previously, TibA-mediated autoaggregation in an enterotoxigenic 
E. coli was affected by changes in pH (22).  The authors speculated that TibA-mediated 
autoaggregation might be promoted by pH-mediated ionic bonds between charged amino acid 
side chains.  It is tempting to conclude that flagella-mediated autoaggregation involves ionic 
bonding due to abolishment at pH 5; however, our observations do not support this conclusion.  
CS29544 cells grown in BHI at pH 5 were growth-impaired, had no visible flagella by staining, 
and were nonmotile by wet mount. 
 The CS29544 genome encodes two different flagellin proteins, fliC and flaA; however, 
only FliC monomers were incorporated into the harvested CS29544 filaments under the 
conditions tested.  Consistent with this study, FliC is the sole C. sakazakii flagellin protein 
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reported in the literature (59,60).  FliC flagellin proteins and its homologs have highly conserved 
N- and C-termini connected by a hypervariable region.  The conserved domains of several 
flagellin proteins self-assemble and form the internal channel of the filament during elongation.  
The conserved domains exposure to the bacterium’s environment is limited and should not 
contribute to flagella-mediated autoaggregation.  Conversely, the hypervariable region is 
invariably externally exposed and likely interacts with components of the bacterium’s 
surroundings.  As a result, our in silico methods centered on the secondary structure and 
hydrophobicity of the hypervariable region.  The entire CS29544 FliC flagellin protein is 
composed of 278 amino acids, of which 50 amino acids comprise the hypervariable region.  Of 
note, the hypervariable region in the C. sakazakii FliC flagellin protein is far shorter than FliC 
flagellin proteins of related Enterobacteriaceae (60).  As seen in the predicted secondary 
structure, the hypervariable region is relaxed and spatially aligned with the conserved regions.  
Unfortunately, the predicted FliC secondary structure did not reveal any obvious structural 
contributions to flagella-mediated autoaggregation.  Rather alterations in hydrophobicity along 
the amino acid sequence illustrated the potential of hydrophobic interactions.  It is hypothesized 
that along the length of every filament are thousands of FliC monomers with alternating 
hydrophobic peaks and valleys (colored in red and yellow, respectively in Figure 4.8).  The 
following hypothesis can be best illustrated by the act of zipping a zipper.  When filaments are in 
close proximity, it is hypothesized that these hydrophobic peaks and valleys interact to allow 
rapid and reversible supercoiling.  Once a sufficient number of CS29544 cells are tethered 
together by their FliC filaments, autoaggregation by this mechanism proceeds.  Further work is 
needed to test these hypotheses and to more precisely define which amino acids interact during 
flagella-mediated autoaggregation in CS29544.  
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 C. sakazakii strains form biofilms on a variety of abiotic surfaces, including stainless 
steel (61–63), silicon (61), latex (61), polyvinyl chloride (40,62,64), and polyurethane (64).  The 
latter two plastics are used for enteral feeding tubes and formation of C. sakazakii biofilms on 
these plastics is concerning.  Hurrell and colleagues (10) isolated C. sakazakii, along with other 
pathogenic Enterobacteriaceae from used enteral feeding tubes.  Biofilm formation on enteral 
feeding tubes is problematic for several reasons.  First, enteral feeding tubes typically reside 
within an infant at body temperature (37°C) for several days (65).  Secondly, infant feeds are 
nutrient-dense and provide sufficient growth substrate for bacteria.  Lastly, with every feeding 
bacteria might dislodge from the biofilm and continuously inoculate the neonate (10,65).  To 
determine the impact of flagella-mediated autoaggregation on C. sakazakii biofilm formation, the 
biofilm formation in the wild-type CS29544 was compared to the ΔmotAB, ΔfliC, and ΔfliC/cfliC 
strains.  To model C. sakazakii biofilm formation on neonatal enteral feeding tubes, flagella-
mediated biofilm formation was tested in a nutrient-dense environment (BHI broth) at 37°C 
using PVC tubing.  In this study, the total cellular biofilm population on PVC tubing ranged from 
3.7-log CFU/cm
2
 in the ΔmotAB strain to 4.4-log CFU/cm2 in the ΔfliC strain.  There was no 
significant difference in biofilm formation between the wild-type CS29544 and the ΔmotAB, 
ΔfliC, and ΔfliC/cfliC strains under the conditions tested.  The observed C. sakazakii population 
density was consistent with the average biofilm population of 4.0-log CFU/cm
2
 on PVC tubing 
of five strains of C. sakazakii grown in TSB at 12°C reported by Kim and colleagues (62).  
Additionally, that study reported an approximately 1.5 log increase in the average biofilm 
population (5.7-log CFU/cm
2
) on PVC tubing when C. sakazakii strains were grown in TSB at 
25°C.  Since 27°C is the optimum temperature for C. sakazakii exopolysaccharide production, 
this result is not surprising.  Admittedly, C. sakazakii biofilm formation due to differences in 
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flagella-mediated autoaggregation phenotype was not robustly tested.  To date, a single study has 
demonstrated the importance of C. sakazakii strain ES5’s flagellum in biofilm formation and 
adhesion to microtiter plates (44).  The data presented here demonstrates that additional research 
into C. sakazakii flagella-mediated autoaggregation, biofilm formation, and gastrointestinal 
colonization is critically needed. 
 A significant shortcoming of this study is its limited scope.  A single strain of C. 
sakazakii was characterized, and generalization to all C. sakazakii strains should be avoided.  
Currently, our collective understanding of C. sakazakii pathogenesis is insufficient.  Several 
decades of work were completed to characterize the diverse pathotypes in E. coli, and it is 
tempting to speculate that C. sakazakii may have definable pathotypes of which flagella-
mediated autoaggregation is important.  Future studies should be designed to characterize 
flagella-mediated autoaggregation contributions to C. sakazakii pathogenesis in vivo with 
suitable animal models.  Concurrently, autoaggregation, not necessarily flagella-mediated, 
should be characterized in several clinical, environmental, and laboratory C. sakazakii strains.  
This current study contributes much-needed knowledge to the C. sakazakii literature. 
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4.7 Tables and Figures  
Table 4.1.  Bacterial strains and plasmids used in this study. 
Strain or plasmid Relevant characteristics or purpose Internal Number Source or reference 
C. sakazakii strains    
CS29544 Cronobacter sakazakii ATCC 29544, wild-type MJM187 ATCC 
CS29544 pKD46 CS29544 harboring pKD46 MJM396 This study 
flhA_CV (2.10) CS29544 flhA nonautoaggregating variant MJM387 This study 
fliG_CV (3.6) CS29544 fliG nonautoaggregating variant MJM388 This study 
ΔflhA  CS29544 flhA MJM425 This study 
ΔfliG  CS29544 fliG MJM426 This study 
ΔmotAB CS29544 motAB MJM476 This study 
ΔfliC CS29544 fliC MJM477 This study 
ΔflaA CS29544 flaA MJM478 This study 
ΔflaA pKD46 CS29544 flaA harboring pKD46 MJM480 This study 
ΔflaAΔfliC CS29544 flaAfliC MJM484 This study 
ΔfliC/cfliC CS29544 fliC/fliC complementation vector MJM481 This study 
ΔflaAΔfliC/cfliC CS29544 flaAfliC fliC complementation vector MJM483 This study 
E. coli strains    
DH5α pKD3 & pCP20 host strain MJM363, MJM364 Gift from J.M. Slauch 
MG1655 pKD46 host strain MJM365 Gift from J.M. Slauch 
Top10 cfliC host strain MJM423 Invitrogen 
Plasmids    
pCP20 bla cat cI857 λPR flp  (46) 
pKD3 bla FRT cat FRT  (47) 
pKD46 bla PBAD gam bet exo  (47) 
cfliC 
1 kb fragment fliC native promoter and ORF 
cloned into pET-11a  
pMJM49 This study 
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Table 4.2. Primer sequences used to create and confirm gene knockouts. 
Locus Primers Sequence (5’ – 3’)1 
cat c2_F GAT CTT CCG TCA CAG GTA GG 
 c1_R TTA TAC GCA AGG CGA CAA GG 
flhA flhA_ko_F ATCACCAAGGGTGCGGGGCGTATCGCGGAAGTGGGCGCGC  
 flhA_ko_R GATAGGCTTCACCGCTGCCGATTTCCACGCCTTTCATCAG 
 flhA_flank_F GAA ATC GGT CAG CAG ATC C 
 flhA_flank_R CAG ACC ACG ACC GTC ATC AC 
fliG fliG_ko_F TGACCATCGGTGAAGACCGCGCGGCGGAGGTGTTCAAACA 
 fliG_ko_R ATAGCTTTCTGTTCGTTTTCCACCTGAGACAGACGCACCG 
 fliG_flank_F AGC GTA AAG AAG TGG AAG AG 
 fliG_flank_R CGT CGA CTT CTT CGC TTT C 
motAB motAB_ko_F TGAACATCCTCGCCATAGCCAACAGCGGAAGGATGATGTC 
 motAB_ko_F AAATGTCTGATAAAAATCGCTAATATCCATACTCACGCTA 
 motAB_flank_F CGTAAACTTTCGCGAGATGCTG 
 motAB_flank_R CGCGGAATATGGCATTTAGCTG 
fliC fliC_ko_F CAACCTGAACAAATCTCAGTCTGCTCTGGGCACTGCTATC 
 fliC_ko_F GAAAGCTTGAGCGTCTATTAACGCAGCAGGGACAGCATGG 
 fliC_flank_F ATGCAGACGCAGGCTATTGAG 
 fliC_flank_R TCCGGCTATATCTGTCGCAAC 
flaA flaA_ko_F GCCACGCCGGTTGAGTCAGCGTCCGGGCAGGCGCGTGACG 
 flaA_ko_F GCCTTGTTAACGACTCTCCGATGTGCGAAACGGCAACCCT 
 flaA_flank_F CTTCCCGCTGACCATTTC 
 flaA_flank_R AACGTGCCGTCCATATCC 
1
 40 bp gene homology was added to the 5’ end of the pKD3 homologous sequences; Forward: 
TGTAGGCTGGAGCTGCTTCG and Reverse: CATATGAATATCCTCCTTAG 
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Figure 4.1.  Autoaggregation of stationary phase CS29544 cultures. (A) Time course of autoaggregation in BHI broth over 6 h.  
Maximum percent autoaggregation (B) in BHI broth during stagnant incubation at different temperatures, (C) in BHI broth in the 
presence of 50 mM EDTA or PBS, (D) in BHI broth following growth aerobically or anaerobically, (D) in a variety of growth media; 
LB10 = LB Miller’s formula (10 g/L NaCL), LB5 = LB Lennox’s formula (5 g/L NaCL), TSB = tryptic soy broth and BPN = motility 
broth, pH of growth media is reported for reference, (E) in BHI at different initial pH values.  Maximum optical density (600 nm) is 
reported for reference.  All experiments are mean ± standard error of three independent replicates.  Values with no letters in common 
are significantly different (p < 0.05). 
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Figure 4.2.  Autoaggregation, motility and flagellation of nonautoaggregating CS29544.  (A) 
Time course of autoaggregation in BHI broth over 6 h.  CS29544 (included for reference) and 
clonal variants: flhA_CV and fliG_CV.  Experiment is mean ± standard error of three 
independent replicates.  (B) Autoaggregation tube assays in BHI broth after stagnant incubation 
for 6 h; WT = CS29544.  (C) Motility agar plates centrally inoculated and imaged after 24 h, 
flagellation as detected by crystal violet staining at 1000X total magnification and TEM, bar = 4 
μm.
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Figure 4.3.  Simplified diagram of the bacterial flagellum highlighting our gene knockout strategy.  (A) Bacterial flagellum labelled 
with gene knockout targets. Filament proteins: FliC and FlaA, Stator (motor) proteins: MotA and MotB, C-ring protein: FliG, and 
Exporter apparatus protein: FlhA.  (B) Hypothesized flagellum structure in the functional mutant: ΔmotAB.  (C) Hypothesized 
flagellum structure in the structural mutants: ΔfliC and ΔflaA, ΔflhA, and ΔfliG. 
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Figure 4.4.  Autoaggregation, motility and flagellation of CS29544 and gene knockout strains.  (A) Time course of autoaggregation in 
BHI broth over 6 h.  Gene knockouts: ΔflhA, ΔfliG, ΔmotAB, ΔfliC, ΔflaA, ΔfliCΔflaA.  Experiment is mean ± standard error of three 
independent replicates.  (B) Autoaggregation tube assays in BHI broth after stagnant incubation for 6 h.  (C) Motility agar plates 
centrally inoculated and imaged after 24 h, flagellation as detected by crystal violet staining at 1000x total magnification and TEM, 
bar = 4 μm. 
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Figure 4.5.  Harvested filaments from of CS29544, gene knockout, and complementation strains.  
Gene knockouts: ΔflhA, ΔfliG, ΔmotAB, ΔfliC, ΔflaA, ΔfliCΔflaA and FliC complements: 
ΔfliC/cfliC and ΔfliCΔflaA/cfliC.  Each lane was loaded with approximately 2 μg of total protein.  
FliC expected size 28.9 kDa.  
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Figure 4.6.  Autoaggregation, motility and flagellation of FliC complementation strains.  (A) 
Time course of autoaggregation in BHI broth over 6 h. FliC complements: ΔfliC/cfliC and 
ΔfliCΔflaA/cfliC.  Experiment is mean ± standard error of three independent replicates.  (B) 
Autoaggregation tube assays in BHI broth after stagnant incubation for 6 h.  (C) Motility agar 
plates centrally inoculated and imaged after 24 h, flagellation as detected by crystal violet 
staining at 1000x total magnification and TEM, bar = 4 μm. 
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Figure 4.7.  Autoaggregation competition assays with harvested filaments from CS29544.  (A) CS29544 wild-type flagella TEM 
image, bar = 4 μm.  Arrows indicate bundles of flagella.  (B) Time course of autoaggregation in BHI broth over 6 h.  Stationary phase 
CS29544 cultures combined with harvested FliC filaments (0.1 – 20 μg/mL), bovine serum albumin (BSA, 20 μg/mL) and PSB (no 
protein control).  Experiment is mean ± standard error of three independent replicates.  
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Figure 4.8.  In silico analysis of the CS29544 FliC protein.  (A) Theoretical secondary structure of FliC from I-TASSER.  Conserved 
regions: N-terminus in blue, C-terminus in green.  Hypervariable region: hydrophobic peak in red, hydrophobic valley in yellow.  (B) 
Hydrophobicity index along the linear amino acid sequence of FliC.  Hydrophobic peak highlighted in red, hydrophobic valley 
highlighted in yellow. 
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Figure 4.9.  Biofilm formation on polyvinyl chloride of CS29544 and select gene knockout and 
complementation strains.  Cellular population are mean ± standard error of three independent 
replicates. Gene knockouts: ΔmotAB and ΔfliC and FliC complements: ΔfliC /fliC. Values with 
no letters in common are significantly different (p < 0.05).  
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CHAPTER FIVE 
A PIGLET MODEL FOR STUDYING CANDIDA ALBICANS COLONIZATION 
OF THE HUMAN ORO-GASTROINTESTINAL TRACT
1
 
5.1 Abstract 
 Pigs from a variety of sources were surveyed for oro-gastrointestinal (oro-GIT) carriage 
of Candida albicans.  Candida albicans-positive animals were readily located, but we also 
identified C. albicans-free pigs.  We hypothesized that pigs could be stably colonized with a C. 
albicans strain of choice, simply by feeding yeast cells.  Piglets were farrowed routinely and 
remained with the sow for 4 days to acquire a normal microbiota.  Piglets were then placed in an 
artificial rearing environment and fed sow milk replacer.  Piglets were inoculated orally with one 
of three different C. albicans strains.  Piglets were weighed daily, and culture swabs were 
collected to detect C. albicans orally, rectally, and in the piglet’s environment.  Stable C. 
albicans colonization over the course of the study did not affect piglet growth.  Necropsy 
revealed mucosally associated C. albicans throughout the oro-GIT with the highest abundance in 
the esophagus.  Uninoculated control piglets remained C. albicans-negative.  These data 
establish the piglet as a model to study C. albicans colonization of the human oro-GIT.  
Similarities between oro-GIT colonization in humans and pigs, as well as the ease of working 
with the piglet model, suggest its adaptability for use among investigators interested in 
understanding C. albicans-host commensal interactions. 
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5.2 Introduction 
 Normally, Candida albicans is a commensal fungus, harmlessly colonizing the human 
oro-gastrointestinal tract (oro-GIT; reviewed in Koh, 2013).  Disruption of the host’s immune 
defenses, compromise of GIT integrity, or alterations in the GIT microbiota, can cause 
commensal fungal cells to turn into a deadly disease-causing inoculum.  Extraintestinal 
translocation of C. albicans is a key part of this process. 
 While considerable effort has been devoted to understanding C. albicans pathogenesis, 
study of C. albicans colonization has come into vogue more recently.  Mouse models are used 
most frequently for these analyses. Koh (2013) presented a thorough and insightful review of 
murine models for studying GIT colonization.  Currently, the most commonly used model 
involves antibacterial treatment of adult mice to alter the GIT microbiota composition, 
introduction of C. albicans by drinking water or oral gavage, and monitoring fungal persistence 
in fecal pellets.  While this model is easily adapted to many laboratories, the murine GIT is 
naturally resistant to C. albicans colonization, leading to concerns about the artificiality of this 
approach. 
 Pigs are frequently used as human biomedical models.  Andrutis et al. (2000) discussed 
selection of pig models for the study of bacterial, viral and parasitic enteric pathogens, because 
of similar pathologies produced in pigs and humans.  Andrutis et al. (2000) used gnotobiotic 
piglets as a model for C. albicans GIT colonization and dissemination.  Perhaps gnotobiotic 
piglets were sought because of the conventional idea that C. albicans is associated with all 
domestic animals (reviewed in Wrobel et al., 2008), thereby requiring extra effort to derive a C. 
albicans-negative animal.  Pigs were delivered by Cesarean section and housed in 
microbiological isolators to prevent introduction of normal microbiota.  Immunosuppressive 
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treatments caused disseminated disease that was similar to humans.  While impressive, this 
gnotobiotic piglet model was labor-intensive, making it difficult to adapt for widespread use. 
 Work described here investigates use of routinely farrowed piglets as a model for C. 
albicans colonization.  Study parameters were selected to promote acquisition of a normal 
microbiota.  Non-intensive housing methods were designed, with the intention of facilitating 
broad use of the model among investigators who study C. albicans-host interactions associated 
with oro-GIT colonization. 
 
5.3 Materials and Methods 
5.3.1 Detection of yeasts in the pig microbiota 
 Nine pigs, from 7 different farms, were submitted for necropsy to the Veterinary 
Diagnostic Laboratory (VDL) at the University of Illinois and sampled to detect yeasts.  Swabs 
from the oral cavity, large colon, and rectum were plated on Sabouraud agar (per liter: 40 g 
glucose, 10 g peptone, 20 g Bacto agar) with chloramphenicol (20 μg ml-1; Sab + Cml), and 
incubated for 24 h at 37 ºC.  Pure cultures were derived for colonies with yeast-like cellular 
morphology.  Each isolate was streaked to CHROMagar Candida (www.chromagar.com) and 
tested for germ tube formation by inoculation into RPMI 1640 medium (Gibco catalog no. 
11875-085).  Yeasts were identified by PCR of genomic DNA using primers ITS4 (5’ 
TCCTCCGCTTATTGATATGC 3’) and ITS5 (5’ GGAAGTAAAAGTCGTAACAAGG 3’) that 
amplify the internal transcribed spacer region of the nuclear-encoded rRNA genes (White et al., 
1990).  DNA sequences were aligned against the non-redundant nucleotide database using 
BLAST.  C. albicans isolates were analyzed using multilocus sequence typing (MLST) as 
described previously (Bougnoux et al., 2003; Wrobel et al., 2008).  Oral and rectal swabs were 
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also collected from normally healthy pigs on the University of Illinois Veterinary Research Farm 
(VRF).  A total of 34 pigs were sampled from a herd of approximately 200.  Fourteen pigs were 
from the nursery unit (15-40 lbs), 10 were growers (40-100 lbs), and 10 were from the finishing 
unit (100-280 lbs).  Swabs were plated on Sab + Cml and yeasts identified as described above.  
Animal experiments were conducted with the approval of the University of Illinois Institutional 
Animal Care and Use Committee. 
 
5.3.2 Farrowing and artificial rearing of piglets 
 VRF piglets are an outbred population that includes a mix of the Yorkshire, Landrace, 
and Duroc breeds.  Piglets were farrowed normally and housed with the sow in farrowing crates 
to ensure intake of colostrum.  On day 4, piglets were moved to an artificial rearing environment.  
Piglets were handled minimally: they were not subjected to any of the normal processing of VRF 
piglets that typically includes ear notching, removal of needle teeth, tail docking, iron dextran 
injection (100 mg; Aspen Veterinary Resources), Penicillin G injection (300,000 units; Butler 
Schein), and castration of males.  Approximately equal numbers of male and female piglets were 
used in the experiments. 
 Piglets were moved to 4 x 4 foot raised pens constructed from painted steel hog panels, 
lined with solid plastic sheeting to prevent animal-to-animal contact.  Pens had plastic slotted 
flooring over a flush pan.  All material was easily disinfected.  Piglets had 24-h access to water 
via a nipple-triggered drinking cup. Rooms were ventilated to outdoor air by a variable-speed, 
12-inch exhaust fan.  Room temperature was controlled by use of a room heater or an air 
conditioning unit.  Heat lamps were lowered over each pen, when additional heat was required.  
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Housing met or exceeded the standards and recommendations of the Guide for the Care and Use 
of Laboratory Animals (8
th
 edition). 
 Piglets were fed Ralco-Birthright Acidified Baby Pig Milk Replacer (Ralco Nutrition, 
Inc.; 5 cups per gallon of water; 360 ml kg
-1
 body weight, up to 2000 ml daily).  In the initial 
study, milk replacer was provided hourly using a timer and pump system.  The pig’s bowl, stock 
bottles, and tubing were washed and bleached daily, and always returned to the same pig’s 
feeding system to prevent cross-contamination between animals.  Subsequent work showed that 
milk replacer can be provided in a plastic baby pig waterer (see Miller Little Giant item number 
291-25).  Half of the total daily volume of milk replacer was provided twice daily.  Plastic 
waterers were washed and bleached daily, then returned to the same pen.  Research workers 
wore clean coveralls and boots.  Gloves were changed between handling animals and materials 
in different pens.  A bleach bootwash outside of each room was used to control spread of C. 
albicans in the animal facility. 
 
5.3.3 Inoculation of piglets with C. albicans and assessment of colonization 
 Piglets and their environment were confirmed C. albicans-free before each study.  Oral 
swabs sampled liberally over all oral surfaces.  For rectal swabs, the swab tip was inserted into 
the pig’s rectum and withdrawn, often covered in fecal material.  Environmental swabs were wet 
in the piglet’s drinking cup, then rubbed thoroughly across all pen surfaces.  Swabs were plated 
on Sab + Cml as described above. 
 After 1 day of acclimation, pigs were inoculated orally with 10
9
 C. albicans cells.  One of 
three strains was used: SC5314 (the most commonly studied isolate, for which the genome 
sequence is known; Jones et al., 2004), 216 (an oral isolate from a normally healthy human; 
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Wrobel et al., 2008), or 3317 (collected from the oral cavity a VDL necropsy pig evaluated for 
lameness; see above).  C. albicans strains were taken from -80 °C storage and streaked to YPD 
plates (per liter: 10 g yeast extract, 20 g peptone, 20 g glucose, 20 g Bacto agar).  Plates were 
incubated at 37 °C for 24 h then stored at 4 °C for ≤ 1 week.  An isolated, representative colony 
was inoculated into 20 ml YPD and incubated for 16 h at 30 °C and 200 rpm shaking.  Yeasts 
were collected by centrifugation, washed twice in Dulbecco’s phosphate buffered saline without 
calcium or magnesium (DPBS), and counted using a hemocytometer.  The yeast inoculum was 
resuspended in 1 ml DPBS.  Piglets readily drank the inoculum or DPBS control from a 
needleless tuberculin syringe. 
 Oral, rectal, and environmental swabs were collected 8 h following inoculation, and once 
every 24 h afterward. Swabs were plated on Sab +Cml.  Plates were incubated for 24 h at 37 °C 
and C. albicans colonies counted.  A 7-category scale was used to report the plating results: 0 
(no growth), 1 (1-25 colonies), 2 (26-99 colonies), 3 (100-499 colonies), 4 (500-1000 colonies), 
5 (>1000 colonies, with distinct colony growth still visible), and 6 (lawn of growth).  Piglets 
were weighed daily to monitor growth. 
 Two independent experiments were conducted.  In the first, C. albicans isolates were 
tested using one pig per strain.  A DPBS-inoculated pig was maintained in the same room to 
control for unintentional C. albicans transfer.  Pigs were monitored for 21 days, including 15 
days on milk replacer and 6 days on solid feed (pelleted Diet 111 from the University of Illinois 
Department of Animal Sciences feed mill; per ton: 625.2 lbs corn, 500 lbs whey, 404.8 lbs 
soybean meal, 200 lbs lactose, 150 lbs appetein, 60 lbs fat, 22.8 lbs lime, 12.6 lbs dicalcium 
phosphate, 8 lbs zinc oxide, 7 lbs swine trace minerals, 4 lbs Vitamix ADEK, 2.8 lbs DL-
methionine, 2 lbs iodized salt, and 0.8 lbs lysine).  In the second experiment, C. albicans isolates 
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were tested using 2 pigs per strain.  Pigs were housed individually, with complete experimental 
replicates in separate rooms, and monitored for 13 (1
st
 group) or 14 days (2
nd
 group) while fed 
milk replacer.  An uninoculated control pig was placed in each room.  Because duplicate animals 
were used for each treatment, results from the second experiment are featured here.  However, 
results were reproducible across both experiments. 
 Pigs were anesthetized with an intramuscular injection of telazol:ketamine:xylazine (4.4 
mg kg
-1
), then euthanized by intracardiac overdose of sodium pentobarbital.  Oral and rectal 
swabs were plated on Sab + Cml.  Tissue sections were collected from the esophagus, stomach, 
duodenum, proximal jejunum, mid jejunum, distal jejunum, ileum, cecum, spiral colon, and large 
colon.  C. albicans associated with the GIT mucosa was evaluated by collecting scrapings from 
the lumen of each tissue using the edge of a sterile glass microscope slide.  A portion of the 
mucosa was weighed and homogenized in DPBS.  Serial 10-fold dilutions were plated on Sab + 
Cml and incubated for 24 h at 37 °C to count colony forming units (CFUs).  Another portion of 
the mucosa was baked overnight in a vacuum oven at 80 °C.  The ratio of dry weight to wet 
weight was calculated, and then multiplied by the mass of the original mucosal sample that was 
homogenized and plated.  This final dry weight equivalent was used as a divisor to calculate 
CFU g
-1
 dry weight.  Reported results were rounded to the nearest order of magnitude. 
 In addition to the piglets housed in the artificial rearing environment, a piglet of similar 
age was selected from the VRF farrowing unit and necropsied as a control.  All samples from 
this animal were negative for C. albicans (data not shown).  
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5.4 Results 
5.4.1 Yeasts isolated from pigs 
 To determine how readily C. albicans could be isolated from pigs, swabs were collected 
from pigs that were submitted to the VDL, and also from pigs at the VRF (see Materials and 
methods).  VDL submissions provided the means to sample pigs from a variety of local sources.  
While some pigs were submitted because of infectious disease (enteritis, pneumonia), others 
were normally healthy (used for teaching purposes), or evaluated for conditions, such as 
lameness.  Eight of the 9 VDL pigs were yeast-positive as detected by our culture technique; C. 
albicans was isolated from 4 of them.  There was no association between C. albicans isolation 
and pig health. Candida tropicalis (2 pigs), Trichosporon asahii (1 pig), and Candida catenulata 
(1 pig) were also isolated from the C. albicans-positive pigs.  Issatchenkia orientalis (2 pigs), C. 
catenulata (1 pig), C. tropicalis (2 pigs) and Candida rugosa (1 pig) were isolated from the C. 
albicans-negative pigs. 
 MLST analysis of the C. albicans pig isolates showed that all were from clade 8, and 
clustered closely with strains commonly found in central Illinois wildlife (Wrobel et al., 2008).  
One isolate had an identical diploid sequence type (DST 785) with a deer isolate (strain DA047).  
In all 4 C. albicans pig strains, genotype designations for the ACC1, ADP1, MPI1, SYA1, and 
ZWF1b loci were identical (7, 6, 3, 6, and 37 respectively), matching 8 of the 11 wildlife isolates 
described by Wrobel et al. (2008). 
 The ease of identifying C. albicans-positive pigs from the VDL contrasted sharply with 
results from VRF pigs.  Of 34 randomly selected VRF pigs, only 9 were yeast-positive (3 nursery 
pigs, 2 growers, and 4 finishers).  Importantly, none of the pigs were positive for C. albicans.  A 
single yeast species each was isolated from 8 of the 9 pigs, including C. catenulata (3 pigs), 
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Trichosporon montevideense (2 pigs), and Candida glabrata, C. tropicalis, and Debaryomyces 
hansenii (1 pig each).  One pig had two different yeasts: C. catenulata and D. hansenii. 
 
5.4.2 Stable C. albicans colonization of piglets  
 Lack of C. albicans isolation from VRF pigs, but frequent isolation among pigs from 
other farms suggested that pigs may be colonized naturally with C. albicans, as long as an 
encounter occurs.  We hypothesized that the C. albicans-negative status of the VRF pigs was due 
to biosecurity practices that prevent direct or indirect contact with pigs with wildlife and/or their 
feces.  To test this hypothesis, normally farrowed VRF piglets were removed from the sow at 4 
days, housed individually in an artificial rearing environment, and fed commercial sow-milk 
replacer.  Following acclimation, pigs were fed a C. albicans inoculum to test the stability of C. 
albicans colonization and its effect on pig growth and health.  Pigs were assigned randomly to 
one of four experimental groups: an uninoculated control, or inoculation with one of three C. 
albicans strains. 
 The mean total change in piglet body weight over the course of the study (Δkg) was 5.0 
kg (Figure 5.1).  There was no significant difference between Δkg values for control and C. 
albicans-inoculated piglets (p = 0.10 using the Generalized Linear Model with Tukey’s mean 
separation).  Colony counts from plating oral, rectal and environmental swabs showed that C. 
albicans passed through the piglets within 24 h (Figure 5.2).  After that time, C. albicans was 
detected readily from rectal swabs of most animals, but at a colony count considerably lower 
than observed for the oral swabs.  Oral swab counts remained high throughout the experiment, 
with greater numbers recorded for strains 216 and 3317 (both strains of oral origin) compared to 
SC5314, a human bloodstream isolate from a disseminated candidiasis patient (Gillum et al., 
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1984).  C. albicans in the environment was low, but detectable over the course of the experiment. 
In all instances, swabs from the uninoculated control piglets were C. albicans-negative. 
 A veterinary pathologist conducted a necropsy of each animal.  Gross examination of the 
entire oro-GIT revealed no evidence of hyperkeratosis, edema, swelling, hemorrhage, erosion, or 
ulceration; consistent with the conclusion that C. albicans was part of the pig commensal 
microbiota.  Limited microscopic examination of GIT tissue revealed yeast cells in the lumen or 
associated loosely with the mucosal surface.  Examination of CFU g
-1
 mucosa dry weight 
showed C. albicans colonization up to 10
7
 CFU g
-1
 in the esophagus (Figure 5.3).  In general, 
CFU g
-1
 values decreased in the lower GIT.  Overall, necropsy data paralleled swab data. For 
example, pig 3317 (1) had few CFU from rectal swabs and necropsy specimens from the lower 
GIT.  C. albicans was detected throughout the GIT in inoculated animals, but not in the negative 
controls, where colony counts were zero.  C. albicans colonies recovered from each animal were 
tested using MLST to verify that the recovered strains were the same as the inoculation strain 
(data not shown).  These data demonstrated that simply feeding C. albicans to a normally 
farrowed, untreated piglet resulted in stable colonization with the C. albicans strain of choice. 
 
5.5 Discussion 
 Our culture-based survey of pigs from various farms established that C. albicans can 
exist as a commensal of normally healthy swine.  Identification of a local source of C. albicans-
negative pigs suggested their utility in creating a model of C. albicans commensalism.  This 
model demonstrated stable colonization without the need for antimicrobial treatment that is a 
hallmark of the most commonly used murine model.  The pig model allows C. albicans-host 
interactions to be studied in the presence of the normal GIT microbiota.  While the overall cost 
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of experimental pigs is higher than mice, our work shows that this work can be conducted in a 
non-intensive environment, without requirements for specialized equipment or skills.  These 
features suggest that the model is easily adaptable for use by other investigators. 
 The yeasts recovered from pigs in our study are among those documented in domestic 
swine. Urubschurov et al. (2008) identified 17 cultivatable yeasts from the GIT of piglets reared 
on both a commercial and research farm in Germany.  All of the yeasts we identified were on 
their list, with the exception of C. rugosa and D. hansenii, suggesting broad commonalities 
between GIT yeasts in swine.  Importantly, none of the German pigs had C. albicans supporting 
our hypothesis that the C. albicans status of a herd is largely the result of management practices. 
 The literature documents the presence of C. albicans in commercial swine herds, even as 
the cause of disease.  Zlotowski et al. (2006) described necropsy findings from two pigs infected 
with porcine circovirus 2 (PCV2) that causes postweaning multisystemic wasting syndrome.  
Each pig had oral or esophageal mucocutaneous lesions from which C. albicans was isolated. 
PCV2 infection is associated with compromised immune function (Lee et al., 2010), 
characterized by decreased counts of circulating B and T lymphocytes and depletion of 
lymphocytes in lymphoid tissues (Segalés et al., 2001; Darwich et al., 2002).  These results 
suggest further intriguing parallels between the pig model and human disease: lymphocyte 
depletion and immunosuppression caused by human immunodeficiency virus infection 
frequently leads to oro-esophageal candidiasis, which is an initial hallmark of AIDS (Powderly et 
al., 1999). 
 An unexpected finding of our work is the large number of C. albicans CFU associated 
with the esophageal mucosa.  Cole et al. (1996) noted that the esophagus is the most common 
site for human gastrointestinal candidiasis, and the gastroesophageal junction is the most 
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frequently colonized site in the human GIT.  These results provide even stronger connections 
between our piglet model and humans, and suggest the potential for C. albicans esophageal 
growth to serve as an inoculum that continually seeds the lower GIT. 
 Future efforts will further evaluate the utility of our piglet model for studying C. 
albicans-host interactions in the context of colonization and disease.  Immunosuppressive 
treatments could be tested for their effect on extraintestinal C. albicans translocation.  The 
normal microbiota could be evaluated for its role in protection against disseminated disease.  The 
presented model may also prove useful for testing potential treatments or nutritional 
interventions that could reduce C. albicans colonization. 
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5.7 Figures 
 
 
 
Figure 5.1.  Pig growth (increase in kg body weight) over the study timeline.  Purple circles = 
strain SC514; red squares = strain 216; blue diamonds = uninoculated control; green triangles = 
strain 3317.  
 166 
 
 
 
Figure 5.2.  Heatmap depiction of C. albicans colonies grown from swabs of each pig’s oral 
cavity, rectum, and environment over the study timeline.  A scale of 0 to 6 (defined in the text; 
colored scale bar shown) described the number of CFU grown from each swab on an agar plate.  
Darker squares indicate higher CFU counts, while beige squares indicate a negative result.  C. 
albicans strain and individual pig numbers are shown at the right of the figure.  Control pigs 
were not inoculated with C. albicans and remained negative throughout the experiment.  Because 
group (1) pigs were necropsied one day later than group (2) pigs, an additional observation was 
available (day 14). White squares were used as placeholders for the group (2) pigs.  
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Figure 5.3.  Heatmap depiction of CFU g
-1
 mucosal dry weight from each pig.  Pig numbers are 
included at the bottom of the figure.  The location from which mucosa was collected is shown at 
the right.  The scale bar indicates CFU g
-1
 mucosal dry weight on a logarithmic scale.  Darker 
colors indicate higher values.  
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CHAPTER SIX 
CONCLUSIONS AND FUTURE DIRECTIONS 
 Consumption of prebiotics can beneficially modulate of the gut microbiota.  For some 
neonates, this modulation may be critical to their health.  In Chapter 2, I demonstrated that 
galactooligosaccharides and polydextrose supplementation in neonatal piglet formula could 
significantly increase the lactobacilli population in the ascending colon of neonatal piglets.  
Further analysis revealed that this increase was not a result of direct fermentation by the 
lactobacilli isolates.  Unfortunately, prebiotic utilization by specific population in vivo is not 
straightforward.  Many individual members of a community may respond to prebiotic 
supplementation and indirectly lead to the increase or decrease of specific members.  I 
hypothesize that commensal microbes specializing in glycan catabolism, such as Bacteroides, 
excrete enzymes extracellularly.  These enzymes cleave glycans indiscriminately making smaller 
molecular substrates available to the community.  It is tempting to speculate that the observed 
increase in lactobacilli occurred by this hypothesis. 
 Similarly, pathogenic microorganisms can benefit from liberated glycans in vivo.  In 
Chapter 3, I observed a significant amount of growth of NEC-associated pathogenic 
Enterobacteriaceae in the presence of a variety of prebiotics and mono- and disaccharides that 
compose human milk oligosaccharides.  Conversely, no Enterobacteriaceae tested was able to 
utilize 2’-fucosyllactose, 6’-siallylactose, and Lacto-N-neotetraose.  To more appropriately 
analyze prebiotic and human milk oligosaccharide utilization, I isolated an Enterobacteriaceae 
consortium from piglet feces.  This community was capable of fermenting several prebiotics and 
the human milk oligosaccharide, Lacto-N-neotetraose.  Further characterization of the 
Enterobacteriaceae inoculum before and after fermentation could determine the microbes 
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associated with the catabolism of the added glycans.  This knowledge could be used to 
understand which pathogenic Enterobacteriaceae in the gastrointestinal tract may proliferate in 
the presence of prebiotics or human milk oligosaccharides.  
 The research presented in Chapters 2 & 3 highlights the challenges researchers 
experience when feeding fermentable substrates to microbial communities.  Future feeding trials 
should focus on distinguishing which microbes are directly or indirectly responding to prebiotic 
supplementation.  These interactions can be explored through analysis of the metagenome.  With 
metagenomics, it is possible to identify which gene pathways are up- or downregulated in 
response to prebiotics supplementation.  A time course evaluation of an ex vivo fecal community 
could begin to uncover the intricate time-dependent shifts in the microbial population.  
Connecting this information with alterations in gene content can begin to answer the questions of 
which microbes provide the enzymatic capacity to the system.  These studies can assist 
identification of the indirect factors that lead to the observed increase in lactobacilli following 
galactooligosaccharides and polydextrose supplementation. 
 In Chapter 4, I demonstrated that autoaggregation in Cronobacter sakazakii ATCC 29544 
is mediated by direct interactions between the flagella of neighboring bacteria.  It is not known if 
autoaggregation in C. sakazakii ATCC 29544 contributes to its ability to form biofilms or 
colonize the gastrointestinal tract.  Based on the breath of literature, determination of its impact 
on biofilm formation would be quite straightforward.  I would suggest testing biofilm formation 
on stainless steel and a variety of plastics, including polyvinyl chloride and polyurethane enteral 
feeding tubes.  This knowledge can assist the development of novel methods to disrupt or 
prevent autoaggregation promoted biofilm formation.  Furthermore, animal models can be 
utilized to analyze if autoaggregation in C. sakazakii ATCC 29544 is required for colonization of 
 172 
 
the gastrointestinal tract.  I would propose that neonatal piglets would be an appropriate model to 
answer these questions.  I can use my experience from Chapter 5 to design and develop a 
colonization or infection C. sakazakii piglet model.  With this model, I can assess whether 
autoaggregating C. sakazakii ATCC 29544 have a competitive advantage over 
nonautoaggregating variants.  For a broader impact, these studies can provide needed 
information into the pathogenesis of C. sakazakii.  Additionally, a surveillance study of 
autoaggregation in several strains of C. sakazakii can identify if this colonization strategy is 
utilized by all strains of C. sakazakii or if it’s unique to C. sakazakii ATCC 29544 and closely 
related strains.  
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APPENDIX A 
CHAPTER TWO SUPPLEMENTAL TABLES AND FIGURES 
Table A.1.  Carbohydrate utilization of the lactobacilli isolated from piglets fed formula 
(FORM), formula supplemented with GOS and PDX (F+GP).
1
 
 
FORM  F+GP 
 Glucose GOS PDX  Glucose GOS PDX 
Ileum        
 Low Utilization
2
 2.3 4.7 51.2  7.3 12.2 58.5 
 
Moderate Utilization 4.7 14.0 48.8  2.4 0.0 41.5 
 
High Utilization 93.0 81.4 0.0  90.2 87.8 0.0 
 
Relative Utilization 
to Glucose
3
 
100 87.5 0.0  100 97.3 0.0 
Ascending Colon        
 
Low Utilization 10.7 10.7 89.3  10.9 10.9 84.8 
 
Moderate Utilization 0.0 12.5 10.7  0.0 26.1 15.2 
 High Utilization 89.3 76.8 0.0  89.1 63.0 0.0 
 
Relative Utilization 
to Glucose 
100 86 0.0  100 70.7 0.0 
1
 Data presented as percent utilizers. 
2
 Utilization defined as low: OD<0.4, moderate: 0.4>OD<0.7 and high: OD>0.7. 
3
 Percent of isolates capable of utilization of glucose in vitro under the chosen conditions.  
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Table A.2.  Genera of ascending colon contents of 21d old piglets fed formula (FORM), formula 
supplemented with GOS and PDX (F+GP).
1 
 Diets 
 FORM 
 
F+GP 
 
ANOVA 
 Mean SEM 
 
Mean SEM 
 
p-value 
Catabacter 0.07 0.02 
 
0.01 0.01 
 
< 0.01 
Hydrogenanaerobacterium 0.97 0.23 
 
0.25 0.11 
 
0.02 
Lactobacillus 0.06 0.02 
 
0.71 0.44 
 
0.04 
Oscillospira 6.45 2.18 
 
1.59 0.57 
 
0.04 
Parabacteroides 8.67 2.22 
 
18.33 3.98 
 
0.04 
Ruminococcus 9.54 2.37 
 
4.13 1.06 
 
0.03 
1 
Genera included in analysis had a False Discovery Rate (FDR) < 0.1, data expressed as percent 
relative abundance.  
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Table A.3.  Lactobacilli detected in ileum and ascending colon of 21d old piglets fed formula 
(FORM), formula supplemented with GOS and PDX (F+GP) or sow-reared (SOW) as 
determined by 16S amplicon sequencing
 1,2
 
 
Ileum  Ascending Colon 
 FORM F+GP SOW  FORM F+GP SOW 
L. agilis 0.7 0.5    1.1  
L. amylovorus 5.3 0.5 14.3   0.6 23.6 
L. coleohominis
3
   0.7   0.6 0.3 
L. crispatus
3
      <0.1  
L. curvatus
3
 0.4 0.8      
L. delbrueckii
3
 1.0 0.9 0.8    1.0 
L. equicursoris
3
 0.5 0.1 0.8     
L. fermentum
3
  0.1      
L. gasseri
3
  0.6      
L. johnsonii 19.2 31.8 29.8  60.9 22.5 36.3 
L. mucosae 43.6 33.4 6.4  26.3 8.0 2.6 
L. pentosus
3
 0.4       
L. plantarum 15.4 0.9      
L. pontis
3
 0.1 0.1      
L. reuteri 1.6 7.6 17.0   1.0 3.1 
L. rogosae     4.3  0.3 
L. ruminis
3
   0.3     
L. salivarius
3
 0.1 0.2      
L. taiwanensis
3
      0.3  
L. vaginalis 7.3 20.4 1.0  5.9 0.3  
Lactobacillus sp. 4.4 2.1 29.0  2.5 65.4 32.8 
1
 Data presented as percent relative abundance. 
2
 Non-detected lactobacilli represented by blank cells. 
3
 Aggregated as Minor Lactobacillus sp in Figure 2.4.  
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Figure A.1.  Ileal microbial communities of 21-d-old piglets fed either a bovine milk-based 
formula (FORM), formula supplemented with GOS and PDX (F+GP) or were sow-reared 
(SOW).  Heat map illustrates the relative abundances of top 20 genera detected in the ileal 
contents.  Hierarchical clustering of unweighted Unifrac distances is represented by the 
dendrogram.  
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Figure A.2.  Ascending colon microbial communties of 21-d-old piglets fed either a bovine 
milk-based formula (FORM), formula supplemented with GOS and PDX (F+GP) or were sow-
reared (SOW).  Heat map illustrates the relative abundances of top 35 genera detected in 
ascending colon contents.  Hierarchical clustering of unweighted Unifrac distances is represented 
by the dendrogram. 
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APPENDIX B 
CHAPTER THREE SUPPLEMENTAL FIGURES 
 
 
Figure B.1.  Lag time, hr, achieved on 1% fermentable substrate (glucose, lactose or maltodextrin) or 1% fermentable substrate 
supplemented with 1% HMO (2’-fucosyllactose (2’-FL), 6’-sialyllactose (6’-SL), lacto-N-neotetraose (LNnT)) in ZMB-1 media.  
Blank is corrected by subtraction of wells containing no cells and no carbohydrate.  Statistical significance determined by ANOVA 
using Dunnett’s test; *p<0.1, **p<0.05, ***p<0.005.  Average of three or more independent experiments.  
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Figure B.2.  Doubling time, hr, achieved on 1% fermentable substrate (glucose, lactose or maltodextrin) or 1% fermentable substrate 
supplemented with 1% HMO (2’-fucosyllactose (2’-FL), 6’-sialyllactose (6’-SL), lacto-N-neotetraose (LNnT)) in ZMB-1 media.  
Blank is corrected by subtraction of wells containing no cells and no carbohydrate.  Statistical significance determined by ANOVA 
using Dunnett’s test; *p<0.1, **p<0.05, ***p<0.005.  Average of three or more independent experiments.  
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Figure B.3.  Max deltaOD, 600nm, achieved on 1% fermentable substrate (glucose, lactose or maltodextrin) or 1% fermentable 
substrate supplemented with 1% HMO (2’-fucosyllactose (2’-FL), 6’-sialyllactose (6’-SL), lacto-N-neotetraose (LNnT)) in ZMB-1 
media.  Blank is corrected by subtraction of wells containing no cells and no carbohydrate.  Statistical significance determined by 
ANOVA using Dunnett’s test; *p<0.1, **p<0.05, ***p<0.005.  Average of three or more independent experiments. 
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APPENDIX C 
CHAPTER FOUR SUPPLEMENTAL VIDEOS 
Video C.1.  Autoaggregation of stationary phase Cronobacter sakazakii and nonautoaggregating 
clonal variant cultures captured by time lapse video.  Autoaggregation tube assays in BHI broth, 
vortexed and held statically at room temperature for 1 h.  Still images were taken every 10 s by a 
stationary DSLR camera with an intervalometer.  Images (360 frames) were stitched together to 
create a video file with 24 frames/s. 
Video C.2.  Autoaggregation of stationary phase Cronobacter sakazakii cultures in the presence 
of harvested wild-type flagella captured by time lapse video.  Autoaggregation tube assays in 
BHI broth containing FliC filaments (5, 10 & 20 μg/mL), bovine serum albumin (BSA, 
20μg/mL), and protein storage buffer (PSB, no protein control), vortexed and held statically at 
room temperature for 6 h.  Still images were taken every 20 s by a stationary DSLR camera with 
an intervalometer.  Images (1080 frames) were stitched together to create a video file with 72 
frames/s.
 182 
 
APPENDIX D 
ADDITIONAL RESEARCH CONTRIBUTIONS 
 
 
Figure D.1.  This research article was the result of collaboration that explored which 
phosphotransferase system transporters were involved in the utilization of lactose in 
Lactobacillus gasseri.  Three putative lactose transporters (PTS 6, 8 & 9) were identified through 
transcript expression analysis and removal of all three transporters resulted in a L. gasseri strain 
unable to utilize lactose. This project was initially submitted with characterization of only PTS 6 
& 8 and was returned for additional experiments.  My primary contributions were to assist 
construction of the PTS 9 knockout in L. gasseri (wild-type, 6, 8, 6/8 double gene replacement), 
transcript analysis confirming upregulation of PTS 9 in PTS 6 & 8 deficient strains, conduct 
bacterial growth experiments with select carbohydrates, including lactose, determination of 
bacterial growth parameters with an in-house MATLAB
®
 script, and revision of the manuscript 
for re-submission. 
 
Francl AL, Hoeflinger JL, Miller MJ. (2012) Identification of lactose phosphotransferase 
systems in Lactobacillus gasseri ATCC 33323 required for lactose utilization. Microbiology 
158(Pt 4):944-952.  
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Figure D.2.  This research article was the result of a collaboration that evaluated the changes in 
the fecal microbiota composition of overweight and obese men following consumption of 
soymilk for three months.  Soymilk consumption was associated with a beneficial shift 
(decrease) in Firmicutes to Bacteroidetes ratio.   Additionally, Lactobacillus abundance 
decreased with consumption of soymilk; whereas, Bacteroides-Prevotella abundance increased 
with consumption of all milks.  My primary contributions involved developing procedures for 
collection and processing of fecal samples, extraction of DNA from feces for microbial analysis, 
quantification of bacterial groups by qPCR, data analysis and figure preparation, and 
composition of the manuscript. 
 
Fernandez-Raudales D*, Hoeflinger JL*, Bringe NA, Dowd S, Miller MJ, Gonzalez de Mejia E. 
(2012) Consumption of different soymilk formulations differentially affects the gut microbiomes 
of overweight and obese men. Gut Microbes 3(6):1-11. *Co-Authors  
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Figure D.3.  This research article was the result of a collaboration that investigated the potential 
hydrolytic capability of rat cecal microbes ex vivo.  Detectable isothiocyanates were observed 
following consumption of broccoli for one or two weeks as compared to no broccoli controls.  
Additionally, isothiocyanate formation was not detected in glucosinolate-free broccoli 
demonstrating that isothiocyanates formation was not promoted by other broccoli components, 
i.e. fiber.  My contributions included designing and conducting the ex vivo experiments, analysis 
of data and assistance with the preparation of the manuscript. 
 
Angelino D, Dosz EB, Sun J, Hoeflinger JL, Van Tassell ML, Chen P, Harnly JM, Miller MJ, 
Jeffery EH. (2015) Myrosinase–dependent and –independent formation and control of 
isothiocyanate products of glucosinolate hydrolysis. Front Plant Sci 6:831.  
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Figure D.4.  This research article was the result of a collaboration that developed and 
implemented an open-source regression script in the Python
 
language.  Experiments utilizing a 
previous MATLAB
®
 script were included in Chapter 3 and the cited poster listed below.  My 
main contributions were assistance in the development of the scripts, providing test bacterial 
growth data sets, data analysis of script output, preparation of the poster and manuscript. 
 
Hoeflinger JL, Hoeflinger DE, Miller MJ. (2014) A dynamic regression analysis for quantitative 
assessment of bacterial growth. Poster #174-17. Presented at the Institute of Food Technologists 
Annual Meeting on June 23, 2014, New Orleans, LA. 
 
Hoeflinger JL, Hoeflinger DE, Miller MJ. (2017) A dynamic regression analysis for quantitative 
assessment of bacterial growth written in Python. J Microbiol Methods 132:83-85. 
